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List of Acronyms and Abbreviations 
In this document the abbreviations and acronyms most commonly 
used in organic chemistry have been used, according to the 




















DFT Density Functional Theory 
DIPE Diisopropyl ether 
DMAP 4-(Dimethylamino)pyridine 
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DMC Dimethyl Carbonate 




DPP Diphenylphosphoric Acid 
dr Diastereomeric Ratio 
ESI Electrospray Ionization 
ee Enantiomeric Excess 
FID Flame Ionization Detector 
Fmoc 9-Fluorenylmethoxycarbonyl 
GABA -Aminobutyric Acid 
GC Gas Chromatotraphy 
HPLC High Performance Liquid Chromatography 
HRMS High-Resolution Mass Spectrometry 
IR Infrared 
L-DOPA (S)-3’,4’-Dihydroxyphenylalanine 
m-CPBA meta-Chloroperoxybenzoic Acid  
MAA Methyl (N)-(acetylamino)acrylate 
MeTHF 2-Methyltetrahydrofuran 
MOM Methoxymethyl 
MsOH Methanesulfonic Acid 
mp Melting Point 




UNIVERSITAT ROVIRA I VIRGILI 





NMR Nuclear Magnetic Resonance 
ORTEP Oak Ridge Thermal Ellipsoid Plot Program 
RT Room Temperature 
SPS Solvent Purification System 
Tfb Tetrafluorobarrelene 
TFA Trifluoroacetic Acid 
TFE Trifluoroethanol 
THF Tetrahydrofuran 
TOF Turnover Frequency 
TON Turnover Number 
Tr Trityl 
TS Transition State 
Rf Retention Factor (in chromatography) 
UV Ultraviolet 
TsOH p-Toluenesulfonic Acid 
Z-MAC Methyl (Z)-(N)-acetylaminocinnamate 
°C Degrees Celsius 
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Any living system is a pool of chirality, as most of the chemical 
building blocks of biological systems are present in an enantiopure form.
1
 
For example, all amino acids that constitute the proteins (except the achiral 
amino acid glycine) have an L- or (S)-configured carbon bearing the amino 
and carboxyl substituents. Carbohydrates, which are one of the components 
of nucleic acids, as well as energy storage materials in living organisms, 
belong exclusively to the D-series.
2
 
Enantiomers (or stereoisomers that are non-superimposable mirror 
images of one another) can generally result in four types of relative 
biological effects: 1) The enantiomers have the same biological activity; 2) 
the enantiomers have qualitatively identical biological effects but their 
intensities are different; 3) only one enantiomer is biologically active; 4) 
the two enantiomers have very different biological properties. For 
instance, Iclaprim (Figure 1), which is a drug marketed as a racemate and 
used in the treatment of bacterial infections, is an example where both 
enantiomers exhibit similar activity against the dihydrofolate reductase 
enzyme (DHFR) and a similar antimicrobial activity against a broad range 
of bacteria.
3
 On the other hand, enantiopure (S)-ibuprofen (Figure 1) 
reaches therapeutic concentrations in blood in 12 minutes while racemic 
mixtures require 30 minutes.
4
 (S,S)-ethambutol (Figure 1) is used for the 
treatment of tuberculosis while (R,R)-ethambutol has been found to cause 
blindness.
5
 Even inactive enantiomers, that cause no side effects, have to 
be metabolized by the human organism, which results in an unnecessary 
physiological burden.
6
 Therefore, in pharmacology, enantiopurity is of 
paramount importance, and efficient methods to obtain enantiopure 
substances are required. 
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Figure 1. Selected examples of pharmaceutical active compounds. 
Asymmetric catalysis,
7
 in which each molecule of a chiral catalyst 
produces many molecules of enantioenriched products by being 
continuously regenerated, has significant potential advantages over non-
catalytic methods. The transfer of chirality from the catalyst to the product 
normally occurs in the transition state (TS) of the stereo-determining step 
(Figure 2). When a substrate containing prochiral elements interacts with 
the catalyst, two transition states, namely TSR and TSS, are generated, 
leading to the (R)-configured and (S)-configured product, respectively. The 
activation energy difference (ER vs. ES) between the two TS’s determines 
the enantioselectivity of the reaction, and the pathway with the lower 
activation energy (e.g. ER in Figure 2) will be kinetically dominant. This 
will result in the production of a higher fraction of the enantiomer arising 
from that pathway. 
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Figure 2. Simplified energy diagram for an enantioselective catalytic process. 
Asymmetric biocatalysis, metal-based catalysis, and organocatalysis are 
the three principal areas in the field of asymmetric catalysis.  Many 
achievements have been made in these three domains. Although 
biocatalysis and organocatalysis are very important classes of 
enantioselective catalysts, they are beyond the scope of this thesis and, 
hence, will not be discussed herein.  
Among the different approaches to achieve enantiocontrol, the use of 
enantiopure transition metal-based complexes as homogeneous catalysts is 
one of the most powerful strategies.
8
 Significant progress has been 
achieved in transition metal-based asymmetric catalysis, as made evident 
by the 2001 Nobel Prize in Chemistry awarded to William S. Knowles , K. 




Furthermore, the use of enantiopure transition metal catalysts may 
contribute with several advantages to the chemical transformation, such as 
atom economy in the chemical transformation, simplicity in large scale 
reactions, energy-saving, minimal by-product formation, and due to the 
generally low catalyst loadings, lower cost.
9b
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The critical step in most asymmetric transition metal-based catalytic 
processes is the formation of a supramolecular system around a metal 
center involving the substrate(s), the metal precursor and an enantiopure 
molecule (the chiral ligand). The ligand is generally bound to the metal 
center through several functional groups. In this supramolecular system,  
the metal center provides a low-energy reaction pathway that enables  
catalysis, whereas the enantiomerically pure ligand enables preferential 
recognition of one of the enantiotopic elements of the substrate.  Figure 3 
illustrates a general example of an asymmetric transition metal-based 
transformation. 
 
Figure 3. Schematic representation of a catalytic enantioselective process. 
Ligand tuning has been successfully employed to develop efficient 
catalytic systems for diverse substrates/reagents in a given 
transformation.
10
 The principle in this strategy for developing efficient 
enantioselective catalysts is to design enantiopure ligands that incorporate 
several independent modules or molecular fragments arranged around a 
carbon backbone. Stereogenic elements of different nature are incorporated 
into the molecular fragments and/or modules. Such modules are designed 
to influence the catalytic center: the steric and electronics of the different 
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molecular fragments are considered the input parameters for catalyst 
optimization. Selective modification of these parameters based on 
mechanistic insight, molecular recognition principles, or the intuition of 
chemists themselves has yielded higher-performing catalytic systems in 
terms of conversion, enantioselectivity and/or substrate scope. 
During the last few decades, significant attention has been dedicated to 
the asymmetric hydrogenation of substrates containing prochiral elements 
(e.g. C=C, C=N or C=O double bonds), mostly catalyzed by enantiopure 
Rh-, Ir-, and Ru-coordination compounds (mostly phosphorus-containing 
derivatives). Efficient Rh-, Ir- or Ru-based catalysts have been developed 
for the asymmetric hydrogenation of a structurally diverse array of C=C-, 
C=O- or C=N-containing substrates (Figure 4). Thus, asymmetric 
hydrogenation can certainly be considered as one of the most  reliable 




Figure 4. Rh-, Ir- and Ru-mediated asymmetric hydrogenations. 
Phosphine-phosphite (POP) ligands are one of the examples of non-
symmetric bidendate ligands that differ in the electronic and steric 
properties of their P-binding groups. Since the reports of the seminal 
UNIVERSITAT ROVIRA I VIRGILI 












other related ligands have been described. These POP ligands encompass 
diverse carbon backbones and stereogenic elements as well as different 
distances between the two phosphorus functionalities.
14
 
Our research group has developed a highly modular synthesis for 1,2- 
POP ligands containing two stereogenic carbons between the two 
phosphorus functionalities. The combination of the modular nature of the 
developed 1,2-POP ligands with a ligand-tuning methodology guided by 
computational analysis has led to highly efficient catalytic systems derived 
from 1,2-POP ligands for asymmetric hydrogenation. A series of 1,2 - 
POP ligands based on the use of enantiomerically pure epoxides as 
starting materials (Sharpless epoxy ethers) has been prepared (see Scheme 
1). The ligand synthesis starts with the ring-opening of the epoxide with a 
nucleophilic trivalent phosphorus derivative (Step A, Scheme 1) and 
continued with the O-phosphorylation of the phosphino alcohol 
intermediate with trivalent phosphorus electrophiles ( i.e. a chlorophosphite 
derived from an enantiomerically pure diol; Step B). As regards to Step A 
(Scheme 1), the ring-opening proceeded smoothly at 30 ºC to room 
temperature. The ring-opened product, which proved to be rather prone to 
oxidation, was protected in situ as the corresponding borane adduct in 
order to make handling and storage easier. The corresponding borane 
complexes were isolated in high yield after column chromatography as air-
stable solids.
15
 In Step B, the free phosphino alcohol was obtained by 
cleavage of the borane adduct, using 1,4-diazabicyclo[2.2.2]octane 
(DABCO, 2.2 equiv.) at 60 ºC in toluene for two hours. After removing 
excess of DABCO by a short chromatographic filtration through SiO 2 
under inert atmosphere, the free phosphino alcohol was transformed into  a 
set of POP ligands by derivatization with the required chlorophosphite 
(1.1 equiv.) in the presence of a base (2.0 equiv. of  NEt3). The final POP 
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ligands were obtained in good yields after a careful chromatographic 




Scheme 1. Synthesis of POP ligands from Sharpless epoxy ethers. 
By the commencement of the research work presented in this Thesis, 
efficient POP ligands (see Figure 5) had been developed for Rh-mediated 
asymmetric hydrogenation of functionalized alkenes (Ligands L1, L3 and 
L4)
16a,b,d,e,f 





Figure 5. Highest performing POP ligands for asymmetric hydrogenations. 
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These bidentate POP ligands were able to form stable, well-defined 
cationic rhodium(I) complexes. These complexes were prepared in good 
yields by reacting stoichiometric amounts of the chiral phosphine–
phosphite ligands and [Rh(nbd)2]BF4 in dichloromethane. The desired 
complexes were completely characterized by standard analytical 
techniques (NMR and HRMS). Furthermore, single crystals of the 
complexes suitable for X-ray diffraction were obtained, thereby 
unambiguously confirming a six-membered chelating coordination mode of 
the POP ligands to the Rh center.
16b
 
In the evaluation of the activity and selectivity in rhodium-mediated 
asymmetric hydrogenations, the reactions were performed using rhodium- 
POP complexes generated in situ from 1.0 mol % of [Rh(nbd)2]BF4 and a 
10 mol % excess of the POP ligand with respect to Rh precursor, under 
20 bar H2. Ligand L1, which contained a phosphite group derived from 
(Sa)-BINOL (BINOL = [1,1'-binaphthalene]-2,2'-diol), afforded excellent 
results with complete conversions and up to 99% ee. The ligand L2, whose 
only difference with respect to L1 is the opposite configuration of the 
phosphite group, provides the opposite absolute configuration of the 
hydrogenated product, though with lower enantioselectivit ies. This is an 
indication that the direction of stereo-discrimination in rhodium-mediated 
hydrogenations is predominantly controlled by the binaphthyl group and 
that L1 contains the matched combination of stereogenic elements in the 
structure of the ligand. The ligand L1 proved to be highly efficient in the 
Rh-catalyzed asymmetric reduction of a wide variety of functionalized 
alkenes (see Scheme 2), including -(acylamino)acrylates, itaconic acid 
derivatives and analogues, -substituted enol ester derivatives and -
arylenamides.
16a,b,f
 Furthermore, the “lead” ligand (L1) tolerates a broad 
range of carbamate-type amino-protecting groups (Boc, Cbz, and Fmoc).
16b 
A substrate-to-catalyst ratio (S/C) up to 10000:1 provided fully 
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hydrogenated dimethyl itaconate, with no loss in conversion or 




Scheme 2. Rh-mediated asymmetric hydrogenation of functionalized alkenes. 
In addition to ligand L1, ligand L3 (see Figure 5) incorporating a 
triphenylmethoxy group at the R
1
-oxy position (see Scheme 1) of the 
carbon backbone was also very efficient in the Rh-mediated asymmetric 
hydrogenation of functionalized alkenes, offering slightly higher 
enantioselectivities for particular substrates.
16d,f
 
The highly modular design of the POP ligands enabled the 
optimization of the catalytic systems by modifying the steric and electronic 
properties of the phosphino functionality. Our research group developed a 
convenient synthetic route for the preparation of cationic rhodium 
complexes, in which the PPh2 moiety had been replaced by the electron-
richer PCy2 group. The preformed Rh-precatalyst derived from L4 gave 
excellent enantioselectivities (up to 99% ee) and catalytic activities (>2500 
TON) for a wide array of substrates. Our synthetic methodology was 
successfully applied for the first time to the enantioselective hydrogenation 
of -alkoxy-substituted -(acylamino)acrylate derivatives, which allowed 
the efficient preparation, with total selectivity and perfect 
enantioselectivity (i.e. 99% ee), of an advanced synthetic intermediate of 
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In short, POP ligands L1, L3 and L4 containing (Sa)-configured 
BINOL-derived phosphite groups (Figure 5) proved to be the highest 
performing ligands for the Rh-mediated asymmetric hydrogenation of 
functionalized alkenes with high enantioselectivities (up to >99%) for a 
wide variety of functionalized alkenes. The catalytic systems derived from 
these POP ligands provided straightforward access to enantiomerically 
pure (or highly enantioenriched) -amino acid, carboxylic acid, amine and 
alcohol derivatives that are highly valuable building blocks for the 
preparation of more complex molecules. It is also noteworthy to mention 
that our methodology has been successfully applied to the enantioselective 
synthesis of a number of intermediates of active pharmaceutical 
ingredients (or APIs) by asymmetric hydrogenation.
16d
 
Besides the efficient application of POP ligands in the Rh-mediated 
asymmetric hydrogenation of functionalized alkenes, the group ’s attention 
was also shifted to use the POP ligands in Ir-catalyzed asymmetric 
hydrogenations of C=N-containing derivatives. 
The POP ligands were also able to form well-defined neutral 
iridium(I) complexes [Ir(Cl)(cod)(POP)] by mixing stoichiometric 
amounts of the iridium precursor ([{Ir(μ-Cl)(cod)}2]) and the POP ligand 
(see Scheme 3). Although attempts to isolate these complexes have 
repeatedly been unsuccessful, the in situ generated iridium(I) complexes 
[Ir(Cl)(cod)(POP)] have been successfully used in asymmetric 
hydrogenation of N-containing heterocyclic compounds. 
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Scheme 3. Preparation of [Ir(Cl)(cod)(POP)] complexes derived from 
phosphine-phosphite ligands. 
The catalytic activity and selectivity of such complexes in the 
hydrogenation of N-containing heterocyclic compounds was evaluated. 
Interestingly, the ligand L2 was the best performing ligand in the reduction 
of 2-methylquinoline as model substrate. Several additives were tested for 
the reduction of 2-methylquinoline catalyzed by [Ir(Cl)(cod)(L2)] and, 
remarkably, the addition of 10 mol % of anhydrous HCl facilitated the 
reaction by increasing the conversion.
17a
 
The Ir-precatalyst derived from ligand L2, in combination with catalytic 
amounts of anhydrous HCl, gave excellent enantioselectivities (up to 92% 
ee) in the hydrogenation of a set of structurally diverse quinolines ( 9 
examples). 2-Methyl-substituded quinoxaline was also enantioselectively 
hydrogenated under the same conditions with ligand  L1 to afford the 
hydrogenated compound in 70% ee.
17a 
 
Scheme 4. Ir-(POP) catalyzed asymmetric hydrogenation of N-containing 
heterocyclic compounds. 
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Furthermore, the “lead” precatalyst [Ir(Cl)(cod)(L2)] was also 
successfully employed for the asymmetric hydrogenation of other types of 
C=N-containing heterocyclic compounds.
17b
 Benzoxazines (see Scheme 4 
for the structures) were efficiently hydrogenated with full conversion and 
up to 95% ee in THF at room temperature under 40 bar of H2 using 0.5  
mol % of [Ir(Cl)(cod)(L2)] as the precatalyst (8 examples). In contrast, 
their carbonyl-containing analogs (i.e. benzoxazinones) required higher 
pressure (80 instead of 40 bar H2) and catalyst loadings (2 mol % instead 
of 0.5 mol %). Under such conditions the corresponding hydrogenated 
products were obtained with excellent enantioselectivities (up to 99% ee; 5 
examples). By using the same reaction conditions, benzothiazinone 
derivatives (see Scheme 4 for the structures) were efficiently hydrogenated 
with full conversion and in up to 96% ee (3 examples). Quinoxalinones 
were also efficiently hydrogenated (conversions ranging from 89 to 99%, 
ee values ranging from 90 to 99%, 9 examples) at lower pressure and lower 
catalyst loading than their sulfur containing analogs. Remarkably, the 
catalytic system tolerates diverse substitution patterns at the trivalent 
nitrogen with excellent enantioselectivities (up to 99% ee) : either no 
protecting group or a wide variety of protecting groups, including Me, 
MOM, and Bn substituents. Furthermore, the N-methyl substituted 
derivative was hydrogenated with a catalyst loading as low as 0.05 mol % 




An additional application of the already mentioned iridium-derived 
catalytic system has also been developed for the asymmetric hydrogenation 
of an array of diversely substituted indoles (see Scheme 4 for the 
structures).
17c
 The synthetic strategy required the use of stoichiometric 
amounts of a Brønsted acid to break indole’s aromaticity and facilitate the 
hydrogenation of the indole’s five-membered ring. The optimized 
conditions implied the use of the environmentally friendly solvent 2-
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methyltetrahydrofuran (MeTHF). Unprotected indoles have been 
efficiently converted to enantiomerically enriched indolines (up to 91% ee ; 
6 examples) by a stepwise process: Brønsted acid-mediated C=C 
isomerization followed by the enantioselective hydrogenation of the 
resulting C=N bond using the above mentioned iridium catalyst. The 
research group also developed a “greener” hydrogenation alternative that 
involved the use of reusable heterogeneous additives (solid -supported 
sulfonic acids). Results were comparable to those obtained with the 
homogeneous catalyts derived from ligand L2.
17c
 
As summarized in this introduction, efficient POP ligands containing 
BINOL-derived phosphite fragments had been developed and successfully 
applied by our research group in rhodium- and iridium-mediated 
asymmetric hydrogenations. However, the synthesis of the highest 
performing POP ligands for rhodium- and iridium-mediated asymmetric 
hydrogenations had only been developed for multi -milligram amounts of 
the ligand. Moreover, the developed synthetic protocols involved 
chromatographic purifications that had to be performed in a very careful 
way under inert conditions. We considered that it would be highly 
interesting to develop a practical method for the preparation of rhodium 
complexes of the highest performing POP ligands in gram amounts, as the 
“asymmetric catalytic community” could in this way gain easy access to 
our precatalysts for enantioselective hydrogenations and benefit by 
applying them to their own transformations of interest.  
Iridium-mediated asymmetric hydrogenation studies of C=N-containing 
heterocycles had been restricted by our group to five- and six-membered 
heterocyclic derivatives. Although nitrogenated seven-membered 
heterocyclic motifs with stereogenic centers constitu te an important 
pharmacophore, examples of asymmetric reduction of seven -membered 
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heterocyclic derivatives were scarce in the literature by the commencement 
of the research work presented in this Thesis.  
Furthermore, no reports on the effects of TADDOL-derived phosphite 
groups [TADDOL = (2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(diphenyl-
methanol)] and biaryl-containing phosphite groups with substituents at the 
3 and 3’ positions of the [1,1'-biaryl]-2,2'-diol motif on the 
enantioselectivity of the rhodium- and iridium-mediated hydrogenations 
had been published at the beginning of the research work presented in this 
Thesis. 
Therefore, the general aims of this thesis are:  
1. To optimize and develop a chromatography-free and practical 
preparation method for the best performing [Rh(POP)]
+
 catalysts 
applied in various enantioselective hydrogenative transformations.   
2. To expand the scope of iridium-(POP)-mediated asymmetric 
hydrogenations to new C=N-containing heterocyclic systems (i.e. 
seven-membered C=N-containing heterocyclic systems). 
3. To prepare new POP ligands with TADDOL- and 3,3’-
disubstituted-BINOL-derived phosphite groups and study their 
catalytic performance in iridium- and rhodium-mediated asymmetric 
hydrogenations. 
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Herein is described a practical method of preparing enantiopure 
rhodium(I) complexes that can be used as efficient catalysts for the 
asymmetric hydrogenation of functionalized alkenes, the hydrogenative 
kinetic resolution of vinyl sulfoxides and the desymmetrization of achiral 
dienes. All these rhodium precatalysts incorporate enantiopure phosphine-
phosphite (POP) ligands as stereochemical directors of the hydrogenative 
transformations. The synthetic route starts with the ring -opening of an 
enantiopure Sharpless epoxy ether with a phosphorus nucleophile followed 
by isolation of the borane-protected phosphino alcohol derivative by 
UNIVERSITAT ROVIRA I VIRGILI 







crystallization. The subsequent cleavage of this borane complex, the O-
phosphorylation of the resulting phosphino alcohol with the corresponding 
phosphorus electrophiles (chlorophosphite derivatives), and finally the 
complexation of the in situ generated POP ligands with [Rh(nbd)2]BF4, 
followed by crystallization, rendered the target precatalysts. 
1.2 Introduction 
The regulatory demands and environmental requests faced by the 
chemical and pharmaceutical industries have fueled the application of 
catalytic enantioselective methods for the preparation of biologically 
relevant compounds at the industrial level. Asymmetric hydrogenation can 
be considered a well-established synthetic methodology that has already 
been incorporated into the standard “tool-box” of industrial chemists.
1
 This 
transformation is considered a convenient method for the preparation of 
enantioenriched compounds, as catalytic amounts of a coordination 
compound (mainly Rh, Ru and Ir complexes) incorporating an enantiopure 
ligand (mostly phosphorus-containing derivatives
2
) mediate the addition of 
dihydrogen to prochiral CC, CN or CO bonds with high yields and 
enantioselectivities.
3
 Furthermore, hydrogenation reactions can easily be 
scaled up at an industrial level as chemical companies have developed safe 
hydrogenation protocols.
1a
 Despite the remarkably advanced state of the 
field, research efforts are still directed towards catalytic systems with 
higher activity and stereoselectivity. In other cases, researchers seek to 
improve the industrial profile of hydrogenation catalysts by developing 
easier preparation methods and by making sure they do not fall within the 
claims of any patent currently in force.  
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1.3 Results and Discussion 
Our group has previously developed an array of structurally diverse 
POP ligands based on the use of enantiomerically pure Sharpless epoxy 
ether 1 as a starting material, which is transformed into the final ligands in 
two steps: ring-opening of the epoxide with a nucleophilic trivalent 
phosphorus derivative (Step A, Scheme 1) followed by O-phosphorylation 
of the phosphino alcohol intermediate with trivalent phosphorus 
electrophiles (i.e. a chlorophosphite derived from an enantiomerically pure 
diol; Step B, Scheme 1). As regards Step A (Scheme 1), the ring-opening 
proceeded smoothly at 30 ºC to room temperature. The ring-opened 
product, which proved to be rather prone to oxidation, was protected in 
situ as the corresponding borane adduct 2 in order to make handling and 
storage easier. Borane complex 2 was isolated in high yield after column 
chromatography as a crystalline
4
 and air-stable solid. In Step B (Scheme 
1), the free phosphino alcohol was obtained by cleavage of the borane 
adduct 2, using 1,4-diazabicyclo[2.2.2]octane (DABCO, 2.2 equiv.) at 60 
ºC in toluene for two hours.
5
 After removing excess DABCO by a short 
chromatographic filtration through SiO2 under an inert atmosphere, the 
free phosphino alcohol was transformed into POP ligands by 
derivatization with the required chlorophosphite (1.1 equiv.) in the 
presence of a base (2.0 equiv. of NEt3).
5
 The final POP ligands were 
obtained in good yields after a careful chromatographic purification over 
neutral Al2O3 under an inert atmosphere.
6
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Scheme 1. Conventional synthetic strategy for the preparation of POP ligands. 
We have also demonstrated the general ability of POP ligands to form 
suitable rhodium(I) precatalysts for hydrogenative reactions by reacting 
ligands 3 and [Rh(nbd)2]BF4 (nbd = norbornadiene).
6c,d,g,h
 The  
[Rh(nbd)(POP)]BF4 complexes were quantitatively formed in solution 
and could be isolated, if desired, by crystallization. For the sake of 
convenience, we have almost exclusively performed the asymmetric 
hydrogenations using [Rh(nbd)(POP)]BF4 complexes, which had been 
generated in situ from [Rh(nbd)2]BF4 and a 10 mol % excess of the the 
POP ligand 3, with respect to rhodium precursor. 
Interestingly, POP-based rhodium precatalysts 4ac efficiently 
mediated three different types of hydrogenative transformations providing 
high catalytic activities and enantioselectivities (up to 99% ee, Scheme 2). 
These transformations encompass the hydrogenation of functionalized 
alkenes
6
 (see structure 5 in Scheme 2), the hydrogenative kinetic 
resolution of racemic vinyl sulfoxides
7
 (substrates 7 in Scheme 2) and the 
hydrogenative desymmetrization of achiral dienes
8
 (substrates 9 in Scheme 
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2). Taking these results into account, we considered that by developing a 
practical method for the preparation of complexes 4ac in gram amounts, 
the “asymmetric catalytic community” could gain  easy access to our 
precatalysts for enantioselective hydrogenations and benefit by applying 
them to their own transformations of interest. Thus, we describe herein our 
efforts to develop and optimize a practical preparation method for rhodium 
precatalysts 4ac. 
 
Scheme 2. Lead POP-based rhodium precatalysts for enantioselective hydrogenative 
transformations. 
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For the optimization of the ring-opening step (Step A in Scheme 1), we 
took advantage of the crystallinity of compound 2 and developed 
crystallization conditions for isolating the target compound.  
Research activities in this field within this PhD thesis have allowed 
for the growth of single crystals of phosphine-borane alcohol 2 and 
analysis of its structure by X-ray diffraction. These studies have confirmed 
previously published results
9
 on the regio- and absolute stereo-chemistry 
of the products derived from the ring-opening of trans-epoxides: anti-
arrangement of the hydroxyl and phosphino functionalities, arising from a 
stereospecific SN2 epoxide ring-opening (inversion of the absolute 
configuration at the attacked carbon, and retention at the other one). This 
recently obtained crystallographic information is included herein and can 
be found in the Experimental Section. Thus, ring-opening was basically 
performed under the same conditions as those previously used in the group 
(molar ratio of KPPh2:1:BH3 = 1:1.02:3).
4,6a
 After an aqueous work-up of 
the reaction mixture, product 2 was extracted, dried and recrystallized 
from a n-hexane:EtOAc mixture (see Experimental Section for details). 
The solution containing product 2 was filtered while hot and the product 
was isolated as a crystalline material after leaving it standing at 5 ºC for a 
few hours (86% yield). Both the yield and the spectroscopic data were in 
agreement with those previously reported
4,6a,6b
 using the usual synthetic 
protocol
6ag
 that involves a chromatographic purification over SiO 2 (80% 
average yield for 6 experiments).  
Next, we envisaged that the preparation of the target rhodium 
precatalysts 4ac could be accomplished in three consecutive synthetic 
steps starting from the borane-protected phosphino alcohol 2 (Scheme 3): 
first, borane cleavage; second, O-phosphorylation; and last, complexation 
with [Rh(nbd)2]BF4 as the metal precursor, where we planned to use this 
rhodium derivative as the limiting reagent of the synthetic sequence. We 
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also decided to perform these three steps with no chromatographic 
separation as we expected to be able to isolate complexes 4ac by 
crystallization. 
 
Scheme 3. Preparation of [Rh(nbd)(POP)]BF4 complexes 4ac. 
Regarding borane cleavage, the free phosphino alcohol was 
quantitatively obtained by deprotection of 2 using DABCO (2.0 equiv.) in 
toluene at 60 ºC for 2 hours. The in situ generated phosphino alcohol was 
subsequently derivatized by treatment with the corresponding 
chlorophosphites (1.1 equiv.). In particular, for the chlorophosphites 
leading to rhodium complexes 4a and 4b, no additional base was required 
for achieving complete O-phosphorylation. DABCO, which was present in 
excess in the reaction media from the borane-cleavage step, sufficed for 
quantitatively mediating the reaction between the free phosphino alcohol 
and the chlorophosphite. However, the reaction of the free 
diphenylphosphino alcohol with the chlorophosphite leading to 4c 
proceeded in THF at a slower rate and required the addition of a base 
(NEt3, 20 equiv. with respect to the chlorophosphite) and catalytic amounts 
of N,N-dimethylpyridin-4-amine (DMAP, 5 mol %).
10
 In all cases, the  
O-phosphorylation reactions were monitored by 
31
P NMR spectroscopy in 
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order to optimize the reaction times (see experimental procedures for 
details). 
The O-phosphorylation reaction mixtures toward complexes 4a and 4b 
were filtered through a short SiO2 pad. The resulting material was allowed 
to react with [Rh(nbd)2]BF4 (ca. 0.98 equiv. with respect to the amount of 
POP ligand, which was roughly estimated by integration of the 
31
P NMR 
spectra). The Rh-(POP) complexes 4a and 4b were isolated by 
crystallization in 77% and 95% overall yield respectively (referring to the 
amount of Rh-precursor). For the preparation of complex 4c, a slightly 
modified procedure was followed. In this case the ligand was purified by 
crystallizing most of the P-containing impurities out of the solution after 
removing the solvents from the O-phosphorylation step. A complexation 
process analogous to that previously described was then followed (52% 





H} NMR spectra of 4ac showed two sharp doublets of 
doublets at around 29 ppm (phosphino group) and 135 ppm (phosphite 
group) for each rhodium complex. The multiplicity of phosphorus signals 




Rh coupling (average 
1
JP-Rh ≈ 266 Hz for 
phosphite and 
1







JP-P ≈ 68 Hz). The rest of the NMR data and HRMS 
measurements unequivocally confirmed the structure of rhodium 
complexes 4ac. 
1.4 Experimental Section 
All manipulations and reactions were run under inert atmosphere using 
anhydrous solvents in either a glove box or with standard Schlenck -type 
techniques. All solvents were dried by using a Solvent Purification System 
(SPS). 
1




H} NMR chemical shifts are quoted in ppm 
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H} NMR chemical shifts are quoted in ppm relative to  
BF3·OEt2 in CDCl3. High resolution mass spectra (HRMS) were recorded 
by using the ESI ionization method in positive mode. Melting points were 
measured in open capillaries and are uncorrected.  
Preparation of 2. A solution of KPPh2 in THF (15.7 mmol, 31.4 mL of 
a 0.5 M solution) was added dropwise under Ar to a 
cooled solution (30 ºC) of 1 (16.0 mmol, 2.623 g) in 
dry THF (50 mL). The mixture was stirred for 1  h at 
this temperature and then slowly allowed to reach rt 
and stirred for one additional hour. The mixture was 
then cooled at 10 ºC and BH3•THF (47.0 mmol, 47 mL of a 1 M solution) 
was added dropwise. The mixture was stirred for 1h at this temperature and 
then allowed to reach rt and stirred for one further hour. The reaction 
mixture was quenched with water (50 mL) and the two phases were 
separated. The aqueous phase was extracted with EtOAc (3 × 50 mL). The 
combined organic phases were washed with brine (2 × 50 mL), dried over 
MgSO4 and concentrated under reduced pressure. The resulting residue 
was re-dissolved in n-hexane:EtOAc (70:30, 75 mL, 10.9 mL per gram of 
crude mixture) while heating at 50 ºC. The solution was filtered while hot 
and allowed to stand overnight at 5 ºC. A white solid was formed, which 
was filtered, washed with hot n-hexane and dried in vacuo (3.826 g, 10.50 
mmol, 66.9% yield). The mother liquors were concentrated in vacuo and 
the crystallization process was repeated in n-hexane:EtOAc (70:30, 25 mL, 
12.4 mL per gram of crude mixture). The second fraction of compound 2 
was obtained (1.106 g, 3.04 mmol, 19.3% yield). mp 108110 °C (reported 
value:
6a
 117.1117.6 ºC); [α]D
25
 = 147.3 (c 0.1, CHCl3) (reported value:
6a
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 = 154.2; c 1.0, CHCl3). Spectroscopic data were in agreement with 
the reported ones.
6a 
Single crystal X-ray analysis of compound 2 
X-ray Data: Single crystals of enantiopure compound 2 suitable for X-
ray diffraction analysis were grown by slow diffusion of n-hexane into an 
EtOAc solution of the compound at room temperature. 
Data collection: Crystal structure determination for 2 was carried out 
using a Apex DUO Kappa 4-axis goniometer equipped with an APPEX 2 
4K CCD area detector, a Microfocus Source E025 IuS using Mo K 
radiation, Quazar MX multilayer Optics as monochromator and a Oxford 
Cryosystems low temperature device Cryostream 700 plus (T = 173 °C). 
Full-sphere data collection was used with  and  scans. Programs used: 
Data collection APEX-2,
11
 data reduction Bruker Saint,
12




Structure Solution and Refinement: Crystal structure solution was 
achieved using direct methods as implemented in SHELXTL
14  
and 
visualized using the program XP. Absolute configuration was determined 
based on the Flack parameter.
15
 Missing atoms were subsequently located 
from difference Fourier synthesis and added to the atom list. Least -squares 
refinement on F2 using all measured intensities was carried out using the 
program SHELXTL. All non-hydrogen atoms were refined including 
anisotropic displacement parameters.  
Crystal data for 2: C22H26BO2P, Mw = 364.21; monoclinic; space 
group P21, a = 9.3550(7) Å, b = 33.043(3) Å, c = 13.5151(11) Å,  = 
107.899(2)°, V = 3975.6(5) Å³, Z = 8, cal = 1.217 Mg/m³,  = 0.151 mm
-1
, 
52980 reflections were collected of which 20660 are unique (Rint = 
0.0572), 18650 Fo > 4 (Fo), 1003 refined parameters, R1 [I > 2(I)] = 
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0.0554, wR2 [I > 2(I)] = 0.1304, Flack parameter: 0.06(6), Goodness of 
fit on F2 = 1.077, maximum residual electron density 0.553 (–0.326) e Å³. 
CCDC 931317 contains the supplementary crystallographic data for 2. This 
data can be obtained free of charge from The Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 1. X-ray structure of 2 (ORTEP drawing showing thermal ellipsoids at 50% 
probability). Non-relevant hydrogen atoms have been omitted for clarity.  
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Synthesis of 4a. The phosphino-borane adduct 2 (1.046 g, 2.87 mmol) 
was azeotropically dried with 16 mL of toluene. 
DABCO (0.724 g, 6.45 mmol) was added to the 
residue and after three freeze-and-thaw cycles 
under Ar, 18 mL of toluene were syringed into 
the Schlenk tube containing compound 2 and 
DABCO. The solution was stirred for 2 h at 60 
ºC. The residue was left to cool down to rt and a 
freshly prepared solution of the chlorophosphite
16
 (1.108 g, 3.16 mmol, 36 
mL of toluene) was added dropwise to the previous solution. The reaction 
mixture was left to stir for 15 h at rt. The reaction mixture was filtered 
through a short, dry, deoxygenated SiO2 pad (5 mL) and the SiO2 
subsequently washed with dry toluene (2 × 6.0 mL). The filtrate was 
collected in a Schlenk flask under inert atmosphere and concentrated in 
vacuo to obtain a spongy white solid that corresponded to the raw 
phosphine-phosphite ligand (1.554 g, ca. 2.10 mmol, ca. 90% purity by 
integration of the signals of the ligand with respect to the rest of the 
signals in the 
31
P NMR spectrum). A freshly prepared solution of the raw 
phosphine-phosphite ligand (1.554 g, ca. 2.10 mmol, 16 mL of 
dichloromethane) was slowly added to a solution of [Rh(nbd)2]BF4 (0.762 
g, 2.04 mmol, 12 mL of dichloromethane) and stirred at rt for 4 h. After 
this period of time, 75% of the solvent amount was evaporated off in 
vacuo. Anhydrous Et2O (24 mL) was carefully layered onto the remaining 
solution of the complex. With gradual stirring of the solution, an orange 
solid was formed. The mother liquors were filtered off and the residue was 
washed with anhydrous Et2O (2 x 10 mL) and dried in vacuo to afford 1.49 
g (1.57 mmol, 77% overall yield with respect to [Rh(nbd)2]BF4) of 
complex 4a as an orange powder. mp 207209 °C; [α]D
25
 = 13.0 (c 0.1, 
THF). Spectroscopic data were in agreement with the reported ones.
6b 
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Synthesis of 4b. The same protocol as for 4a was used, with the 
following amounts of reagents (solvent amounts were adapted so that 
concentrations were the same): compound 2 (1.578 g, 4.33 mmol), DABCO 
(1.042 g, 9.29 mmol), chlorophosphite
17
 (2.54 g, 4.97 mmol) and 
[Rh(nbd)2]BF4 (1.084 g, 2.90 mmol). A spongy white solid that 
corresponded to the raw phosphine-phosphite ligand (2.74 g, ca. 2.96 
mmol, ca. 89% purity by integration of the signals of the ligand with 
respect to the rest of the signals in the 
31
P NMR spectrum) was obtained. 
After following a crystallization process identical to that described above, 
3.06 g (2.76 mmol, 95% overall yield with respect to [Rh(nbd) 2]BF4) of 
complex 4b as an orange powder were obtained. mp 224.3226.3 °C; [α]D
25 
= 52.7 (c 0.12, THF). 
1
H NMR (400 MHz, CD2Cl2): δ = 8.028.00 (m, 
2H, Harom), 7.857.82 (m, 2H, Harom), 7.727.30 (m, 14H, Harom), 
7.197.03 (m, 5H, Harom), 6.716.61 (m, 4H, Harom), 5.95 (bs, 1H, =CH 
vinylic, nbd), 5.41 (bs, 1H, =CH vinylic, nbd), 4.77 (bs, 1H, =CH vinylic, 
nbd), 4.42 (bs, 1H, =CH vinylic, nbd), 4.18 (bs, 1H, CH allylic, nbd), 3.88 
(bs, 1H, CH allylic, nbd), 3.833.70 (m, 2H, CH-PPh2 and CH-OPO), 
3.072.92 (m, 7H, OCH3 and 2 x CH2 o-Ph-H8-BINOL), 2.802.61 (m, 3H, 
CHH-OMe and 1 x CH2 o-Ph-H8-BINOL), 2.492.36 (m, 3H, CHH-OMe 





H} NMR (125 MHz, CD2Cl2) δ = 142.20 (Cq arom), 
142.16 (Cq arom), 141.9 (Cq arom), 141.8 (Cq arom), 139.35 (Cq arom), 139.34 
(Cq arom), 138.38 (Cq arom), 138.37 (Cq arom), 137.2 (Cq arom), 137.10 (Cq arom), 
137.09 (Cq arom), 136.5 (Cq arom), 136.2 (Cq arom), 135.4 (CH  arom), 135.3 (CH 
arom), 132.6 (Cq arom), 132.2 (Cq arom), 131.85 (Cq arom), 131.82 (Cq arom), 
131.6 (CH  arom), 131.54 (CH  arom), 131.48 (CH  arom), 131.44 (CH  arom), 
131.40 (CH  arom), 131.35 (CH  arom), 131.27 (CH  arom), 130.3 (CH  arom), 129.8 
(CH  arom), 129.65 (CH  arom), 129.57 (CH  arom), 129.3 (CH  arom), 128.8 (CH  
arom), 128.7 (CH  arom), 128.6 (CH  arom), 128.4 (CH  arom), 128.0 (CH  arom), 
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127.94 (CH  arom), 127.92 (CH  arom), 127.4 (CH  arom), 126.2 (Cq arom), 125.8 
(Cq arom), 103.7 (=CH vinylic, nbd), 100.6 (d, J = 12.3 Hz, =CH vinylic, 
nbd), 93.1 (=CH vinylic, nbd), 79.8 (=CH vinylic, nbd), 75.4 (dd, J = 6.1 
Hz, CH-OPO), 72.4 (CH2 nbd), 69.8 (dd, J = 8.8 Hz, CH2-OMe), 58.2 
(OCH3), 55.6 (CH allylic, nbd), 55.3 (CH allylic, nbd), 42.0 (d, J = 28.7 
Hz, CH-PPh2), 29.3 (CH2), 29.2 (CH2), 27.8 (CH2), 27.7 (CH2), 22.6 




H} NMR (202 MHz, 
CD2Cl2): δ = 130.3 (dd, J = 263.8, 69.7 Hz, PO), 23.7 (dd, J = 146.0, 













 calcd for C61H58O4P2Rh: 1019.2860; found: 1019.2865. 
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Synthesis of 4c. The same experimental protocol as for 4a was used, 
with the following amounts of reagents (solvent 
amounts were adapted so that concentrations 
were the same): compound 2 (2.475 g, 6.80 
mmol), DABCO (1.675 g, 14.95 mmol), 
chlorophosphite
18
 (3.98 g, 7.50 mmol) and 
[Rh(nbd)2]BF4 (0.690 g, 1.85 mmol). 
Additionally, the following changes to the original recipe were made. After 
the borane cleavage, the solvent was removed and substituted by THF (135 
mL). NEt3 (19 mL, 136 mmol) and DMAP (0.415 g, 0.34 mmol) were 
added to the reaction mixture under N2. A spongy white solid that 
corresponded to the raw phosphine-phosphite ligand (2.715 g, ca. 1.83 
mmol, ca. 58% purity by integration of the signals of the ligand with 
respect to the rest of the signals in the 
31
P NMR spectrum) was obtained 
after precipitating (40 mL, n-hexane:Et2O 75:25) and filtering out P-
containing impurities (this precipitation/filtration process was repeated 
twice). The rhodium complex obtained as indicated for 4a was 
recrystallized by layering n-hexane (15 mL) onto a solution of the complex 
in DCM (5 mL). Compound 4c was isolated as an orange powder (1.07 g, 
0.95 mmol, 52% overall yield with respect to [Rh(nbd) 2]BF4) after 
filtering, washing with anhydrous Et2O (2 x 10 mL) and drying in vacuo. 
mp 182185 °C; [α]D
27
 = 324.0 (c 0.10, THF). 
1
H NMR (500 MHz, 
CD2Cl2): δ = 7.947.90 (m, 2H, Harom), 7.827.78 (m, 1H, Harom), 
7.727.69 (m, 2H, Harom), 7.597.40 (m, 14H, Harom), 7.337.13 (m, 10H, 
Harom), 7.056.99 (m, 4H, Harom), 6.646.60 (m, 2H, Harom), 6.16 (bs, 1H, 
=CH vinylic, nbd), 5.46 (d, J = 8.0 Hz, 1H, OCH-CHO, TADDOL), 5.33 
(bs, 1H, =CH vinylic, nbd), 5.26 (bs, 1H, =CH vinylic, nbd), 5.14 (d, J = 
8.0 Hz, 1H, OCH-CHO, TADDOL), 4.85 (bs, 1H, =CH vinylic, nbd), 4.33 
(bs, 1H, CH allylic, nbd), 4.04 (bs, 1H, CH allylic, nbd), 3.94 (d, J = 8.0 
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Hz, 1H, CH-PPh2), 3.363.31 (m, 1H, CH-OPO), 2.92 (s, 3H, OCH3), 2.31 
(dd, J = 9.4 Hz, 1H, CHH-OMe), 1.951.92 (m, 1H, CHH , nbd), 1.791.74 
(m, 2H, CHH-OMe and CHH, nbd), 1.10 (s, 3H, CH3, TADDOL), 0.34 (s, 




H} NMR (125 MHz, CD2Cl2): δ = 144.3 (Cq 
arom), 144.2 (Cq arom), 143.8 (Cq arom), 139.72 (Cq arom), 139.66 (Cq arom), 
138.6 (Cq arom), 134.9 (CH  arom), 134.8 (CH  arom), 132.8 (CH  arom), 132.43 
(CH arom), 132.35 (CH  arom), 131.6 (Cq arom), 130.91 (CH arom), 130.89 (CH  
arom), 130.4 (Cq arom), 130.1 (CH  arom), 130.0 (CH  arom), 129.0 (CH  arom), 
128.93 (CH  arom), 128.90 (CH  arom), 128.7 (CH  arom), 128.64 (CH  arom), 
128.61 (CH  arom), 128.5 (Cq arom), 128.3 (CH  arom), 128.2 (Cq arom), 127.9 
(CH  arom), 127.7 (CH  arom), 127.2 (CH  arom), 126.9 (CH  arom), 114.0 (C-Me2, 
TADDOL), 95.8 (=CH vinylic, nbd), 95.7 (=CH vinylic, nbd), 90.8 (d, J = 
19.1 Hz, OC-Ph2, TADDOL), 90.2 (d, J = 17.6 Hz, OC-Ph2, TADDOL), 
88.3 (=CH vinylic, nbd), 87.4 (=CH vinylic, nbd), 80.6 (d, J = 3.2 Hz, 
OCH-CHO, TADDOL), 78.5 (d, J = 4.6 Hz, OCH-CHO, TADDOL), 74.5 
(d, J = 7.9 Hz, CH-OPO), 71.5 (CH2, nbd), 68.7 (dd, J = 8.7 Hz, CH2-
OMe), 58.3 (OCH3), 55.6 (CH allylic, nbd), 54.8 (CH allylic, nbd), 40.6 




H} NMR (202 MHz, CD2Cl2): δ = 108.0 (dd, J = 267.0, 68.1 Hz, 




H} NMR (128 MHz, 




H} NMR (376 MHz, CD2Cl2): δ = 153.2 




 calcd for C60H58O6P2Rh: 
1039.2758; found: 1039.2772. 
1.5 Additional Experiments 
1.5.1 Neutral Rh-complexes containing the acetylacetonate 
ligand 
Besides the cationic [Rh(nbd)(POP)]BF4 complexes, whose practical 
preparation has already been described, we have also prepared neutral Rh 
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complexes incorporating the POP and the acetylacetonate (acac) ligands 
following the same strategy. We considered that the 
[Rh(2O,O’-acac)(POP)] complexes could find application both in 
asymmetric hydrogenation and hydroformylation reactions as 
precatalysts.
19
 An analogous protocol to that described for 4ac was used 
in this case, but employing [Rh(2O,O’-acac)(cod)] as the rhodium 
precursor (see Scheme 4 for the synthetic strategy and structures 5a and 5b 
for the complexes prepared). The one-pot synthesis starting from 2 by 
deprotection and O-phosphorylation with the chlorophosphites derived 
from (Sa)-BINOL and (Ra)-BINOL
16
 (BINOL = [1,1'-binaphthalene]-2,2'-
diol) provided crude mixtures of the corresponding POP ligands (purity 
by 
31
P NMR ca. 94%). Subsequent complexation with substoichiometric 
amounts of [Rh(2O,O’-acac)(cod)] (i.e. 0.98 equiv.) and then isolation of 
the target complexes by crystallization afforded a yellow fine powder 
corresponding to the [Rh(2O,O’-acac)(POP)] complexes 5a and 5b in 
high yield (74% and 89% respectively, see Scheme 4). Their structure was 
determined by standard spectroscopic techniques (NMR spectroscopy and 
HRMS-MALDI spectrometry) and unambiguously confirmed by X-ray 
single crystal analysis. 
 
Scheme 4. Preparation of [Rh(2O,O’-acac)(POP)] complexes 5a and 5b. 
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Synthesis of 5a. The same protocol as for 4a was used, with the 
following amounts of reagents (solvent amounts 
were adapted so that concentrations were the 
same): compound 2 (1.408 g, 3.86 mmol), 
DABCO (0.974 g, 8.5 mmol), chlorophosphite
16
 
(1.492 g, 4.26 mmol) and [Rh(2O,O’-acac)(cod)] 
(0.866 g, 2.74 mmol). A spongy white solid that 
corresponded to the raw phosphine-phosphite 
ligand (1.974 g, ca. 2.8 mmol, ca. 94% purity by integration of the signals 
of the ligand with respect to the rest of the signals in the 
31
P NMR 
spectrum) was obtained. After following a crystallization process identical 
to that described above, 1.758 g (2.028 mmol, 74% overall yield with 
respect to [Rh(2O,O’-acac)(cod)]) of complex 5a as a yellow powder were 
obtained. [α]D
24  =  (c 0.17, THF). 
1
H NMR (500 MHz, CD2Cl2) δ 
8.19–8.14 (m, 2H, H arom), 8.01–7.99 (m, 1H, H arom), 7.98–7.94 (m, 1H, H 
arom), 7.90–7.86 (m, 3H, H arom), 7.69 (bs, 2H, H arom), 7.55–6.99 (m, 18H, 
H arom), 5.26 (s, 1H, =CH, acac), 4.90–4.78 (m, 1H, CH-OPO), 4.04 (dd, J 
= 14.8, 3.1 Hz, 1H, CH-PPh2), 3.26 (s, 3H, O-CH3), 3.09 (dd, J = 9.4, 5.4 
Hz, 1H, CHH-OMe), 3.00 (t, J = 9.0 Hz, 1H, CHH-OMe), 1.61 (s, 3H, C-




H} NMR (125 MHz, CD2Cl2) 
δ 186.5 (C=O, acac), 185.0 (C=O, acac), 149.1 (Cq arom), 149.0 (Cq arom), 
148.5 (Cq arom), 148.4 (Cq arom), 136.7 (CH  arom), 136.3 (CH  arom), 135.64 
(CH  arom), 135.55 (CH arom), 134.4 (CH  arom), 134.3 (CH arom), 133.9 (Cq 
arom), 133.2 (Cq arom), 132.5 (CH arom), 132.4 (CH arom), 132.3 (Cq arom), 
132.1 (Cq arom), 131.9 (Cq arom), 131.8 (Cq arom), 130.4 (CH  arom), 130.3 (CH  
arom), 130.0 (CH  arom), 129.9 (CH  arom), 128.9 (CH  arom), 128.83 (CH  arom), 
128.77 (CH  arom), 128.7 (CH  arom), 128.2 (CH arom), 127.50 (CH  arom), 127.48 
(CH  arom), 127.43 (CH  arom), 127.35 (CH  arom), 126.7 (CH  arom), 126.4 (CH  
arom), 125.5 (CH arom), 125.43 (CH  arom), 124.4 (CH arom), 123.3 (Cq arom), 
122.8 (Cq arom), 122.2 (CH arom), 100.1 (=CH, acac), 74.3-74.1 (m, CH-
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OPO), 72.5 (dd, J = 8.7 Hz, CH2-O-CH3), 59.4 (O-CH3), 41.1 (d, J = 34.3 




H} NMR (202 
MHz, CD2Cl2) δ 144.3 (dd, J = 302.3, 96.7 Hz, P-O), 45.3 (dd, J = 174.5, 
96.8 Hz, P-O); HRMS (MALDI
+
): m/z calcd for C47H41O6P2Rh 866.1428, 
found 866.1540. 
Single crystal X-ray analysis of compound 5a 
X-ray Data: Single crystals of enantiopure Rh complex 5a suitable for 
X-ray diffraction analysis were grown by slow diffusion of diethyl ether 
into an EtOAc (3:1 of Et2O:EtOAc) and left in the freezer (22 ºC) of the 
glove box. 
Data collection and structure solution and refinement of 5a were carried 
out as compound 2. 
 
Figure 2. X-ray structure of 5a (ORTEP drawing showing thermal ellipsoids at 50% 
probability). Non-relevant hydrogen atoms have been omitted for clarity.  Selected 
bond lengths [Å] and angles [º]: Rh1-O5 = 2.064(3), Rh1-O6 = 2.062(3), Rh1-P1 = 
2.1340(10), Rh1-P2 = 2.2056(10), P1-Rh1-P2 = 90.61(4). 
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Table 1. Crystal data and structure refinement of 5a. 
 
Empirical formula  C51H51O7P2Rh  
Formula weight  940.77 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 9.8775(4) Å, = 90° 
 b = 18.4163(7) Å,   = 99.8204(15)° 
 c = 12.3470(5) Å,  = 90°. 
Volume 2213.10(15) Å3 
Z 2 
Density (calculated) 1.412 Mg/m3 
Absorption coefficient 0.511 mm-1 
F(000) 976 
Crystal size 0.20 x 0.20 x 0.03 mm3 
Theta range for data collection 2.006 to 30.527°. 
Index ranges 14≤h≤13, 25≤k≤20, 
  17≤l≤14 
Reflections collected 21153 
Independent reflections 11697 [R(int) = 0.0360] 
Completeness to theta = 30.527° 97.2%  
Absorption correction Empirical 
Max. and min. transmission 0.985 and 0.921 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11697/ 1/ 555 
Goodness-of-fit on F2 1.023 
Final R indices [I>2 (I)] R1 = 0.0396, wR2 = 0.0662 
R indices (all data) R1 = 0.0507, wR2 = 0.0708 
Flack parameter x = 0.004(13) 
Largest diff. peak and hole 0.737 and 0.441 e.Å-3 
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Synthesis of 5b. The same protocol as for 4a was used, with the 
following amounts of reagents (solvent amounts 
were adapted so that concentrations were the 
same): compound 2 (0.850 g, 2.34 mmol), DABCO 
(0.588 g, 5.14 mmol), chlorophosphite
16
 (0.958 g, 
2.56 mmol) and [Rh(2O,O’-acac)(cod)] (0.572 g, 
1.81 mmol). A spongy white solid that 
corresponded to the raw phosphine-phosphite ligand (1.306 g, ca. 1.846 
mmol, ca. 94% purity by integration of the signals of the ligand with 
respect to the rest of the signals in the 
31
P NMR spectrum) was obtained. 
After following a crystallization process identical to that described above, 
1.404 g (1.619 mmol, 89% overall yield with respect to [Rh(2O,O’-
acac)(cod)]) of complex 5b as a yellow powder were obtained. [α]D
24  = 
 (c 0.090, THF). 
1
H NMR (500 MHz, CD2Cl2) δ 8.29–8.18 (m, 2H, H 
arom), 7.99–7.86 (m, 4H, H arom), 7.86–7.82 (m, 1H, H arom), 7.62–7.50 (m, 
4H, H arom), 7.47–7.37 (m, 5H, H arom), 7.36–7.19 (m, 8H, H arom), 7.14–
7.10 (m, 1H, H arom), 7.03–6.98 (m, 2H, H arom), 5.19 (s, 1H, =CH, acac), 
4.74–4.52 (m, 1H, CH-OPO), 4.07–3.93 (m, 1H, CH-PPh2), 3.12 (s, 3H, O-
CH3), 3.09–2.98 (m, 2H, CH2-OMe), 1.62 (s, 3H, C-CH3, acac), 0.87 (s, 




H} NMR (125 MHz, CD2Cl2) δ 186.4 (C=O, acac), 
184.9 (C=O, acac), 149.1 (Cq arom), 149.0 (Cq arom), 148.5 (Cq arom), 148.5 
(Cq arom), 136.4 (Cq arom), 136.1 (Cq arom), 135.3 (CH  arom), 135.2 (CH  arom), 
134.4 (CH  arom), 134.3 (CH  arom), 134.0 (Cq arom), 132.7 (CH  arom), 132.6 
(CH  arom), 132.2 (Cq arom), 131.9 (Cq arom), 131.7 (Cq arom), 130.6 (CH  arom), 
130.1 (CH arom), 129.9 (CH  arom), 129.8 (CH  arom), 129.83 (CH  arom), 129.1 
(CH  arom), 129.0 (CH  arom), 128.82 (CH  arom), 128.76 (CH  arom), 128.3 (CH 
arom), 127.6 (CH  arom), 127.5 (CH  arom), 127.4 (CH  arom), 127.36 (CH  arom), 
127.3 (CH arom), 126.6 (CH  arom), 126.4 (CH  arom), 125.4 (CH arom), 125.36 
(CH  arom), 123.8 (CH  arom), 123.6 (Cq arom), 123.0 (Cq arom), 122.6 (CH  arom), 
99.8 (=CH, acac), 74.8–74.6 (m, CH-OPO), 72.8 (dd, J = 8.2 Hz, CH2-
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OCH3), 59.4 (O-CH3), 40.6 (d, J = 34.7 Hz, CH-PPh2), 27.6 (CH3, acac 




H} NMR (202 MHz, CD2Cl2) δ 144.7 (dd, J = 





] calcd for C47H41O6P2Rh 866.1428, found 866.1774. 
Single crystal X-ray analysis of compound 5b 
X-ray Data: Single crystals of enantiopure Rh complex 5b suitable for 
X-ray diffraction analysis were grown by slow diffusion of diethyl ether 
into an EtOAc (3:1 of Et2O:EtOAc) and left in the freezer (22 ºC) of the 
glove box. 
Data collection and structure solution and refinement of 5b were carried 
out as compound 2. 
 
Figure 3. X-ray structure of 5b (ORTEP drawing showing thermal ellipsoids at 50% 
probability). Non-relevant hydrogen atoms have been omitted for clarity.  Selected 
bond lengths [Å] and angles [º]: Rh1-O1 = 2.071(8), Rh1-O2 = 2.065(6), Rh1-P1 = 
2.123(3), Rh1-P2 = 2.204(3), P1-Rh1-P2 = 90.75(12). 
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Table 2. Crystal data and structure refinement of 5b. 
 
Empirical formula  C47H41O6P2Rh  
Formula weight  866.65 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 9.786(6) Å, = 90° 
 b = 10.684(9) Å,   = 90° 
 c = 37.861(19) Å,  = 90° 
Volume 3958(4) Å3 
Z 4 
Density (calculated) 1.454 Mg/m3 
Absorption coefficient 0.563 mm-1 
F(000) 1784 
Crystal size 0.08 x 0.02 x 0.01 mm3 
Theta range for data collection 1.980 to 25.730° 
Index ranges 10≤h≤11,12≤k≤13, 
 43≤l≤46 
Reflections collected 36493 
Independent reflections 7116[R(int) = 0.2059] 
Completeness to theta = 25.730° 95.3% 
Absorption correction Empirical 
Max. and min. transmission 0.994 and 0.592 
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 7116/ 336/ 508 
Goodness-of-fit on F2 1.004 
Final R indices [I>2(I)] R1 = 0.0674, wR2 = 0.1259 
R indices (all data) R1 = 0.1330, wR2 = 0.1531 
Flack parameter x = 0.02(5) 
Largest diff. peak and hole 0.963 and 1.482 e Å-3 
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1.6 Conclusion and Outlook 
In conclusion, we have developed and optimized a practical synthesis 
for “lead” enantiopure rhodium complexes derived from POP ligands. We 
have previously reported that these rhodium complexes have been 
efficiently applied as precatalysts in a number of enantioselective 
hydrogenative transformations. The herein described synthetic protocols 
may enable these efficient hydrogenation catalysts to be easily accessed by 
the “asymmetric catalytic community”. This protocol was also applied for 
the practical synthesis of neutral Rh(I)-complexes containing the POP 
and the acetylacetonate (acac) ligands. Finally, this methodology may be 
further extended to other metal complexes to be used as catalysts in other 
asymmetric transformations of interest. 
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13C{1H} NMR spectrum of 4a 
 
 
Pendant NMR spectrum of 4a  
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1H NMR spectrum of 4b 
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11B{1H} NMR spectrum of 4b 
 
19F{1H} NMR spectrum of 4b 












UNIVERSITAT ROVIRA I VIRGILI 
DEVELOPMENT OF P-OP LIGANDS WITH NEW STRUCTURAL MOTIFS FOR RHODIUM- AND IRIDIUM- MEDIATED 
ASYMMETRIC HYDROGENATIONS 
Balakrishna Bugga 
Practical Synthesis of Rhodium Precatalysts  
[53] 
 
 NMR spectra of 4c 1.7.3
 
1H NMR spectrum of 4c
 
31P{1H} NMR spectrum of 4c 


































































































































































































































































































































































































































UNIVERSITAT ROVIRA I VIRGILI 








13C{1H} NMR spectrum of 4c 
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13C{1H} NMR spectrum of 5a 
 
DEPTQ-135 NMR spectrum of 5a 
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Different methods for transforming N-heteroarenes into more reactive 
derivatives for catalytic asymmetric hydrogenation are highlighted. The 
first strategy consists of facilitating hydrogenation by the formation of 
positively charged derivatives of the heteroarene. Catalyst deactivation 
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processes arising upon binding of the substrate to the metal center can thus 
be prevented and, additionally, hydrogenation of positively charged 
heteroarenes may also be more favored than that of their neutral analogues. 
The second strategy is based on introducing a ligating group onto the 
substrate to assist its coordination to the metal center and facilitate 
hydrogenation by chelation assistance. The last strategy involves breaking 
the aromaticity of the heteroarene by inducing a double  bond migration 
process. This microreview summarizes advances made in the above 
mentioned strategies, which have allowed the development of highly 
enantioselective catalytic hydrogenation of N-heteroarenes for the 
production of fully or partially saturated chiral heterocycles . 
2A.2 Introduction 
Enantiopure organic compounds are important constituents of 
commercially produced chemicals including plastics, active 
pharmaceutical ingredients, agrochemicals, food additives, etc.
1
 The ever-
increasing demand for compounds of this kind has fueled the development 
of efficient synthetic methods for their preparation.
2
 Asymmetric catalysis, 
in which a small amount of a chiral catalyst, by virtue of being regenerated 
many times, yields a much larger amount of enantiomerically pure product, 
is a priori the most elegant, productive, and resource-efficient approach 
for synthesizing enantiomerically pure (or enantioenriched) compounds. 





asymmetric catalysis has evolved significantly since its onset and now 
encompasses nearly all transformations subject to three-dimensional bias. 
Asymmetric hydrogenation is considered to be a straightforward entry 
to the preparation of enantiopure compounds,
4
 because many transition-
metal coordination compounds (mostly phosphorus-containing complexes
5
) 
mediate the addition of dihydrogen to prochiral CO, CC and CN 
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Catalytic Asymmetric Hydrogenation of C=N-
Containing Heterocyclic Compounds 
double bonds with high enantioselectivities. Thus, many highly efficient 
catalysts have been developed for the asymmetric hydrogenation of 
prochiral ketones, alkenes and imines.
6
 
Many valuable biologically active compounds contain a chiral 
heterocyclic structural motif.
7
 Asymmetric hydrogenation of the 
corresponding heteroaromatic precursors can be considered one of the 
most practical and atom-efficient methods for synthesizing fully or partly 
reduced heteroaromatic derivatives in enantiomerically pure form (Scheme 
1).
8
 This synthetic strategy also benefits from a great diversity of starting 
materials. In terms of synthetic simplicity, asymmetric hydrogenation is 
also an attractive route, as it minimizes the manipulation of functional 
groups during the preparation of the target heterocyclic compounds in 
enantiomerically pure form. 
Despite the attractiveness of the asymmetric hydrogenation of 
heteroaromatic compounds, this area of chemistry is much less explored, 
with many fewer successful examples than in the cases of the  asymmetric 
hydrogenation of prochiral ketones, alkenes, and imines. Several factors 
are behind the difficulties in asymmetrically hydrogenating heteroaromatic 
compounds: 
 Firstly, heteroaromatic compounds are highly stable, which translates 
into a requirement for harsh hydrogenation conditions in order to 
break the aromaticity of the starting materials ( i.e. high hydrogen 
pressures and temperatures). Although high pressures are normally not 
a problem and result only in a more demanding reaction setup, high 
temperatures may unfortunately be associated with low 
enantioselectivities in the final hydrogenated products. In this respect, 
there are many examples of partial hydrogenation of bicyclic 
heteroaromatic compounds with good enantioselectivities and with 
one aromatic ring being preserved, but literature examples of highly 
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selective hydrogenation of monocyclic heteroaromatic compounds are 
scarce. 
 Secondly, many of the heteroaromatic derivatives to be hydrogenated 
lack an auxiliary coordination group to the metal center. Many 
successful applications of enantiomerically pure transition -metal 
complexes in asymmetric hydrogenation rely on the ability of the 
substrate to form a metal chelate involving the double bond to be 
hydrogenated and a donor atom from the substrate (for instance, the 
chelation-assistance of an acyl group is the classical paradigm for 
achieving high reactivity and enantioselectivity in rhodium-mediated 
asymmetric hydrogenations).
9
 A lack of auxiliary coordination 
between the heteroaromatic substrate and the catalyst may result in 
more than one low-energy direction of approach for the substrate to 
the metal center with overall low enantioselectivity in the 
transformation. 
 Lastly, the activity of the catalyst may be reduced, or even suppressed 
altogether, by the substrates or hydrogenation products, because both 
compounds may contain ligating groups, such as nitrogen or sulfur, 
capable of coordinating to the metal center with subsequent loss of 
catalytic activity. 
Chemists have developed various strategies for overcoming these 
difficulties: 
o “Ligand tuning” has enabled the development of efficient 
catalytic systems for certain types of heteroaromatic 
compounds. Catalyst activation involving the addition of 
additives to form more reactive catalytic systems 
complements ligand design and tuning and has also been 
successfully exploited in this chemistry. Ligand tuning and 
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catalyst activation have recently been reviewed and are both 
outside the scope of this text.
8
 
o Hydrogenation or reduction of a heteroaromatic compound 
involves the sequential reduction of several C=C and/or C=N 
bonds. An elegant strategy has been devised that first 
involves the partial reduction of the initial heteroaromatic 
compound to a new prochiral heterocyclic compound by the 
use of an achiral catalytic system. The subsequent reduction 
of this intermediate heterocyclic compound to the final 
enantiopure derivative is mediated by a second catalytic 
system present in the reaction mixture, which is responsible 
for enantioselection. This strategy is known as “relay 
catalysis” and has also recently been reviewed.
10
 
2A.3 Substrate Activation 
The heteroarene to be hydrogenated has been synthetically manipulated 
and transformed into a related heterocyclic system that is more reactive in 
asymmetric hydrogenation (“Substrate Activation”). A first strategy 
consists in facilitating hydrogenation by the formation of positively 
charged derivatives of the heteroarene. Catalyst deactivation processes 
arising upon binding of the substrate to the metal center can thus be 
prevented and it is worth noting that, with this strategy, the coordinating 
ability of the ligating groups of the substrate and/or product toward the 
catalyst are neutralized (see Strategy I in Scheme 1). The hydrogenation of 
positively charged heteroarenes may also be more favored than that of 
their neutral analogues. In a second approach, the heteroarene is 
synthetically modified to introduce a ligating auxiliary group to assist its 
coordination to the metal center and facilitate hydrogenation by chelation -
assistance. In addition to the activation effects produced by the ligating 
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auxiliary group, it should be noted that Strategy II also benefits from the 
advantages of quaternizing the sp
2
-nitrogen group previously mentioned 
for Strategy I. Overall, the hydrogenation of the modified substrate may 
proceed more rapidly than that of the original derivative (see Strategy II in 
Scheme 1). The last strategy involves breaking the aromaticity of the 
heteroaromatic compound by inducing an acid- or base-mediated double-
bond migration process (see Strategy III in Scheme 1). It is worth 
mentioning that, whilst the products arising from Strategies I and II may 
not correspond exactly to the hydrogenated substrate, the hydrogenated 
products obtained by Strategy III are formal hydrogenation products of the 
starting heteroarenes.  
 
 
Scheme 1. General representation of the substrate manipulation strategies for 
improving the reactivity of heteroarenes in asymmetric hydrogenation.  
As previously indicated, several reviews deal with ligand design in the 
asymmetric hydrogenation of heteroaromatic compounds and highlight the 
different additives that increase the activity of a given catalytic sys tem or 
use the concept of relay catalysis for hydrogenating heteroaromatic 
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compounds, but none of these reviews provide a comprehensive and timely 
overview on the different methods for transforming the substrate into a 
more reactive derivative towards asymmetric hydrogenation. This 
microreview will therefore focus on the progress of synthetically 
manipulating heteroaromatic compounds in order to increase their 
reactivity in asymmetric hydrogenation mediated by enantiomerically pure 
transition-metal complexes.
11
 The discussion is divided into three sections 
corresponding to these three different strategies. 
2A.3.1 Strategy I: Activation by formation of positively charged 
derivatives of the substrate 
In this strategy, the hydrogenation process is facilitated by the 
formation of positively charged derivatives of the heteroarene. One of the 
main problems to overcome in the hydrogenation of heteroarenes is 
catalyst deactivation due to substrate coordination to the metal center 
during the whole catalytic cycle. Those working on asymmetric catalysis 
have therefore sought to eliminate the ability of the substrate and product 
to bind to the catalytic metal by removing the lone pair of electrons from 
the ligating groups. In this strategy a dative covalent bond is formed 
between the lone pairs of electrons from the substrate and a suitable 
derivatization agent forming positively charged species. Moreover, these 
substrates are activated toward hydrogenation by quaternization of the 
nitrogen groups. Transition metal-mediated asymmetric hydrogenations of 
nitrogen containing heteroarenes proceed in many cases by stepwise proton 
transfer followed by the addition of a hydride.
12
 This later step should be 
better favored with an iminium motif ( i.e. CN
+
 double bond) rather than 
with the neutral CN group present in the original heteroarene.  
Thus, two main strategies have been devised for favoring hydrogenation 
through the formation of positively charged substrate derivatives:  
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 Firstly, the formation of positively charged derivatives of the 
substrate prior to the hydrogenation in a reversible manner and 
subsequent neutralization of the hydrogenation products.  
 Secondly, formation of positively charged derivatives based on 
covalent chemistry. 
The following discussion is divided into two sections corresponding to 
these two substrategies for suppressing the binding ability of the substrate 
to the metal center. The reader is referred to Section 2A.3.2 for examples 
in which the formation of a positively charged derivative also involves 
introducing a ligating group that facilitates hydrogenation through 
chelation assistance. 
2A.3.1.1 Reversible formation of positively charged derivatives of 
the substrate and subsequent neutralization 
Substrate activation should ideally be achieved with easy che mistry 
and in a minimum number of synthetic steps. The activating agent should 
also be easily removable. With these ideas in mind, activation of C=N -
containing heteroarenes by protonation with Brønsted acids as activators 
appeared an obvious strategy to follow. A wide variety of Brønsted acids 
are easily available and hydrogenated protonated products can easily be 
transformed into the neutral compounds by adjusting the workup 
conditions. 
Significant progress has been made by Ohshima, Ratovelomanana, 
Mashima, et al.
13
 in the area of asymmetric hydrogenation of quinoline 
derivatives by use of this activation approach.
14
 These authors used the 
cationic dinuclear triply halogen bridged iridium complexes C1 as 
catalysts in the hydrogenation of quinolines. Interestingly, the asymmetric 
hydrogenation of the challenging 2-phenylquinoline in the presence of C1 
led to lower enantioselectivities than those obtained from the quinolinium 
analogues (an increase of up to 9% in the ee), thus indicating that 
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formation of quinolinium salts prior to hydrogenation was beneficial for 
enantioinduction. With the optimal catalyst and hydrogenation conditions 
in hand, the authors extended their chemistry to an array of diversely 
substituted quinolinium salts (thirteen examples) with excellent levels of 
conversions and enantioselectivities (up to 95% conversion and 95%  ee; 
Scheme 2a). Although the authors normally used the same halogen ligand 
in C1 or in the substrate derivative, they demonstrated that the original 
halogen ligand in C1 remained in the catalytically active complex (similar 
results were obtained in the hydrogenation of 2-phenylquinoline 
hydrobromide or hydrochloride with C1●Cl). A series of isoquinolinium 
salts were hydrogenated by Mashima et al. with outstanding results using 
the same catalytic system.
15
 Interestingly, diverse substitution patterns in 
the isoquinolinium ring are tolerated (Scheme 2b): 1-substitution (11 
examples, up to 99% conv., up to 99% ee), 3-substitution (seven examples, 
up to 99% conv., up to 95%  ee), 1,3-disubstitution (10 examples, up to 
99% conv., 99% ee, complete syn-selectivity), 1,4-disubstituted- (one 
example not represented in Scheme 2b, up to 99% conv., syn:anti = 4:1; ee 
up to 97% for the anti isomer) and 3,4-disubstituted- (one example not 
represented in Scheme 2b, up to 99% conv., syn:anti = >95:5; 43% ee) 
isoquinolinium derivatives. 
Mashima et al. have also reported the hydrogenation of 2-aryl-
substituted pyridinium salts with a second alkyl substituent at the 3- or 6-
position in the presence of C1 as the enantioselective catalyst.
16
 Even 
though a higher catalyst amount was used in this case (5 mol %, Scheme 
2c), enantioselectivities were lower (up to 82%  ee) than those reported for 
the quinolinium and isoquinolinium salts already discussed.  
More recently, Zhou et al. also reported the hydrogenation of 3-
(trifluoromethyl)pyridinium hydrochloride derivatives in the presence of 
an iridium catalyst based on (R)-difluorphos ligand L1. A cis arrangement 
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in all three substituents was found in the corresponding piperidines after 
the basic work-up, with enantioselectivities up to 90% ee (Scheme 2d).
17
  
Asymmetric hydrogenation of quinazolinium salts catalyzed by halide -
bridged dinuclear iridium complexes has recently been described by 
Mashima et al. (Scheme 2e).
18
 Although enantioselectivities are very high 
(ee values ranging from 96 to 99%), this method suffers from low 
chemoselectivity for certain substrates: for R
1
 = p-MeOC6H4 significant 
amounts of the two partially reduced dihydroquinazolines (34%) were 
obtained. 
As a conclusion, it is worth noting that protonation has activated a 
wide range of heteroarenes towards efficient asymmetric hydrogenation in 
the presence of well-established iridium catalysts.  
Kuwano et al. have developed an analogous activation strategy for the 
hydrogenation of pyrimidines with the use of Lewis acids as activators.
19
 A 
broad range of chiral phosphines and Lewis acids were assayed in the 
iridium-mediated asymmetric hydrogenation of 2,3-disubstituted 
pyrimidines. High enantioselectivities were obtained with use of ligand 
L2, [{Ir(-Cl)(cod)}2], iodine as additive and an excess of Yb(OTf)3 as the 
Lewis acid (Scheme 2f). Enantioselectivities were high (18 examples, up 
to 99% ee) and installing a substituent at the ortho position of R
2
 was 
beneficial for enantioselection. Pyrimidines bearing R
2
 substituents other 
than aryl also underwent hydrogenation with high enantioselection.  
The previously discussed activation examples involve the use of 
preformed N-protonated heteroarene salts (Scheme 2ae) or of an excess of 
a Lewis acid (Scheme 2f). Several groups have reported the use of 












) and quinoxalines (piperidinium 
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hydrochloride
26
). Despite the improvement in catalyst activity and/or 
selectivity induced by these additives, their role has not been elucidated 
until now. Because they were used in catalytic amounts with respect to the 
substrates, it is not possible that these Brønsted acids completely prevent 
the binding of the heteroarene to the metal center. Several hypotheses have 
been made regard to the role of these additives. Firstly, it has been 
proposed that ammonium salts (either directly added or formed in situ 
through reaction between the heteroarene and the additive) increase the 
stability of the metal catalyst with an overall increase in the catalyst 
activity.
22
 Secondly, experimental and theoretical studies on the 
hydrogenation of nitrogen-containing heteroarene rings have revealed that 
successive additions of dihydrogen and double bond migrations  take place 
during hydrogenation.
12
 Thus, it is also conceivable that these Brønsted 
acid additives facilitate the migration of double bonds in par tially reduced 
heteroarene rings with an overall increase in catalyst activity.
27 
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Scheme 2. Activation of C=N-containing heterocycles towards asymmetric 
hydrogenation by N-quaternization. 
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2A.3.1.2 Substrate N-derivatization 
Several research groups have envisaged that the activation of simple 
pyridines might be achieved by derivatization at the nitrogen. Chen, Zhang, 
and co-workers recently reported the transformation of 2 -substituted 
pyridines into N-benzylpyridinium bromides and their subsequent 
asymmetric hydrogenation in the presence of iridium(I) complexes derived 
from enantiomerically pure bisphosphines as catalysts.
28
 After catalyst 
optimization, these authors identified that a combination of ligand L3 and 
[{Ir(μ-Cl)(cod)}2] (the standard iridium precursor in this chemistry) in a 
1,2-dichloroethane (DCE)/acetone solvent mixture (1:1, v/v) provided very 
high levels of conversion and enantioselectivity (8196% ee) in the 
hydrogenation of N-alkyl or N-aralkyl substituted pyridinium derivatives 
with aryl substituents in the 2-position (Scheme 3a). On the contrary, 2-
alkylpyridinium substrates were obtained with low to moderate levels of 
enantioselection (2469% ee). Zhou and coworkers have also reported the 
highly enantioselective iridium-catalyzed hydrogenation of N-benzylated 
pyrrolo[1,2a]-pyrazinium systems (Scheme 3b).
29
 The catalytic system 
consisted of [{Ir(-Cl)(cod)}2] as iridium precursor and L4 as ligand. 
Interestingly, L4 incorporates central and axial stereogenic elements and 
provided up to 95% ee. 
Enantioselectivities ranged from 80 to 95% ee in cases involving aryl -
substituents in the pyrazinium ring (R
1
 = substituted aryl groups), whereas 
the presence of alkyl substituents at the same position led to a significant 
drop in the enantioselectivity. The use of cesium carbonate increased the 
degree of conversion and inhibited racemization of the hydrogenated 
products. 
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Scheme 3. Activation of heteroarenes by derivatization of the substrate.  
2A.3.2 Strategy II: Chelation assistance during hydrogenation 
Significant progress in the asymmetric hydrogenation of certain kinds 
of heteroarenes was already being made in the early 2000s. For instance, a 
number of efficient catalytic systems that mediate the hydrogenation of 
several heterocyclic systems, such as quinolines and quinoxalines, were 
developed. However, the hydrogenation of other kinds of relevant 
heterocycles such as pyridines, isoquinolines and indoles remained a 
challenge. Because the hydrogenation products of these heteroarenes ( i.e. 
piperidines, isoquinolidines and indolines) are extremely important 
pharmacophores found in many bioactive compounds, chemists developed 
a conceptually elegant and practical synthesis of piperidines, 
isoquinolidines, and indolines based on chelation assis tance during 
asymmetric hydrogenation. 
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The underlying principle in this strategy involved the attachment to the 
substrate of an auxiliary coordinating group capable of coordinating to the 
metal center. On the basis of the superb enantioselectivities obtained in 
chelation assisted asymmetric rhodium-mediated hydrogenations,
9
 it was 
envisaged that coordination between the substrate and the metal center  
would be beneficial for controlling enantioselectivity. Because an acyl 
group is the classical model system for achieving high enantioselectivity 




31 , 32 , 33
, and Andersson
34
 also attached acyl motifs to 
various six-membered heteroarenes to be hydrogenated in the presence of 
iridium-based enantioselective catalysts. Examples of this strategy are 
shown in Scheme 4. 
Charette and co-workers transformed substituted pyridines into the 
corresponding N-acyliminopyridinium ylides, which were then subjected to 
asymmetric hydrogenation (Scheme 4a).
30
 After screening different 
catalytic systems, the authors found that iridium cationic complexes 
derived from phosphinooxazoline ligands -C3- provided the highest levels 
of conversion and enantioselectivity. Conversion was essentially complete 
for all substrates tested (eight examples), although in some cases small 
quantities of partially hydrogenated compounds were detected. 
Enantioselectivities were generally high (up to 90%). Disubstituted 
pyridinium ylides were also studied. Whereas 2,3-disubstituted compounds 
afforded the cis-diastereoisomers with rather low enantioselectivities (it 
was observed that substitution at the 3-position was detrimental to 
enantioselectivities), 2,5-disubstituted pyridinium ylides were 
hydrogenated with high enantio- but lower diastereoselectivity. The final 
compounds could be efficiently converted into the corresponding 
piperidine derivatives by NN bond cleavage. 
An analogous strategy has been developed for the hydrogenation of 
quinolines and isoquinolines (Scheme 4b).
31
 Quinolines were activated by 
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formation of the phenoxycarbonylquinolinium derivatives (R
3
 = Bn) by 
derivatization in situ with benzyl chloroformate and a base. An array of 
substituted quinolines was efficiently hydrogenated with this activation 
strategy. 2-Alkyl substituted quinolines were hydrogenated with high 
enantioselectivity regardless of the length of the alkyl chain (ca. 90% ee) 
and the reaction did not prove to be very sensitive to the substituent in the 
6-position. 
Isoquinolines were also activated by the same authors with use of the 
same strategy (Scheme 4b). In this case, monohydrogenation took place 
and the corresponding 1,2-dihydroisoquinoline systems were obtained. 
Furthermore, conversions and enantioselectivities were lower than those 
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Scheme 4. Chelation-assistance during asymmetric hydrogenation of six-
membered heteroarenes.  
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Enantioselectivities were close to 80% in most cases for 
monosubstituted isoquinolines (R
2
 = H), although substitution in the 
carbocyclic ring (R
2
 = OMe) led to a drop in enantioselectivity and 
conversion (ca. 64% ee). The authors did not provide any direct evidence 
of the participation of the acyl groups in the coordination sphere of the 
metal in the examples indicated in Scheme 4. However, the hydrogenation 
of analogous derivatives to the heterocycles indicated in Scheme 4a and 4b, 
but without a chelating substituent, did not proceed
30
 or led to 
hydrogenated products with lower enantioselectivity.
35
 
More recently, Zhou and co-workers reported the transformation of 2-
substituted pyridines into N-aralkylpyridium bromides and subsequent 
asymmetric hydrogenation in the presence of iridium(I) complexes derived 
from enantiomerically pure bisphosphines as catalysts.
32
 A benzyl group 
with a CO2iPr substituent at its ortho-position (Scheme 4c) was crucial in 
achieving high enantioselectivity, as the CO group at the benzyl group is 
probably coordinated to the metal center of the catalyst, thus favoring 
control of enantioselectivity. After catalyst optimization, these authors 
demonstrated that the combination of ligand L6 with the standard iridium 
precursors in this chemistry in a toluene/dichloromethane solvent mixture 
(1:1 v/v) provided very high conversions and enantioselectivit ies in the 
hydrogenation of N-substituted pyridinium derivatives with alkyl, benzyl 
and aryl substituents in the 2-position. Whereas iridium catalysts derived 
from L6 enabled enantioselectivities ranging from 78 to 93% ee in the aryl 
substituted hydrogenated products, alkyl or benzyl substituents at the 2 -
position provoked a drop in enantioselectivity.  
The same authors have described an analogous approach for the 
asymmetric hydrogenation of isoquinolinium salts.
33
 The catalytic system 
involves ligand L4, which incorporates central and axial stereogenic 
elements. Excellent enantioselectivities are obtained for 1 -aryl-substitued 
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substrates (up to 96% ee) and once again, the presence of a chelating CO 
motif is crucial for controlling enantioselection (Scheme 4d). As observed 
for N-benzyl 2-alkylsubstituted pyridines, alkyl substituted isoquinolinium 
derivatives at the 1- and 3-positions (Scheme 4d) were hydrogenated with 
much lower ee values (4374% ee). 
Andersson et al. reported the hydrogenation of ortho-substituted N-
iminopyridinium ylides mediated by the iridium complex C4. Eight 
substrates were explored and the ee values of the hydrogenated products 
ranged from 10 to 90% ee (Scheme 4e). Substrate chelation proved to be 
beneficial in achieving high levels of stereoselection.
34
 
With regard to catalytic enantioselective hydrogenations of five -
membered heteroaromatic rings, those long remained a challenge until 
Kuwano and coworkers reported that ruthenium complexes of  enantiopure 
bisphosphines efficiently catalyzed the highly enantioselective 
hydrogenation of N-acyl indoles.
36
 Although each of their hydrogenated 
indole derivatives contain a N-acyl group, which is a priori capable of 
coordinating to the metal center, Kuwano and coworkers do not attribute 
any effect of the potential coordination of the substrate to the metal center 
to the outstandingly high levels of conversion and enantioselectivity 
achieved. Further examples of successful hydrogenation of indole 
derivatives with N-Ac, N-Boc and N-Ts substituents were reported by the 
same research group,
37
 by Pfaltz and coworkers
38
 and by Feringa, de Vries 
and coworkers.
39
 The results described for N-acetyl, N-Boc and N-
tosylindoles by all these research groups demonstrate that the substituent 
at the nitrogen greatly influences the level of conversion and 
enantioselectivity achieved in the hydrogenation processes.
3639
 However, 
no conclusive evidences on the coordination of the N-substituents to the 
metal center is provided by the authors.  
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2A.3.3 Strategy III: Hydrogenation after breaking the aromaticity  
The stability of these heteroaromatic compounds can result in the need 
for harsh hydrogenation conditions for breaking their aromaticity and low 
enantioselectivities of the hydrogenated products due to the high 
temperatures normally required. Breaking the aromaticity of the 
heteroarenes to be hydrogenated is not feasible for all kinds of substrates, 
but it was considered an intuitive step to undertake in order to facilitate 
hydrogenation, whenever aromaticity could be broken. For instance, it was 
known that simple unprotected indoles reacted with strong Brønsted acids 
to form iminium derivatives through protonation of the CC double bond 




Scheme 5. Strategies for breaking the aromaticity in indoles.  
Zhang, Zhou, and co-workers developed this idea and envisaged that the 
iminium compounds produced in situ according to Method A in Scheme 5 
might be more prone to hydrogenation than the original indole derivatives. 
Catalyst screening studies in the hydrogenation of 2-methyl indole 
identified palladium complexes incorporating ligand L7 as the most 
efficient catalyst. The combined use of these palladium complexes and L-
camphorsulfonic acid (L-CSA) in a mixture of dichloromethane and 
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trifluoroethanol (TFE) as a solvent mediated the asymmetric hydrogenation 
of 2-methyl indole with a high levels conversion (>95%) and 
enantioselectivity (91%  ee in favor of the (R)-enantiomer of the 
corresponding indoline).
41
 Under the optimized reaction conditions, an 
array of diversely substituted indoles (13 examples), each possessing only 
one substituent in the five-membered ring, was hydrogenated with 




Hydrogenation of 2,3-disubstituted indoles by this methodology deserves 
especial mention,
42
 because it results in the formation of two contiguous 
stereogenic centers, one of which (the one corresponding to C3) should be 
formed during protonation and the other (the one relating to C2) during the 
hydrogenation process (Scheme 6b). The authors reasoned that if 
protonation could be made to take place at a higher rate than 
hydrogenation, the overall process could be driven under dynamic kinetic 
resolution conditions and might benefit from a reduction in the number of 
formed stereoisomers. The use of the palladium complexes incorporating 
ligand L7 in combination with a protic acid different from that used for 
monosubstituted indoles (p-TsOH instead of L-CSA) at a higher reaction 
temperature in the same solvent mixture enabled the efficient preparation 
of 2,3-disubstituted indolines. Under these conditions, a variety of 2,3 -
substituted indoles (17 examples) were hydrogenated with excellen t yields 
(up to 97%), diastereo- (only cis-diastereoisomers were obtained) and 
enantioselectivities (up to 98% ee; Scheme 6b). Alkyl, aryl and aralkyl 
substituents were tolerated in the indole ring, though enantioselectivities 
for 3-benzyl-substituted indoles were slightly lower than those for their 3 -
alkyl analogues. Fused-ring substrates were also satisfactorily 
hydrogenated (up to 96% ee). The effects of the substituents in the 
carbocycle were not extensively studied, although trisubstituted indoles 
with a 5-F substituent displayed slightly lower  ee values than their F-
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unsubstituted analogues (up to a 4% decrease in the  ee). Combined 
experimental and theoretical studies suggest that the aforementioned 
bisphosphine-palladium complexes mediated the hydrogenations through 
an outer-sphere mechanism with stepwise proton and hydride transfers.
42
 
The authors reported the hydrogenation of unprotected indoles by the same 
strategy with ligand L8 and EtSO3H as additive, although the results 
obtained in terms of enantioselectivity were not as good  (up to 87%  ee; 
Scheme 6c) as with p-TsOH (Scheme 6b).
43
 
Liu, Wang and coworkers also reported the hydrogenation of indole 
systems with Pd(II) complexes derived from the BridgePhos ligand L9, 
which exhibits a large bite angle, with excellent enantioselectivities (up to 




Although the above examples constituted efficient asymmetric 
hydrogenation of indoles, several practical challenges remained. First and 
foremost, stoichiometric amounts of a Brønsted acid are required, which 
calls for the recycling and reuse of the activator. Secondly, relatively high 
catalyst loadings (2 mol % of palladium precursor and 2.4 mol % of 
ligand) are used. Vidal-Ferran and coworkers reported the use of neutral 
iridium complexes of enantiomerically pure POP ligand L10 (1 mol %) 
and (reusable) Brønsted acids for the efficient conversion of unprotected 
indoles into enantiomerically enriched indolines (six examples, up to 78% 
isolated yield and up to 91% ee; Scheme 6e).
45
 Interestingly, the 
DOWEX
TM
 resin used in this approach was recovered, recycled and reused 
up to twice, giving comparable catalytic activity.  
A similar strategy combining enantiomerically pure palladium 
complexes derived from ligand L11 and ethanesulfonic acid as activator 
enabled the efficient hydrogenation of 2-alkyl-5-aryl-substituted pyrroles 
(15 examples, up to 91% yield, up to 92% ee) to afford the corresponding 
3,4-dihydro-2H-pyrrole derivatives (Scheme 6f).
46
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Scheme 6. Asymmetric hydrogenation of indoles and pyrroles.  
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Very recently, Zhou et al. reported the asymmetric hydrogenation of 
fluorinated pyrazol-5-ols by capturing one of the tautomers with the aid of 
a strong Brønsted acid as activator. Two catalytic systems were developed 
for 4-unsubstituted of 4-substituted pyrazol-5-ols, which based on the use 
of ligand L12 or L13 and TFA or L-CSA as activators, respectively 
(Scheme 6g).
47
 The hydrogenation of up to 17 examples was reported, with 
overall enantioselectivity in the corresponding substituted hydrogenated 
compounds ranging from 82 to 96% ee.  
Because partially saturated indoles represent an interesting class of 
organic molecules that can be found in many bioactive compounds, other 
activation methods for increasing the reactivity of indole derivatives 
towards hydrogenation involving CC double bond migration have also 
been developed (Method B in Scheme 5).
48
 Easily available 3-(-
hydroxyalkyl)indoles can readily be dehydrated in the presence of a 
Brønsted acid to form a conjugated iminium derivatives, in which the 
aromaticity has been partially broken.
49
 Zhou, Jiang et al. took advantage 
of some of the palladium-based enantioselective catalytic systems 
described previously (see Scheme 7) for the hydrogenation of 3H-indol-1-
ium derivatives.
48
 In this case, the iminium derivatives (produced in situ) 
were efficiently hydrogenated in the presence of the standard palladium 
precursor and ligand L7 in high yields (up to 99%) and with 
enantioselectivities ranging from 85 to 97% (Scheme 7a). This 
methodology provided an efficient route to enantiomerically enriched 2,3 -
disubstituted indolines (20 examples) all possessing relative cis-
stereochemistry of the two substituents of the indoline ring. A wide variety 
of aryl and aralkyl substituents at the 2- and 3-positions of the indole 
system did not provoke major changes in the enantioselectivities (ee values 
ranged from 88 to 94% ee). Substitution at the  5-position of the indole 
with a fluoro group brought ee values to the lowest levels seen in the 
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series due to steric and electronic effects, whereas the highest 
enantioselectivities were obtained with a methyl group at the 7-position, 





 prepared a set of enantioenriched indolines 
analogous to that reported by Zhou, Jiang and coworkers
48
 using an elegant 
tandem condensation and hydrogenation process. The tandem process 
involved a Brønsted-acid-promoted Friedel-Crafts reaction of the C3-
unsubstituted indole to yield the corresponding 3-(-hydroxyalkyl)indoles, 
which were directly hydrogenated in the presence of the catalytic system 
incorporating ligand L7 (Scheme 7a). The overall selectivity of the process 
is similar regardless of how the 3-(-hydroxyalkyl)indoles are prepared 
(preformed in Zhou’s and Jiang’s method
48




Analogous 2,3-disubstituted indolines were obtained from 3-
(tolylsulfonamidoalkyl)indoles (Scheme 7b), their asymmetric 
hydrogenation catalyzed by palladium complexes of ligand L7 was 
triggered by acid-mediated elimination of toluenesulfonamide (TsNH 2). 
This method also proved to be highly efficient and fourteen di- or tri-
substituted indolines were efficiently prepared (up to 97% yield and 97% 
ee) following this approach.
51 
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Scheme 7. Elimination-triggered asymmetric hydrogenation of indoles. 
As a conclusion to this section, asymmetric hydrogenation of indoles 
triggered either by protonation or by double bond migration has enabled 
access to a wide variety of mono-, di-, or tri-substituted indolines with 
high enantioselectivities. Palladium- or iridium-based hydrogenation 
catalysts have been used for this transformation. A strategy for recovering, 
recycling, and reusing the stoichiometric amounts of the required Brønsted 
acids has also been developed. However, the main limitation lies in  the 
fact that triggering hydrogenation by protonation or double bond migration 
can intrinsically only be applied to a reduced number of heteroarenes (for 
instance, indole, pyrrole, and pyrazole derivatives, as has been 
demonstrated to date). 
2A.4 Conclusions and Future Outlook 
In this review we have focused on the various strategies devised to 
activate heteroaromatic substrates towards asymmetric hydrogenation by 
manipulation of their structures. The published examples have been 
classified into three different strategies, and the most relevant 
experimental details (catalyst employed, reaction conditions used, type of 
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heteroarene, structural diversity, and catalyst activity in terms of 
conversion and enantioselectivity) have been highlighted in the different 
schemes throughout the text. These strategies include the formation of 
positively charged derivatives of the heteroarene (Strategy I), the 
introduction of a coordinating group that facilitates the hydrogenation by 
chelation assistance (Strategy II), and hydrogenation after breaking of the 
aromaticity (Strategy III). The use of an appropriate activation strategy for 
a given type of heteroarene has enabled access to a wide variety of fully 
and partially hydrogenated mono- and bi-cyclic heterocyclic compounds 
with excellent levels of conversion and enantioselectivity. In view of the 
wide repertoire of available ligand scaffolds and the ever -increasing 
number of reports on the application of substrate manipulation as a tool for 
improving the reactivity of heteroarenes in asymmetric hydrogenation, one 
can only imagine that the near future will witness several new examples of 
successful application of this methodology.  
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Subchapter B- Expansion of the scope of 
POP mediated iridium hydrogenations to 
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1  The rationalization of the enantioselectivity by means of computational studies has been 
performed by Mr. Antonio Bauzá under the supervision of Prof. Dr. Antonio Frontera 
(Universitat de les Illes Balears). A summary of the main conclusions of these calculations have 
been included in this subchapter to aid discussion. 
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2B.1 Abstract 
Iridium(I) complexes of phosphine-phosphite ligands efficiently 
catalyze the enantioselective hydrogenation of diverse seven -membered 
CN-containing heterocyclic compounds (eleven examples; up to 97% ee). 
POP ligand L3, which incorporates an ortho-diphenyl substituted 
octahydrobinol phosphite fragment, provided the highest 
enantioselectivities in the hydrogenation of most of the  N-heteroarenes 
that were studied. The observed sense of stereoselection was rationalized 
by means of DFT calculations. 
2B.2 Introduction 
Many biologically active compounds contain a chiral heterocyclic 
structural motif.
7
 Method development to access partly or fully reduced 
enantiopure heterocycles has been growing in scope and importance in 
recent years. The enantioselective reduction of heterocyclic compounds is 
becoming more important in the preparation of their partly or fully reduced 
analogues, as this strategy benefits of a great diversity of starting materials 
and minimizes the need for manipulation of functional groups during the 
preparation of the target compounds.
8,10,11, 52
 Transition metal-catalyzed 
asymmetric hydrogenation has been employed to reduce a large number of 
nitrogenated heterocyclic compounds (for instance pyridines and other 
monocyclic nitrogenated derivatives, quinolines, isoquinolines, 
quinoxalines and related compounds, benzoxazines and related derivatives, 
indoles, etc.) with high catalytic efficiencies and enantioselectivities. 
Although nitrogenated seven-membered heterocyclic motifs with 
stereogenic centers constitute an important pharmacophore,
53
 examples of 
asymmetric reduction of seven-membered heterocyclic derivatives are 
scarce in the literature.
54
 
We recently reported the hydrogenation of an array of structurally 
diverse five- and six-membered heterocyclic compounds 1 mediated by 
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iridium(I) complexes of phosphine-phosphite ligands
55
 [Ir(Cl)(cod)(POP)] 
with high catalytic activity (Scheme 8).
25,27,45 
Ligand L1, which 
incorporates an (Ra)-configured [1,1'-binaphthalene]-2,2'-diol phosphite 
group, provided the highest enantioselectivities in the asymmetric 
hydrogenation of heterocyclic compounds 1. Interestingly, we described 





 and stoichiometric amounts of 
rac-camphorsulfonic acid for indoles
45
) increased the conversion of the 
hydrogenation reaction and even positively affected the 
enantioselectivity.
25
 Herein we report the development of efficient 
[Ir(POP)] complexes as catalysts for the enantioselective asymmetric 
hydrogenation of diversely substituted seven-membered CN-containing 
heterocyclic compounds (see structures 3, 5, 7, 9 and 11 in Scheme 8). 
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Scheme 8. Enantioselective partial hydrogenation of nitrogenated heterocyclic 
compounds. 
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2B.3 Results and Discussion 
2B.3.1 Ir-catalyzed asymmetric hydrogenation. Initial screening 
and optimization 
The present work began with the enantioselective hydrogenation of 
oxazepine 3a as model substrate using well-established
25
 in situ prepared 
iridium complexes of POP ligands L1L4 as precatalysts. The reaction 
conditions studied (1 mol % cat.; [3a] = 0.2 M in THF, 80 bar H2, rt) 
efficiently led to the hydrogenated product 4a with complete conversion in 
the absence of HCl as additive (see entries 1, 3, 5 and 7 in Table 1) with 
enantioselectivities ranging from 16% ee for L4 to 79% ee for L3.
56
 
Enantioselectivities were improved by using 10 mol % of HCl in the case 
of ligands L1, L2 and L3 (compare entries 1, 3 and 5 with entries 2, 4 and 
6 in Table 1), with ligand L3 providing the highest enantioselectivities 
(86% ee, entry 6 in Table 1). The effects of a set of achiral and 
enantiomerically pure additives on the hydrogenation of substrate 3a were 
also studied,
57
 however the best results were obtained with HCl as the 
additive. Further attempts to optimize the hydrogenation conditions were 
aimed at varying the amount of HCl (see entry 9 in Table 1) and reducing 
the temperature (see entry 10 in Table 1). Increasing of the amount of 
additive did not have any effect on the catalytic activity (compare entries 6 
and 9 in Table 1). The hydrogenation of 3a was also run at lower 
temperature (0 ºC instead of rt), based on the premise that lowering the 
temperature normally offers higher enantioselectivity. As listed in entry 10 
of Table 1, the ee at 0 ºC was 1% higher than at rt. However, further 
hydrogenation studies at this temperature were not considered, as 
conversion was not complete. The enantioselectivity of the hydrogenation 
of 3a was solvent dependent, and 2-methyltetrahydrofuran (MeTHF), 
dichloromethane (DCM) or toluene lead to a noticeable increase in the ee 
of the reaction (compare entries 11, 12 and 13 with entry 6 in Table 1). 
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Table 1. Asymmetric hydrogenationa of 3a mediated by [Ir(Cl)(cod)(L1L4)] 
 








1 L1 No additive 99 42 (S) 
2 L1 10 mol % of HCl 99 53 (S) 
3 L2 No additive 99 29 (S) 
4 L2 10 mol % of HCl 99 57 (S) 
5 L3 No additive 99 79 (R) 
6 L3 10 mol % of HCl 99 86 (R) 
7 L4 No additive 99 16 (S) 
8 L4 10 mol % of HCl 99
e
 8 (S) 
9 L3 20 mol % of HCl 99 86 (R) 
10 L3 10 mol % of HCl, 0 ºC 90 87 (R) 
11 L3 10 mol % of HCl, DCM 99 91 (R) 
12 L3 10 mol % of HCl, toluene 99 91 (R) 
13 L3 10 mol % of HCl, MeTHF
f
 99 91 (R) 
a Reaction conditions: [{Ir(Cl)(cod)}2]/POP ligand/substrate = 0.5:1.1:100 for 
precatalyst levels of 1 mol %, respectively, at rt, 20 h and a substrate 
concentration of 0.20 M in THF. If additive was present, the indicated amount of 
additive with respect to 3a was added to a solution of the substrate before adding 
the catalyst. The values shown are the average of at least two runs. b Conversions 
were determined by 1H NMR. c Determined by HPLC analysis using chiral 
stationary phases. d Absolute configuration was assigned by comparison with 
literature data (see ref. 54c). e The selectivity of the reaction towards 4a was 35%.  
f MeTHF ≡ 2-methyltetrahydrofuran.  
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2B.3.2 Expanding the substrate scope 
Once the optimal hydrogenation conditions for 3a had been established, 
the hydrogenation of an array of seven-membered heterocycles was 
studied. 2-Methyltetrahydrofuran was chosen as the optimal solvent for 
further studies, given the overall good results in the hydrogenation of 3a. 
The heterocycles studied and the optimal ligand (L1 or L3) for achieving 
the highest ee’s are summarized in Table 2. The results using 10 mol % of 
HCl are only indicated in Table 2 when this additive provided higher 
conversions and/or ee’s. The reader is referred to  the Supplementary 
Information (Table SI3) for the complete hydrogenation results employing 
L1 or L3 as ligands and in the absence or presence of anhydrous HCl as 
additive. 
Several trends can be extracted from the results listed in Table 2. 
Firstly, L3 was the ligand of choice for heterocycles with R = alkyl group 
(entries 1, 35, 7, 9 and 11 in Table 2). For these substrates, ee’s ranged 
from 70 to 91%, with the highest ee’s being obtained for oxazepine 4a and 
thiazepine 9a (91% ee; see entries 1 and 9 in Table 2). Secondly, the use 
of HCl as additive in the hydrogenation of substrates with R being an alkyl 
group had, with the exception of substrates 3c and 5a (see entries 3 and 5 
in Table 2), a positive effect on the ee’s.
58
 Examples of the use of Brønsted 
acids as substrate activators in iridium-mediated hydrogenations are 
numerous
52j
 but, despite the improvement in catalyst activity and/or 
selectivity induced by these additives, their role remains unclear.
52j
 The 
third and last trend that can be extracted from the data summarized in 
Table 2, is that the hydrogenation of the substrates with R = Ph 
(compounds 3b, 5b, 7b and 9b) was more complicated than that of their 
alkyl substituted analogues. Though the hydrogenation of the O- and S-
containing substrates took place efficiently in the absence of HCl 
(conversions up to 97%, ee’s up to 97%, entries 2 and 10 in Table 2), the 
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hydrogenation of carbon and nitrogen-analogues 5b and 7b proceeded with 
low conversions and ee’s (entries 6 and 8 in Table 2). 
Table 2. Asymmetric hydrogenationa of seven-membered N-Heterocyclic 












1 3a (O, Me)
e
 L3 10 mol % of HCl 99 91 (R) 
2 3b (O, Ph) L1 none 97 83 (S) 
3 3c (O, iPr) L3 none 99 73 (R) 
4 3d (O, Bn) L3 10 mol % of HCl 99
f
 87 (R) 
5 5a (CH2, Me) L3 none 99 70 (R) 
6 5b (CH2, Ph) L3 10 mol % of HCl 33
g
 9 (S) 
7 7a (NMe, Me)  L3 10 mol % of HCl 99 84 (R) 
8 7b (NMe, Ph)  L1 none 24
g
 36 (S) 
9 9a (S, Me) L3 10 mol % of HCl 99 91 (R) 
10 9b (S, Ph) L3 none 72
f
 97 (S) 
11 11a (SO2, Me) L3 10 mol % of HCl 99
f
 77 (R) 
a Reaction conditions: [{Ir(Cl)(cod)}2]/POP ligand/substrate = 0.5:1.1:100 for 
precatalyst levels of 1 mol %, respectively, at rt, 20 h and a substrate 
concentration of 0.20 M in MeTHF. If additive was present, the indicated amount 
of additive with respect to substrate was added to a solution  of the substrate before 
adding the catalyst. The values shown are the average of at least two runs. b 
Conversions were determined by 1H NMR. Isolated yields after chromatography 
were >95%, unless otherwise stated. c Determined by HPLC analysis using chiral 
stationary phases. d Absolute configurations of 4a, 4b, 4d, 10a and 10b were 
assigned by comparison with literature data (see ref. 54c for the oxazepines and 
ref. 54h for the thiazepines). The configurations of 4c, 6a, 6b, 8a and 8b were 
assumed by analogy. The absolute configuration of 12a was determined by X-ray 
analysis (see SI for details). e These results have been already summarized in Table 
1, but are included here for comparison. f Isolated yields for 4d, 10b and 12a were, 
32%, 53% and 59%, respectively. g Isolation was not attempted due to low 
conversions and ee’s.  
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Previous work from our group on asymmetric hydrogenations mediated 
by Ir-
 25, 27, 45 
or Rh-complexes
59
 of POP ligands revealed that the 
phosphite group was the principal stereochemical director in the reaction 
(opposite configurations for the resulting hydrogenated products are 
obtained when the configuration of the phosphite moiety is inverted). 
Moreover, the introduction of substituents at the 3 and 3’ positions of the 
[1,1'-biaryl]-2,2'-diol group did not change the configuration of the final 
product in Rh-mediated hydrogenations.
59
 Interestingly, ligands L1 (or L2) 
and L3, whose main difference is the presence or absence of substituents 
at the 3 and 3’ positions of the binaphthyl motif, led to opposite 
enantiomers of 4, 6 and 8 depending on the nature of the R substituent 
(alkyl or aryl groups; as an example, see Scheme 9 for the hydrogenation 
reactions leading to 4). 
 
Scheme 9. Hydrogenation reactions of 3 leading to products 4. 
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2B.3.3 Rationalization of the stereochemical outcome of the 
hydrogenations by DFT calculations 
To shed light on the correlation between the features of the POP 
ligands and enantioselection in the hydrogenation towards alkyl -
substituted products, we performed a theoretical investigation into the 
reactivity of the catalytic systems derived from ligands L1 and L3 with 
substrate 3a. We considered this substrate to be suited to our purposes, as 
the configuration of the final product depends on whether the substituents 
at the 3 and 3’ positions of the phosphite group are H (L1; S-configured 
product, see entries 1 and 2 in Table 1 and Scheme 9) or Ph groups (L3; R-
configured product; see entries 5 and 6 in Table 1 and Scheme 9) and the 
absolute stereochemistry of its hydrogenated product was unequivocally 
assigned. The usual approach for theoretical studies on enantioselective 
processes is to focus on the stereo-determining step and compare the 
energy of transition states (TS’s) for the paths leading to the (R) and (S) 
products.
60
 The mechanism for the hydrogenation of iminic bonds is 
complex but has been explored at the experimental and theoretical level by 
a number of groups. Mechanistic studies from Pfaltz and co-workers have 
revealed that the employed iridium complexes react with the acyclic C=N -
containing substrates to form a cyclometallated iridium complex that is the 
real hydrogenation catalyst.
61
 On the contrary, a number of mechanistic 
studies from other research groups have revealed that the most favored 
process is the transfer of proton and hydride to the CN bond of the 
heterocyclic derivative being non-coordinated to the metal center.
62
 
We first explored the possibility of the hydrogenation pathway 
involving the formation of cyclometallated iridium complexes derived 
from 3a. The stabilities of the plausible four-membered iridacycles derived 
from 3a were computed at the BP86/def2-SVP level of theory (see Figure 
SI67), which is a good compromise between the size of the system (up to 
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139 atoms for the iridacycle involving L3) and the accuracy of the results. 
The energy content of the resulting four-membered iridacycles was very 
elevated indicating the highly strained nature of these compounds.
63
 
Therefore this hydrogenation pathway via the formation of such 
intermediates derived from 3a was not further explored. As regards the 
hydrogenation pathway involving proton and hydride transfers to the CN 
bond of heterocyclic derivatives, Crabtree and Eisenstein
62b
 identified 
octahedral dihydrido mono-dihydrogen iridium complexes as crucial 
intermediates in the hydrogenation process, as hydrogen transfer from H 2 
to the CN bond starts with proton migration from the dihydrogen ligand 
to the nitrogen atom. Once the CN bond is protonated,
64
 the position 
alpha to nitrogen is activated for the subsequent hydride transfer, which is 





 have demonstrated that the complexation of POP 
ligands with [{Ir(-Cl)(cod)}2] quantitatively leads to compounds 
[Ir(Cl)(cod)(POP)], which correspond to the expected neutral 
pentacoordinated iridium(I) complexes. Removal of the cod ligand under 
hydrogenative conditions led to a complex mixture of [Ir(POP)] 
complexes. Unfortunately, neither NMR nor X-ray analysis allowed us to 
unequivocally establish the structure of the iridium complexes present in 
solution (no crystals suitable for X-ray analysis could be isolated from this 
mixture). For this reason, the relative stabilities of the plausible 
[Ir(Cl)(H)2(HH)(L1 or L3)] complexes were computed at the BP86/def2-
SVP level of theory. From among all the possible isomers in an octahedral 
iridium complex with one bidentate (L1 or L3) and one chlorido ligand, 





 (hydrogen transfer from [Ir(Cl)(H)2(HH)(L1 
or L3)] complexes will lead to a trihydrido iridium complex and metal 
trihydrides have an intrinsic preference
62b
 for a fac geometry to avoid 
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hydrido ligands that are mutually placed in a trans fashion). Interestingly, 
in [Ir(Cl)(H)2(HH)(L1)] the favorable fac isomers (see Figure 1) present 
the chlorido ligand pointing in the same direction and perpendicular to the 
plane that contains the POP and Ir atoms (see Figure 1a,b). The slightly 
more favored complex (difference 0.3 kcal·mol
–1
) has the HH ligand cis 
to the phosphite group. With regard to [Ir(Cl)(H)2(HH)(L3)], the lowest 
energy isomers also present the chlorido ligand perpendicular to the same 
plane but pointing in the opposite direction with respect to the 
[Ir(Cl)(H)2(HH)(L1)] complexes (see Figure 1c,d). This is due to the 
formation of intramolecular CH···Cl bonds (see Figure 1 and SI69). This 
differentiating feature is very important for rationalizing the opposite 
enantioselectivity observed for L1 and L3 with methyl substituted 
substrates such as 3a (vide infra). 
 
Figure 1. (ad) Optimized geometries of the most stable isomers of 
[Ir(Cl)(H)2(HH)(L1 or L3)] (some H atoms omitted for clarity; distances in Å, 
Relative energy profiles in kcal·mol–1). 
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Protonation of 3a by [Ir(Cl)(H)2(HH)(L1 or L3)]
64 
leads to the 
[H3a][Ir(Cl)(H)3(L1 or L3)] assembly (see Figure 2a,b). Either isomer of 
complex [Ir(Cl)(H)2(HH)(L1)] (see Figure 1a,b) yields the same fac 
trihydrido iridium complex upon proton transfer (same behavior for L3), 
which simplifies the study. Proton transfer is not the stereo -determining 
step and the configuration of the final product is determined at later stages 
of the catalytic cycle. Therefore we started the calculations for 
understanding the stereochemical outcome of the reaction from the 
protonated substrate (H3a). Beginning from the initial geometry after 
proton transfer, where the N–H group points to the Ir–H motif (see Figure 
2a,b), we examined different orientations for the protonated substrate 
(H3a) interacting with [Ir(Cl)(H)3(L1 or L3)]. Remarkably, we found a 
pre-TS complex for each ligand (see Figure 2c,d) that were lower in 
energy than the initial assembly due to the formation of favorable non-
covalent interactions. In the case of L1, the preferred arrangement is 
governed by two interactions that fix the geometry of the substrate (H -
bond and CH3··· interactions, see Figure 2c). This preorganized complex 
facilitates the nucleophilic attack of the hydrido group that is located 3.0 Å 
away from the C atom in the CN group (pro-(S) attack). In the case of L3, 
the presence of the chlorido ligand at the opposite position to the POP 
containing plane with respect to L1 and the formation of a strong 
NH···Cl interaction fixes the substrate in a different arrangement 
compared to L1. Moreover the formation of a CH···HIr non-covalent 
interaction (see Figure 2b) fixes the position of the substrate, facilitating 
the pro-(R) attack of the hydrido ligand (located at 3.1 Å). The pre-TS 
complexes that would organize the protonated substrate towards the minor 
enantiomer (i.e. pro-(R) attack for L1 and pro-(S) attack for L3) were not 
found in the potential hypersurface. The geometries of the TS’s are shown 
in Figure 3 and Figure SI70. It is important to note the existence of strong 
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N–H···Cl hydrogen bonds in the favored TS’s. These interactions are 
crucial in rationalizing the observed sense of stereoselection. The 





) is mainly governed by the different strength of two 
hydrogen-bond interactions: an NH···Cl hydrogen-bond for the TS 
leading to the major enantiomer (TSS; see Figure 3a) and an NH···O 
hydrogen-bond for the TS leading to the minor enantiomer (TS R; see 
Figure SI70a). Since the NH···Cl interaction involves an anionic ligand, 
it is electrostatically favored with respect to the NH···O interaction. As 
regards to L3, the transition state leading to the major enantiomer is also 
stabilized by an NH···Cl hydrogen-bond (TSR; see Figure 3b), whilst that 
leading to the minor enantiomer is only stabilized by a weaker NH··· 
interaction involving a phenyl group (see Figure SI70b). Since this 
NH··· interaction involving TSS derived from L3 is also weaker than the 
NH···O hydrogen bond in TSR derived from L1 (both leading to the 
minor enantiomers of the hydrogenation product of 3a), the ΔΔG
#
 value 
for L3 (4.3 kcal·mol
-1
) is higher than that for L1 (2.2 kcal·mol
-1
). This 
observation is in agreement with the higher  enantioselectivity observed 
experimentally in the hydrogenation of 3a with L3 than that with L1 
(compare entry 5 with entry 1 in Table 1, respectively). 
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Figure 2. (a,b) Optimized geometries of [H3a][Ir(Cl)(H)3(L1 or L3)] assemblies. (c, 
d) Distances in Å of pre-TS complexes found for [H3a][Ir(Cl)(H)3(L1 or L3)] (some 
H atoms omitted for  clarity).  
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Figure 3. Optimized geometries of the transition states of L1 (a) and L3 (b) and their 
energetic profiles in kcal·mol –1 (some H atoms omitted for clarity).  
2B.4 Conclusions 
In conclusion, catalytic screening in enantioselective hydrogenation 
reactions revealed that the iridium complexes of chiral POP ligands L1 
and L3 are excellent catalysts in the hydrogenation of various seven -
membered heterocycles that contain CN bonds. The “lead” precatalyst for 
alkyl-substituted seven-membered heterocycles (derived from ligand L3) 
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in combination with catalytic amounts of  HCl exhibits excellent catalytic 
properties in this transformation. The hydrogenation of aryl -substituted 
seven-membered heterocycles was more complicated and highly efficient 
hydrogenation conditions could only be developed for phenyl substituted 
oxa- and thia-azepines employing L1 without additive. The 
enantioselectivity has been rationalized by means of DFT calculations, 
which have identified the position of the Cl-ligand in catalytically relevant 
iridium structures and a number of non-covalent interactions (i.e. 
NH···Cl, CH··· and CH···HIr interactions
67
) as key features in 
rationalizing the stereochemical outcome of the reactions with ligands L1 
and L3. 
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2B.5 Experimental Section 
2B.5.1 General procedure for the Ir-catalyzed asymmetric 
hydrogenation 
A solution of the required amount of [{Ir(μ-Cl)(cod)}2] (5 mol) and 
the POP ligand (0.011 mmol) in the corresponding dry and deoxygenated 
solvent (5.0 mL) was loaded into an autoclave under N 2, in which the 
required amounts of substrate (1 mmol) and additives (if necessary) were 
placed beforehand. The concentration of the substrate was adjusted to a 
final 0.20 M concentration. The autoclave was purged three times with H 2 
(at a pressure not higher than the one selected) and finally, the autoclave 
was pressurized with H2 to the desired pressure. The reaction mixture was 
stirred at the desired temperature for the stated reaction time. The 
autoclave was subsequently depressurized, the reaction mixture passed 
through a short pad of SiO2 and further eluted with EtOAc (2 x 1 mL). The 
resulting solution was evaporated in vacuo. The conversion was 
determined by 
1
H NMR and enantioselectivities were determined by HPLC 
analysis on chiral stationary phases. 
2B.6 Supporting information 
2B.6.1 General considerations 
Air- and moisture-sensitive manipulations or reactions were done under 
inert atmosphere using anhydrous solvents, either in a glove box or with 
standard Schlenk techniques. Glassware was dried under vacuum and was 
heated with a hot air gun before use. All solvents were dried in a Solvent 
Purification System (SPS). Silica gel 60 (230-400 mesh) was used for 
column chromatography. NMR spectra were recorded on 400 MHz or 500 
MHz spectrometers in CDCl3, unless otherwise cited. 
1




H} NMR chemical shifts are quoted in ppm relative to the residual 
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H} NMR chemical shifts are quoted in ppm relative to 
85% phosphoric acid in water. High-resolution mass spectra (HRMS) were 
recorded using ESI ionization method in positive mode. GC-MS analyses 
were performed using EI as ionization method. Enantiomeric excesses 
were determined by HPLC analyses, using chiral stationary phases. HPLC 
analyses were performed on an instrument equipped with a diode array UV 
detector (DAD). 
2B.6.2 General synthetic procedure for the POP ligands 








 has been 
previously reported by us in the literature. The preparation methods for L2, 
L4 and L6 are indicated below. 
 
Figure SI1. Set of enantiomerically pure POP ligands. 
Preparation of Ligand L2 . The borane complex of (1R,2S)-1-
(diphenylphosphanyl)-3-methoxy-1-phenylpropan-2-ol
68
 (772 mg, 2.12 
mmol) and diazabyciclo[2.2.2]octane (485 mg, 4.24 mmol) were charged 
in a flame-dried schlenk flask. The system was purged with three 
vacuum/Ar cycles and dry and deoxygenated toluene (12.0 mL) was added. 
A solution of the required chlorophosphite
70
 (871 mg, 2.33 mmol) in THF 
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(12 mL) was then added dropwise. The mixture was stirred for 16 h at 
room temperature. The reaction mixture was filtered through celite under 
inert atmosphere and the filtrate was evaporated in vacuo. Rapid 
chromatography of the residue over SiO2 (12 g) inside a glove box using 
dry and deoxygenated solvents (1:1; CH2Cl2:Hexane) gave the ligand L2 
as a white solid (824 mg, 58%). mp = 9496 ºC; [α]D
25 = 235.1 (c 0.117, 
CH2Cl2); IR absorption (neat) ῡ 3053, 2925, 2856, 1583, 1467, 1433. 
1
H 
NMR (500 MHz, CDCl3) 7.82-7.72 (m, 2H), 7.53 (d, J = 8.2 Hz, 1H), 
7.43-7.36 (m, 3H), 7.35-7.28 (m, 2H), 7.23-7.07 (m, 9H), 7.01 (d, J = 8.2 
Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 4.40-4.33 (m, 1H), 3.76 (dd, 
2
JH-P = 4.8 
Hz, 
3
JH-H = 3.3 Hz, 1H), 3.20 (s, 3H), 3.20-3.16 (m, 1H), 2.96-2.66 (m, 7H), 





(125 MHz, CDCl3) 146.86 (C), 146.84 (C), 138.5 (C), 137.5 (C), 137.4 
(C), 137.2 (C), 137.1 (C), 136.4 (C), 136.2 (C), 135.3 (CH), 135.1 (CH), 
134.5 (C), 133.8 (C), 133.2 (CH), 133.1 (CH), 131.3 (CH), 131.2 (CH), 
130.0 (C), 129.9 (C), 129.8 (C), 129.2 (CH), 129.1 (CH), 129.02 (CH), 
128.98 (CH), 128.3 (CH), 128.2 (CH), 128.11 (CH), 128.06 (CH), 126.9 





JC-P = 12.1 Hz, CH), 58.9 (CH3), 48.2 (dd,
 1
JC-P = 15.0 Hz, 
3
JC-P = 
6.4 Hz, CH), 29.6 (CH2), 29.4 (CH2), 28.1 (CH2), 27.9 (CH2), 23.1 (CH2), 




H} NMR (202 MHz, CDCl3) 
149.5 (bs, PO), 4.8 (bs, PC); HRMS (ESI+): calculated for 
C42H43O4P2 (M+H)
+ 
673.2657; observed 673.2631. 
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Figure SI2. 1H NMR spectrum of L2. 
 
 
Figure SI3. 13C{1H} NMR spectrum of L2. 
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Figure SI4. 31P{1H} NMR spectrum of L2. 
Preparation of Ligand L4 . The borane complex of (1R,2S)-1-
(diphenylphosphanyl)-3-methoxy-1-phenylpropan-2-ol
68
 (354 mg, 0.972 
mmol) and diazabyciclo[2.2.2]octane (223 mg, 1.94 mmol) were charged 
in a flame-dried schlenk flask. The system was purged with three 
vacuum/Ar cycles and dry and deoxygenated toluene (6.0 mL) was added. 
The reaction mixture was heated at 60 ºC and stirred for 2 h, allowed to 
cool down to room temperature, passed through a short SiO 2 pad under N2 
atmosphere and further eluted with dry and deoxygenated toluene (4.0 mL) 
giving a solution of (1R,2S)-1-(diphenylphosphanyl)-3-methoxy-1-
phenylpropan-2-ol which was then dried under vacuum. The residue was 
dissolved in THF (5 mL) and NEt3 (2.52 mL, 18.2 mmol) and DMAP (5.94 
mg, 0.048 mmol) were added to the phosphino alcohol solution. A solution 
of the required chlorophosphite
71
 (568 mg, 1.07 mmol) in THF (12 mL) 
was then added dropwise. The mixture was stirred for 16 h at room 
temperature. The reaction mixture was filtered through celite under inert 
atmosphere and the filtrate was evaporated in vacuo. Rapid 
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chromatography of the residue over SiO2 (12 g) inside a glove box using 
dry and deoxygenated solvents (1:1; CH2Cl2:Hexane) gave the ligand L4 
as a white solid (598 mg, 73%). mp = 99101 ºC; [α]D
25 = 242.1 (c 0.124, 
CH2Cl2); IR absorption (neat) ῡ3056, 2986, 2926, 1599, 1492; 
1
H NMR 
(400 MHz, CDCl3)  7.68-7.47 (m, 8H), 7.35-6.95 (m, 27H), 5.06 (dd, 
3
JH-
H = 8.2 Hz, 
4
JH-P = 2.3 Hz, 1H), 4.97 (d, 
3
JH-H  8.2 Hz, 1H), 4.81-4.70 (m, 
1H), 3.96 (dd, 
2
JH-P = 4.88 Hz, 
3
JH-H = 3.3 Hz, 1H), 3.36-3.29 (m, 1H), 





(125 MHz, CDCl3)  146.4 (C), 146.0 (C), 142.02 (C), 142.00 (C), 141.0 
(C), 137.6 (C), 137.5 (C), 137.03 (C), 136.97 (C), 136.8 (C), 134.3 (CH), 
134.1 (CH), 133.9 (CH), 133.7 (CH), 131.6 (CH), 131.5 (CH), 129.32 
(CH), 129.26 (CH), 129.2 (CH), 129.0 (CH), 128.8 (CH), 128.7 (CH), 
128.3 (CH), 128.0 (CH), 127.84 (CH), 127.79 (CH), 127.76 (CH), 127.6 
(CH), 127.50 (CH), 127.48 (CH), 127.4 (CH), 127.3 (CH), 127.1 (CH), 
126.5 (CH), 112.7 (C), 84.7 (d, JC-P = 5.8 Hz, C), 82.6 (d, JC-P = 19.0 Hz, 
CH), 82.5 (d, JC-P = 4.6 Hz, C), 81.6 (d, JC-P = 3.7 Hz, CH), 73.5 (bs, CH2), 
72.8 (dd,
 1
JC-P = 16.6 Hz, 
3









H} NMR (162 
MHz, CDCl3)  146.01 (d, 
4
JP-P = 13.9 Hz, P-O), 8.43 (d, 
4
JP-P = 13.9 Hz, 
P-C); HRMS (ESI
+
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Figure SI5. 1H NMR spectrum of L4. 
 
Figure SI6. 13C{1H} NMR spectrum of L4. 






































































































































































































































































































































































































UNIVERSITAT ROVIRA I VIRGILI 








Figure SI7. 31P{1H} NMR spectrum of L4. 
Preparation of Ligand L6. The same protocol as for L4 was used, 
with the following amounts of reagents (solvent amounts were adapted so 
that concentrations were the same): borane complex of (1R,2S)-1-
(diphenylphosphanyl)-3-methoxy-1-phenylpropan-2-ol (0.331 g, 0.908 
mmol),
68
 DABCO (0.208 g, 1.82mmol), NEt3 (2.52 mL, 18.2 mmol), 
DMAP (5.94 mg, 0.0486 mmol) and chlorophosphite
71
 (0.506 g, 0.045 
mmol). L6 was obtained as a white solid (0.527 g, 69%). mp = 186189 
ºC; [α]D
25  = 72.4 (c 0.155, CH2Cl2); IR absorption (neat) ῡ 3056, 2933, 
1599, 1491, 1448; 
1
H NMR (500 MHz, CDCl3) 7.68-7.47 (m, 6H), 7.46-
7.00 (m, 29H), 5.38 (d, 
3
JH-H = 8.2 Hz, 1H), 5.11 (d, 
3
JH-H = 7.8 Hz, 1H), 
4.59-4.51 (m, 1H), 3.90 (dd, 
2
JH-P = 4.8 Hz, 
3
JH-H = 3.0 Hz, 1H), 3.09 (s, 




H} NMR (126 MHz, CDCl3) 146.0 (C), 145.7 (C), 142.1 (C), 141.5 
(C), 137.0 (C), 136.9 (C), 136.8 (C), 136.7 (C), 134.7 (CH), 134.6 (CH), 
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133.7 (CH), 133.5 (CH), 131.6 (CH), 131.5 (CH), 129.4 (CH), 129.3 (CH), 
128.8 (CH), 128.7 (CH), 128.4 (CH), 128.2 (CH), 128.0 (CH), 127.94 
(CH), 127.88 (CH), 127.8 (CH), 127.61 (CH), 127.56 (CH), 127.5 (CH), 
127.27 (CH), 127.25 (CH), 127.1 (CH), 126.5 (CH), 113.6 (C), 86.2 (d, JC-
P = 10.2 Hz, C), 83.3 (C), 82.3 (d, JC-P = 13.0 Hz, CH), 80.1 (d, JC-P = 4.6 
Hz, CH), 73.0 (bs, CH2), 72.8 (dd, 
 1
JC-P = 17.5 Hz, 
3
JC-P = 13.9 Hz, CH), 
58.7 (CH3), 47.5 (dd,
 1
JC-P = 14.2 Hz, 
3





H} NMR (202 MHz, CDCl3) 143.2 (d, 
4
JP-P = 25.2 Hz, P-O), 
8.5 (d, 
4
JP-P = 25.0 Hz, P-C); HRMS (ESI
+
): calculated for C53H50NaO6P2 
(M+Na)
+




Figure SI8. 1H NMR spectrum of L6. 
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Figure SI9. 13C{1H} NMR spectrum of L6. 
 
Figure SI10. 31P{1H} NMR spectrum of L6. 
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2B.6.3 Synthetic procedure for the preparation of heterocyclic 
compounds 3ad, 5a, 5b, 7a, 7b, 9a, 9b and 11a. 
Compounds 3ad, 5a, 5b, 9a and 9b were synthesized in 2 steps from 
the substituted anilines SI-1 by following a known literature procedure.
54c
 
Scheme SI1. Synthetic procedure for the preparation of heterocyclic compounds 
3ad, 5a, 5b, 9a, and 9b. 
Commercially available aniline derivatives SI-1 (5 mmol) were 
dissolved in 15 mL of CH2Cl2 and cooled to 0 ºC. The corresponding 
acetyl chloride (1.05 mmol) was added slowly to the solution. Then the 
temperature of the reaction mixture was allowed to reach rt and further 
stirred at this temperature. After the reaction was complete (TLC control, 
ca. 2 h), water (20 mL) was added to the reaction mixture. The organic 
layer was washed with brine (2 × 20 mL), dried over anhydrous MgSO 4 
and concentrated in vacuo. The residue was purified by flash 
chromatography over SiO2 using mixtures of n-hexane and EtOAc (90:10 
to 70:30) to obtain the products SI-2. These derivatives were used in the 
synthetic protocol without any further purification. Thus, compounds SI-2 
(3 mmol) were added to a mixture of polyphosphoric acid (PPA) (18 
mmol) and phosphorus oxychloride (18 mmol). The reaction mixture was 
heated at 120 ºC and the dense solution was stirred for 3 h. The reaction 
mixture was allowed to cool down to rt. DCM (6 mL) was added to the 
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original dense solution and the new solution was slowly poured onto iced 
water. The aqueous solution was neutralized with an ammonia solution 
(30%; ca. 10 mL), extracted with CH2Cl2 (30 mL). The organic solution 
was washed with brine (2 x 30 mL) and dried with anhydrous MgSO 4, 
concentrated under vacuum. The crude mixture was purified by column 
chromatography over SiO2 eluting with mixtures of n-hexane and EtOAc 











 were previously 
reported and the obtained physical and spectroscopic data were in 
agreement with the reported ones. Compound 5a was previously reported 
but complete spectroscopic data was not detailed in the corresponding 
publication.
72
 These data is summarized below. Compounds 3c and 5b are 
new compounds and the spectroscopic data are indicated below.  
Compound 3c: Yellow solid; 61% yield; mp = 6466 ºC; IR 
absorption (neat) ῡ3065, 2967, 1620, 1598, 1472; 
1
H NMR (500 MHz, 
CDCl3)  7.47–7.38 (m, 2H), 7.32–7.28 (m, 1H), 7.20 (ddd, J = 8.1, 6.9, 





H} NMR (126 MHz, CDCl3)  174.7 (C), 161.9 (C), 152.6 
(C), 141.1(C), 132.3 (CH), 128.8 (C), 127.9 (CH), 127.9 (CH), 127.0 
(CH), 125.6 (CH), 125.2 (CH), 120.9 (CH), 120.6 (CH), 36.7 (CH), 21.2 
(CH3); HRMS (ESI
+
): calculated for C15H14N (M+H)
+




 Yellow Solid; 74% yield; mp = 9799 ºC; IR 
absorption (neat) ῡ3061, 2952, 1612, 1562; 
1
H NMR (500 MHz, CDCl3)  
7.50 (dd, J = 8.1, 1.3 Hz, 1H), 7.39–7.34 (m, 1H), 7.29–7.17 (m, 6H), 7.10 




H} NMR (126 MHz, 
CDCl3)  167.6 (C), 145.7 (C), 142.6 (C), 133.8 (C), 132.9 (C), 131.0 
(CH), 127.3 (CH), 127.2 (CH), 126.8 (CH), 126.6 (CH), 126.0 (CH), 125.3 
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(CH), 39.3 (CH2), 28.8 (CH3); HRMS (ESI
+
): calculated for C15H14N 
(M+H)
+
 208.1118; observed 208.1121. 
Compound 5b: Yellow solid; 89% yield; mp = 152154 ºC; IR 
absorption (neat) ῡ3053, 2958, 1588, 1441; 
1
H NMR (500 MHz, CDCl3)  
7.90–7.82 (m, 2H), 7.51–7.38 (m, 5H), 7.35 (dd, J = 7.7, 1.2 Hz, 1H), 





H} NMR (126 MHz, CDCl3)  167.1 (C), 145.9 (C), 143.9 (C), 
141.3 (C), 133.1 (C), 131.8 (C), 131.3 (CH), 130.3 (CH), 130.1 (CH), 
130.0 (CH), 128.3 (CH), 127.2 (CH), 127.1 (CH), 126.6 (CH), 126.2 (CH), 
125.9 (CH), 125.8 (CH), 39.5 (CH2); HRMS (ESI
+
): calculated for 
C20H16N (M+H)
+
 270.1266; observed 270.1277. 
Compounds 7a and 7b were synthesized in 2 steps by Cu-mediated 
coupling of the corresponding aminophenones with o-iodo aniline
73
 
followed by N-alkylation. 
 
Scheme SI2. Synthetic procedure for the preparation of heterocyclic compounds 
7a and 7b. 
A mixture of 2-aminoacetophenone or 2-aminobenzophenone (2.6 
mmol), 2-iodoaniline (2.0 mmol), Cu2O (0.2 mmol) and K2CO3 (5 mmol) 
in dry xylene (50 mL) was stirred at 145 °C under Ar until TLC analysis 
showed no starting material left (24 h). The reaction mixture was allowed 
to cool down to rt and the residue was washed with EtOAc (25 mL). The 
combined organic extracts were washed with H2O (25 mL) and sat. NaCl 
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solution (25 mL). The organic layers were dried over MgSO4, filtered and 
evaporated under reduced pressure. The residue was purified by 
chromatography over SiO2 with hexanes:EtOAc mixtures of increasing 
polarity (10:1 to 10:3) to afford dibenzodiazepine derivatives SI-3 as a 
yellow solids. These derivatives were used in the next step without any 
further purification. The unprotected dibenzodiazepine derivatives SI-3 
(2.0 mmol) were dissolved in dry DMF (15 mL) and the solution was 
cooled to 0 ºC. NaH (60% dispersion in mineral oil, 4.0 mmol) was then 
added and the reaction mixture allowed to stir for 10 min. Methyl iodide 
(4.0 mmol) was added, the reaction mixture was stirred at 0 ºC for another 
2 h and then quenched with glacial acetic acid (16 mmol). The reaction 
mixture was poured into H2O (30 mL) and extracted with EtOAc (3 × 30 
mL). The organic layer was washed with saturated NaHCO 3 (2 x 30 mL) 
and brine (1 x 30 mL) and then dried over MgSO 4. The solvent was 
removed in vacuo to give a solid that was purified by flash 
chromatography over SiO2 using hexanes/EtOAc mixtures of increasing 
polarity (up to a 1:1 mixture) as the eluent to give 7a and 7b. 
Compound 7a and 7b was previously reported but complete 
spectroscopic data was not detailed in the corresponding publication.
74
 
These data is summarized below. 
Compound 7a:
74
 Brown compound; 24% yield; mp = 9799 ºC; IR 
absorption (neat) ῡ3058, 2950, 1627, 1590, 1469; 
1
H NMR (500 MHz, 
CDCl3)  7.37–7.28 (m, 2H), 7.15 (dd, J = 7.6, 1.7 Hz, 1H), 7.09 (td, J = 
7.6, 1.8 Hz, 1H), 7.06–6.99 (m, 2H), 6.95 (ddd, J = 15.4, 8.1, 1.2 Hz, 2H), 




H} NMR (126 MHz, CDCl3)  170.2 (C), 
156.8 (C), 146.7 (C), 142.7 (C), 131.4 (CH), 131.0 (C), 128.5 (CH), 127.1 
(CH), 126.2 (CH), 124.2 (CH), 123.3 (CH),  117.7 (CH), 117.2 (CH), 37.0 
(CH3), 28.7 (CH3). HRMS (ESI
+
): calculated for C15H15N2 (M+H)
+ 
223.1223; observed 223.1230. 
UNIVERSITAT ROVIRA I VIRGILI 






Catalytic Asymmetric Hydrogenation of C=N-
Containing Heterocyclic Compounds 
Compound 7b:
74
 Yellow solid; 89% yield; mp = 114116 ºC; IR 
absorption (neat) ῡ3058, 2808, 1627, 1734, 1609, 1468; 
1
H NMR (500 
MHz, CDCl3)  7.80–7.75 (m, 2H), 7.48–7.37 (m, 4H), 7.32 (dd, J = 7.6, 





NMR (126 MHz, CDCl3)  = 169.5 (C), 158.1 (C), 146.8 (C), 143.0 (C), 
141.1 (C), 131.6 (CH), 131.3 (CH), 130.2 (CH), 129.7 (CH), 129.1 (C), 
128.1 (CH), 127.7 (CH), 126.4 (CH), 124.1 (CH), 122.8 (CH), 117.6 (CH), 
117.4 (CH), 36.9 (CH3); HRMS (ESI
+
): calculated for C20H17N2 (M+H)
+ 
285.1390; observed 285.1386. 
Compound 11a was obtained by oxidation of 9a. 
 
Scheme SI3. Synthetic procedure for the preparation of heterocyclic compound 11a. 
Compound 9a (1.35 mmol) was dissolved in DCM (20 mL) and 3-
chloroperbenzoic acid (4.1 mmol) was added. After 5 hours stirring at 
room temperature the mixture was diluted with DCM (10 mL) and washed 
with saturated aq. NaHCO3 (3 x 30 mL). The organic phase was dried over 
MgSO4, filtered and evaporated to dryness. Purification by column 
chromatography over SiO2 eluting with mixtures of cyclohexane:ethyl 
acetate of increasing polarity (from 90:10 to 50:50) afforded 11a (189 mg, 
54% yield). mp = 127130 ºC; IR absorption (neat) ῡ3059, 2925, 1622, 
1585, 1456; 
1
H NMR (400 MHz, CDCl3)  8.06 (d, J = 7.7 Hz, 1H), 8.02–
7.97 (m, 1H), 7.75–7.68 (m, 2H), 7.63 (ddd, J = 7.8, 4.8, 3.9 Hz, 1H), 7.56 
(ddd, J = 8.1, 7.3, 1.5 Hz, 1H), 7.37 (dd, J = 8.1, 1.2 Hz, 1H), 7.30 (ddd, J 




H} NMR (101 MHz, CDCl3)  
168.1 (C), 144.6 (C), 143.5 (C), 134.2 (C), 133.9 (CH), 133.7 (CH), 131.3 
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(CH), 131.1 (C), 128.3 (CH), 127.0 (CH), 125.7 (CH), 125.7 (CH), 124.6 
(CH), 77.5 (CH), 77.2 (CH), 76.9 (CH), 29.8 (CH 3); HRMS (ESI
+
): 
calculated for C14H11NNaO2S (M+Na)
+ 




C NMR spectra of compounds 3ad, 5a, 5b, 7a, 7b, 9a, 9b and 
11a 
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Figure SI11. 1H NMR spectrum of 3a. 
 
Figure SI12. 13C{1H} NMR spectrum of 3a. 





































































































































1H NMR (500 MHz, CDCl3) 

























































































UNIVERSITAT ROVIRA I VIRGILI 








Figure SI13. 1H NMR spectrum of 3b. 
 
 
Figure SI14. 13C{1H} NMR spectrum of 3b. 













































































































































1H NMR (500mHz, CDCl3)
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Figure SI15. 1H NMR spectrum of 3c. 
 
Figure SI16. 13C{1H} NMR spectrum of 3c. 

























































































































































1H NMR (500mHz, CDCl3)





























































































13C{1H} NMR (126 MHz, CDCl3)
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Figure SI17. 1H NMR spectrum of 3d. 
 
 
Figure SI18. 13C{1H} NMR spectrum of 3d. 





















































































































































































1H NMR (500MHz, CDCl3)
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Figure SI19. 1H NMR spectrum of 5a. 
 
Figure SI20. 13C{1H} NMR spectrum of 5a. 




























































































































1H NMR (500MHz, CDCl3)






















































































13C{1H} NMR (126MHz, CDCl3)
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Figure SI21. 1H NMR spectrum of 5b. 
 
 
Figure SI22. 13C{1H} NMR spectrum of 5b. 












































































































































1H NMR (500 MHz, CDCl3) 















































































































13C{1H} NMR (126 MHz, CDCl3) 
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Figure SI23. 1H NMR spectrum of 7a. 
 
Figure SI24. 13C{1H} NMR spectrum of 7a. 










































































































1H NMR (500mHz, CDCl3)






























































































13C{1H} NMR (126MHz, CDCl3)
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Figure SI25. 1H NMR spectrum of 7b. 
 
Figure SI26. 13C{1H} NMR spectrum of 7b. 


































































































































































1H NMR (500 MHz, CDCl3) 
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Catalytic Asymmetric Hydrogenation of C=N-
Containing Heterocyclic Compounds 
 
Figure SI27. 1H NMR spectrum of 9a. 
 
Figure SI28. 13C{1H} NMR spectrum of 9a. 
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Figure SI29. 1H NMR spectrum of 9b. 
 
Figure SI30. 13C{1H} NMR spectrum of 9b. 





















































































































































1H NMR (500MHz, CDCl3)











































































































13C{1H} NMR (126MHz, CDCl3)
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Catalytic Asymmetric Hydrogenation of C=N-
Containing Heterocyclic Compounds 
 
Figure SI31. 1H NMR spectrum of 11a. 
 
Figure SI32. 13C{1H} NMR spectrum of 11a. 
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1H NMR (400 MHz, CDCl3)
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2B.6.4 General procedure for the Ir-mediated asymmetric 
hydrogenations 
A solution of the required amount of iridium precursor ([{Ir(μ-Cl)(cod)}2]) 
(0.005 mmol) and the POP ligand (0.011 mmol) in the corresponding dry 
and deoxygenated solvent (5.0 mL) was loaded into an autoclave under N 2 
atmosphere, in which the required amounts of substrate (1 mmol) and 
additives (if necessary) were placed beforehand. In all cases, the molar 
concentration of the substrate in the reaction medium was adjusted to a 
final 0.20 M concentration. The autoclave was purged three times with H 2 
(at a pressure not higher than the selected one) and finally, the autoclave 
was pressurized with H2 to the desired pressure. The reaction mixture was 
stirred at the desired temperature for the stated reaction time. The 
autoclave was subsequently depressurized, the reaction mixture passed 
through a short pad of SiO2 and further eluted with EtOAc (2 x 1 mL). The 
resulting solution was evaporated in vacuo. The conversion was 
determined by 
1
H NMR and enantioselectivities were determined by HPLC 
analysis on chiral stationary phases.  
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2B.6.5 Complete set of hydrogenation results 
Table SI1. Asymmetric hydrogenation
a
 of compound 3a mediated by complexes 
[Ir(Cl)(cod)(L1L7)] 
 
Entry Ligand Reaction conditions Conv.b ee (%)c 
(config.)d 
1 L1 No additive, THF 99 42 (S) 
2 L1 10 mol % HCl, THF 99 53 (S) 
3 L2 No additive, THF 99 29 (S) 
4 L2 10 mol % HCl, THF 99 57 (S) 
5 L3 No additive, THF 99 79 (R) 
6 L3 10 mol % HCl, THF 99 86 (R) 
7 L3 20 mol % HCl, THF 99 86 (R) 
8 L3 10 mol % HCl, THF, 0 ºC 99 87 (R) 
9 L3 10 mol % HCl, DCM 99 91 (R) 
10 L3 10 mol % HCl, toluene 99 91 (R) 
11 L3 10 mol % HCl, MeTHF
e 99 91 (R) 
12 L4 No additive, THF 99 16 (S) 
13 L4 10 mol % HCl, THF 99
f 08 (S) 
14 L5 10 mol % HCl, THF 99 27 (R) 
15 L6 10 mol % HCl, THF 99
f rac 
16 L7 10 mol % HCl, THF 99 65 (S) 
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a  Reaction conditions: [{Ir(Cl)(cod)}2]/POP ligand/substrate = 0.5:1.1:100 
for a precatalyst levels of 1 mol %, respectively, at rt, 20 h and a substrate 
concentration of 0.20 M in THF unless otherwise stated. If additive was present, 
the indicated amount of additive with respect to substrate was added to a 
solution of the substrate before adding the catalyst. The values shown are the  
average of at least two runs. b  Conversions were determined by 1H NMR. c  
Determined by HPLC analysis using chiral stationary phases. d  Absolute 
configuration was assigned by comparison with literature data (see Table S3 and 
the following sections in this subchapter). e  MeTHF = 2-methyltetrahydrofuran.  f  
The selectivity of the reaction towards 4a was ca. 30%. 
The effects of a set of achiral and enantiomerically pure additives on 
the hydrogenation results of substrate 3a were also studied. The best 
results were obtained with HCl as the additive. For a complete summary on 
the effects of the additives, see Table SI2. 
Table SI2. Effect of the additives in the asymmetric hydrogenation a of compound 3a 











1 TFA 99 88 (R) 
2 DPP 99 89 (R) 
3 (R)-BNP 99 87 (R) 
4 (S)-BNP 99 89 (R) 
5 TsOH 99 89 (R) 
6 D-CSA 99 89 (R) 
7 L-CSA 99 90 (R) 
8 HCl 99 91 (R) 
a, b, c, d See notes a, b, c and d in Table SI1. 
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Table SI3. Asymmetric hydrogenationa of compounds 3ad, 5a, 5b, 7a, 7b, 9a, 9b 





Entry Substrate Ligand Reaction conditions Conv.b ee (%)c 
(config.)d 
1 3a (X= O, R= Me) L1 No additive, THF 99 42 (S)e 
2 3a (X= O, R= Me) L1 10 mol % HCl, THF 99 52 (S)e 
3 3a (X= O, R= Me) L3 No additive, THF 99 79 (R)e 
4 3a (X= O, R= Me) L3 10 mol % HCl, THF 99 86 (R)e 
5 3b (X= O, R= Ph) L1 No additive, THF 82 78 (S)e 
6 3b (X= O, R= Ph) L1 10 mol % HCl, THF 21 66 (S)e 
7 3b (X= O, R= Ph) L3 No additive, THF 18 4 (S)e 
8 3b (X= O, R= Ph) L3 10 mol % HCl, THF 5 5 (S)e 
9 3b (X= O, R= Ph) L1 No additive, MeTHF 97 83 (S)e 
10 3c (X= O, R= iPr) L1 No additive, MeTHF 99 32 (S) f 
11 3c (X= O, R= iPr) L1 10 mol % HCl, MeTHF 99 26 (S) f 
12 3c (X= O, R= iPr) L3 No additive, MeTHF 99 73 (R) f 
13 3c (X= O, R= iPr) L3 10 mol % HCl, MeTHF 99 65 (R) f 
14 3d (X= O, R= Bn) L1 No additive, MeTHF 99 8 (S)e 
15 3d (X= O, R= Bn) L1 10 mol % HCl, MeTHF 99 12 (S)e 
16 3d (X= O, R= Bn) L3 No additive, MeTHF 99 86 (R)e 
17 3d (X= O, R= Bn) L3 10 mol % HCl, MeTHF 99 87 (R)e 
18 5a (X= CH2, R= Me) L1 No additive, MeTHF 99 32 (S)
f 
19 5a (X= CH2, R= Me) L1 10 mol % HCl, MeTHF 99 48 (S)
f 
20 5a (X= CH2, R= Me) L3 No additive, MeTHF 99 70 (R)
f 
21 5a (X= CH2, R= Me) L3 10 mol % HCl, MeTHF 99 25 (R)
f 
22 5b (X= CH2, R= Ph) L1 No additive, MeTHF 21 9 (S)
f 
23 5b (X= CH2, R= Ph) L1 10 mol % HCl, MeTHF 37 5 (S)
f 
24 5b (X= CH2, R= Ph) L3 No additive, MeTHF 67 4 (S)
f 
25 5b (X= CH2, R= Ph) L3 10 mol % HCl, MeTHF 33 9 (S)
f 
26 7a (X= NMe, R= Me) L1 No additive, MeTHF 99 41(S) f 
27 7a (X= NMe, R= Me) L1 10 mol % HCl, MeTHF 99 60 (S) f 
28 7a (X= NMe, R= Me) L3 No additive, MeTHF 99 76 (R) f 
29 7a (X= NMe, R= Me) L3 10 mol % HCl, MeTHF 99 84 (R) f 
30 7b (X= NMe, R= Ph) L1 No additive, MeTHF 24 36 (S) f 
31 7b (X= NMe, R= Ph) L1 10 mol % HCl, MeTHF <5 ndg 
32 7b (X= NMe, R= Ph) L3 No additive, MeTHF 25 12 (S) f 
33 7b (X= NMe, R= Ph) L3 10 mol % HCl, MeTHF <5 ndg 
34 9a (X= S, R= Me) L1 No additive, MeTHF 99 7 (R)h 
35 9a (X= S, R= Me) L1 10 mol % HCl, MeTHF 99 25 (R)h 
36 9a (X= S, R= Me) L3 No additive, MeTHF 99 79 (R)h 
37 9a (X= S, R= Me) L3 10 mol % HCl, MeTHF 99 91 (R)h 
38 9b (X= S, R= Ph) L1 No additive, MeTHF 31 65 (S)h 
39 9b (X= S, R= Ph) L1 10 mol % HCl, MeTHF 41 23 (S)h 
40 9b (X= S, R= Ph) L3 No additive, MeTHF 72 97 (S)h 
41 9b (X= S, R= Ph) L3 10 mol % HCl, MeTHF <5 ndg 
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Table SI3. Cont. 
42 11a (X= SO2, R= Me) L1 No additive, MeTHF 99 56 (R)
i 
43 11a (X= SO2, R= Me) L1 10 mol % HCl, MeTHF 99 65 (R)
i 
44 11a (X= SO2, R= Me) L3 No additive, MeTHF 99 75 (R)
i 
45 11a (X= SO2, R= Me) L3 10 mol % HCl, MeTHF 99 77 (R)
i 
For a,  b,  c,  d See notes a,  b,  c and d in Table SI-1.  e The absolute configuration of compounds 4a,  4b  
and 4d was established by comparison with reported values of specific optical rotations (see ref. 54c). f  
The absolute configuration of products 4c,  6a,  6b,  8a,  8b and 10b were tentatively assigned by analogy 
with the stereochemical outcome of the reactions leading to 4a,  4b and 4d.  g not determined.  h The 
absolute configuration of compounds 10a and 10b was established by comparison with reported values 
of the specific optical rotation (see ref. 54h). i  The absolute configuration could be  unambiguously 
determined by X-ray analysis (see section 2B.6.7 of the SI), which is furthermore in agreement with the 
expected stereochemical outcome of the reaction by analogy with the results obtained for 4a,  4d and 
10a.  
2B.6.6 Characterization and determination of the 
enantiomeric excesses of reaction products 4ad, 6a, 
6b, 8a, 8b, 10a, 10b and 12a 











 were previously reported and the obtained physical and 
spectroscopic data obtained in the present work were in agreement with the 
reported ones. Measured optical rotation data and chromatographic data on 
chiral stationary phases are indicated below. Compounds 4c, 6a, 6b, 8a, 8b, 
and 12a are new compounds and the spectroscopic data, measured optical 
rotation data and chromatographic data on chira l stationary are indicated 
below. 
 
(R)-11-methyl-10,11-dihydrodibenzo[b,f][1,4]oxazepine (4a): [α]D 
27 = 
+42.7 (c 0.36, CHCl3) for 91% ee, [Lit:
54c
 [α]D 
30 = 109 (c 1.26, CHCl3) for 
94% ee (S)]; HPLC conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 cm), 
80:20 n-hexane/2-propanol, 0.7 mL/min, 254 nm, t1 (S) = 7.9 min, t2 (R) = 
9.2 min. 
 
(S)-11-phenyl-10,11-dihydrodibenzo[b,f][1,4]oxazepine (4b):  [α]D 
27 = 
20.6 (c 0.23, CHCl3) for 83% ee, [Lit:
 54c [α]D 
30 = 16.4 (c 0.2, CHCl3) for 
78% ee (S)]; HPLC conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 cm), 
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70:30 n-hexane/2-propanol, 0.7 mL/min, 254 nm, t1 (S) = 9.2 min, t2 (R) = 
12.4 min. 
 
(R)-11-isopropyl-10,11-dihydrodibenzo[b,f][1,4]oxazepine (4c):  
White solid; mp = 6063 ºC; IR absorption (neat) ῡ3398, 2958, 2867, 
1607, 1486; 
1
H NMR (400 MHz, CDCl3)  7.26–7.20 (m, 1H), 7.14 (dd, J 
= 8.0, 1.3 Hz, 1H), 7.11–7.00 (m, 3H), 6.84 (ddd, J = 7.9, 7.2, 1.5 Hz, 1H), 
6.62–6.66 (m, 1H), 6.56 (dd, J = 7.9, 1.6 Hz, 1H), 3.52 (d, J = 10.2 Hz, 




H} NMR (101 MHz, CDCl3)  156.7 (C), 143.5 (C), 137.3 (C), 133.8 
(C), 129.4 (CH), 128.9 (CH), 124.5 (CH), 124.1 (CH), 121.8 (CH), 121.4 
(CH), 118.5 (CH), 118.4 (CH), 66.9 (CH), 32.2 (CH), 20.9 (CH 3), 20.6 
(CH3). [α]D 
27= 32 (c 0.15, CHCl3) for 74% ee; HPLC conditions: Daicel 
Chiralcel
®
 AD-H (25 cm x 0.46 cm), 80:20 n-hexane/2-propanol, 0.7 





 240.1380; observed 240.1383. 
 
(R)-11-benzyl-10,11-dihydrodibenzo[b,f][1,4]oxazepine (4d): [α]D 
27 = 
+27.1 (c 0.15, CHCl3) for 87% ee, [Lit:
54c
 [α]D 
30= 100.3 (c 1.02, CHCl3) 
for 52% ee (S); HPLC conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 
cm), 80:20 n-hexane/2-propanol, 0.7 mL/min, 254 nm, t1 = 8.9 min (minor), 
t2 = 10.4 min (major). 
 
(R)-6-methyl-6,11-dihydro-5H-dibenzo[b,e]azepine (6a): IR 
absorption (neat) ῡ3396, 3018, 2965, 1602, 1477; 
1
H NMR (400 MHz, 
CDCl3)  7.30–7.15 (m, 4H), 7.04–6.98 (m, 1H), 6.98–6.90 (m, 1H), 6.61 
(td, J = 7.4, 1.2 Hz, 1H), 6.42 (dd, J = 8.0, 1.2 Hz, 1H), 5.23 (q, J = 6.7 Hz, 





H} NMR (101 MHz, CDCl3)  145.8 (C), 140.5 (C), 139.8 
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(C), 130.6 (CH), 128.3 (CH), 127.8 (CH), 127.7 (CH), 127.2 (CH), 123.7 
(CH), 123.2 (CH), 118.3 (CH), 117.4 (CH), 49.8 (CH), 40.1 (CH 2), 20.3 
(CH3); [α]D 
25 = +39.3 (c 0.14, CHCl3) for 70% ee; HPLC conditions: Daicel 
Chiralcel
®
 AD-H (25 cm x 0.46 cm), 80:20 n-hexane/2-propanol, 0.7 
mL/min, 254 nm, t1 = 9.8 min (major), t2 = 10.6 min (minor); HRMS 
(ESI
+
): calculated for C15H16N [M+H]
+ 
210.1270; observed 210.1277.  
 
(S)-6-phenyl-6,11-dihydro-5H-dibenzo[b,e]azepine (6b): White solid; 
mp = 146149 ºC; IR absorption (neat) ῡ3410, 3016, 2924, 1597, 1488; 
1
H NMR (400 MHz, MHz, CDCl3)  7.42–7.15 (m, 8H), 7.06–6.99 (m, 3H), 
6.68 (m, 1H), 6.60 (dd, J = 8.3, 1.2 Hz, 1H), 5.75 (s, 1H), 4.40 (s, 1H), 




H} NMR (101 MHz, CDCl3)  144.7 (C), 140.5 
(C), 139.3 (C), 137.6 (C), 130.8 (CH), 130.7 (CH), 129.2 (CH), 129.0 
(CH), 128.9 (CH), 128.7 (CH), 128.6 (CH), 127.7 (CH), 127.1 (CH), 126.9 
(CH), 126.3 (CH), 124.5 (CH), 118.9 (CH), 115.8 (CH), 62.3 (CH) 39.5 
(CH). [α]D 
27= 7.5 (c 0.16, CHCl3) for 4% ee; HPLC conditions: Daicel 
Chiralcel
®
 AD-H (25 cm x 0.46 cm), 80:20 n-hexane/2-propanol, 0.7 
mL/min, 254 nm, t1 = 13.4 min (major), t2 = 14.1 min (minor). HRMS 
HRMS (ESI
+






White solid; mp = 123125 ºC, IR absorption (neat) ῡ3387, 3049, 2979, 
2887, 1586, 1478; 
1
H NMR (500 MHz, CDCl3)  7.29–7.22 (m, 1H), 7.18 
(dd, J = 7.6, 1.6 Hz, 1H), 7.10 (dd, J = 8.1, 1.2 Hz, 1H), 7.01 (td, J = 7.5, 
1.2 Hz, 1H), 6.92 (dd, J = 7.6, 1.9 Hz, 1H), 6.78 – 6.62 (m, 2H), 6.48 (dd, 





H} NMR (126 MHz, CDCl3)  150.6 (C), 139.5 (C), 137.3 
(C), 136.4 (C), 128.1 (CH), 124.5 (CH), 122.9 (CH), 122.3 (CH), 120.0 
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(CH), 118.9 (CH), 118.0 (CH), 117.5 (CH), 50.2 (CH), 39.9 (CH 3), 20.5 
(CH3). [α]D 
27= 71.3 (c 0.14, CHCl3) for 83% ee; HPLC conditions: Daicel 
Chiralcel
®
 AD-H (25 cm x 0.46 cm), 80:20 n-hexane/2-propanol, 0.7 
mL/min, 254 nm, t1 = 9.7 min (minor), t2 = 10.3 min (major); HRMS 
(ESI
+
): Calculated for C15H17N2 [M+H]
+
 225.1382, found 225.1386. 
 
(S)-5-methyl-11-phenyl-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepine 
(8b): White solid. 36% ee; IR absorption (neat) ῡ3407, 3024, 2943, 2799, 
1597, 1488; 
1
H NMR (400 MHz, CDCl3)  7.42–7.23 (m, 6H), 7.12 (d, J = 
8.0, 1H), 6.97–6.88 (m, 3H), 6.80–6.72 (m, 2H), 6.59 (dd, J = 7.2, 2.1 Hz, 
1H),
 




H} NMR (126 MHz, CDCl3)  150.1 
(C), 143.2 (C), 139.1 (C), 136.9 (C), 136.0 (C), 128.4 (CH), 128.3 (CH), 
128.2 (CH), 127.2 (CH), 127.2 (CH), 122.5 (CH), 122.4 (CH), 120.2 (CH), 
119.4 (CH), 118.5 (CH), 117.9 (CH), 61.4 (CH), 39.6 (CH 3); [α]D 
27= 15.8 
(c 0.09, CHCl3) for 36% ee; HPLC conditions: Daicel Chiralcel
®
 AD-H (25 
cm x 0.46 cm), 80:20 n-hexane/2-propanol, 0.7 mL/min, 254 nm, t1 = 
17.26 min (major), t2 = 19.54 min (minor); HRMS (ESI
+
): calculated for 
C20H19N2 [M+H]
+ 




27= 89.0 (c 0.47, CHCl3) for 92% ee; [Lit:
54h
 [α]D 
20 = 87.1 (c 0.48, 
CHCl3) for 92% ee (R); HPLC conditions: Daicel Chiralcel
®
 AD-H (25 cm 
x 0.46 cm), 80:20 n-hexane/2-propanol, 0.7 mL/min, 254 nm, t1 = 15.9 min 
(minor), t2 = 17.0 min (major). 
 
(S)-11-phenyl-10,11-dihydrodibenzo[b,f][1,4]thiazepine (10b): 
Compound 10b was isolated from the reaction mixture containing 
unreacted starting material by chromatography over SiO 2 (hexane: EtOAc, 
from 90:10 to 80:20), 53% isolated yield;  [α]D 
27 = +9.2 (c 0.25, CHCl3) for 
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20  = 9.5 (c 0.38, CHCl3) for 56% ee (R); HPLC 
conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 cm), 97:03 n-hexane/2-




(12a): Compound 12a was isolated from the reaction mixture containing 
unidentified by-products by preparative TLC over SiO2 (hexane:DCM, 1:2), 
59% isolated yield; pale yellow solid; mp = 167169 ºC; IR absorption 
(neat) ῡ3363, 3066, 2982, 1602, 1524, 1479; 
1
H NMR (500 MHz, CDCl3) 
 8.08 (dd, J = 7.8, 1.4 Hz, 1H), 7.99 (dd, J = 8.3, 1.6 Hz, 1H), 7.69 (td, J 
= 7.6, 1.4 Hz, 1H), 7.53–7.40 (m, 2H), 7.30–7.21 (m, 1H), 6.76 (dd, J = 
8.2, 7.0 Hz, 1H), 6.54 (dd, J = 8.4, 1.1 Hz, 1H), 6.05 (q, J = 6.7 Hz, 1H), 




H} NMR (126 MHz, CDCl3) 
 143.6 (C), 140.0 (C), 136.8 (C), 134.8 (CH), 134.4 (CH), 128.4 (CH), 
127.0 (CH), 126.5 (CH), 124.6 (CH), 122.2 (CH), 118.5 (CH), 117.1 (CH), 
47.2 (CH), 19.0 (CH3). [α]D 
27 = 49.2 (c 0.13, CHCl3) for 80% ee; HPLC 
conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 cm), 80:20 n-hexane/2-
propanol, 0.7 mL/min, 254 nm, t1 = 12.6 min (minor), t2 = 13.5 min 
(major). HRMS (ESI
+





2B.6.7 X-ray crystallographic data of compound 12a 
Crystals of 12a were obtained by leaving a saturated solution of this 
compound in a Hexane/DCM mixture (3:1) stand overnight at 5 ºC. The 
measured crystals were stable under atmosphere conditions; nevertheless, 
they were prepared under inert conditions immersed in perfluoropolyether 
as protecting oil for manipulation.  
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Data collection: Crystal structure determination for 12a was carried out 
using a Apex DUO diffractometer equipped with a Kappa 4 -axis 
goniometer, an APEX II 4K CCD area detector, a Microfocus Source E025 
IuS using MoK radiation, Quazar MX multilayer Optics as 
monochromator and an Oxford Cryosystems low temperature device 
Cryostream 700 plus (T = 173 
°
C). Full-sphere data collection was used 
with  and  scans. Programs used: Data collection APEX-2 75 , data 
reduction Bruker Saint
76
 V/.60A and absorption correction SADABS
77
. 
Structure solution with  
Structure Solution and Refinement:  Crystal structure solution was 
achieved using SHELXS-97 as implemented in SHELXTL
78
. Visualization 
was performed with the program SHELXle
79
. Least-squares refinement on 
F
2




This compound crystallizes in the chiral space group P21. The absolute 
configuration of the product was determined to be R, according to a Flack 
value
81




CCDC 1452862 contains the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure SI33. ORTEP plot (thermal ellipsoids at 50% probability) showing the 
molecular structure of compound 12a. 
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Table SI4. Crystal data and structure refinement for 12a 
Empirical formula  C14H13NO2S 
Formula weight  259.31 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.1592(15) Å  = 90°. 
 b = 10.0169(16) Å  = 98.587(8)°. 
 c = 8.646(2)Å  = 90°. 
Volume 613.1(2) Å3 
Z 2 
Density (calculated) 1.405 Mg/m3 
Absorption coefficient  0.256 mm-1 
F(000) 272 
Crystal size 0.40 x 0.30 x 0.05 mm3 
Theta range for data collection 2.382 to 31.059° 
Index ranges -8<=h<=10,-14<=k<=8,-12<=l<=12 
Reflections collected 6695 
Independent reflections 3040 [R(int) = 0.0508] 
Completeness to theta = 31.059° 99.299995%  
Absorption correction Multi-scan 
Max. and min. transmission 0.987 and 0.657 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  3040/ 1/ 164 
Goodness-of-fit on F2 1.090 
Final R indices [I>2(I)] R1 = 0.0667, wR2 = 0.1752 
R indices (all data) R1 = 0.0729, wR2 = 0.1821 
Flack parameter x = 0.04(8) 
Largest diff. peak and hole 1.207 and -0.473 e.Å-3 
  
UNIVERSITAT ROVIRA I VIRGILI 






Catalytic Asymmetric Hydrogenation of C=N-
Containing Heterocyclic Compounds 
2B.6.8 NMR spectra of compounds and HPLC traces of 
hydrogenated products. 
 
Figure SI34. 1H NMR product 4a. 
 
Figure SI35. 13C{1H} NMR product 4a. 
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Figure SI36. HPLC trace product 4a. 
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Figure SI37. 1H NMR product 4b. 
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Figure SI39. HPLC trace product 4b. 
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Figure SI40. 1H NMR product 4c. 
 
Figure SI41. 13C{1H} NMR product 4c. 
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Figure SI42. HPLC trace product 4c. 
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Figure SI43. 1H NMR product 4d. 
 
Figure SI44. 13C{1H} NMR product 4d. 
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Figure SI45. HPLC trace product 4d. 
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Figure SI46. 1H NMR product 6a. 
 
Figure 47. 13C{1H} NMR product 6a. 
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Figure SI48. HPLC trace product 6a. 
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Figure SI49. 1H NMR product 6b. 
 
Figure SI50. 13C{1H} NMR product 6b. 
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Figure SI51. HPLC trace product 6b. 
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Figure SI52. 1H NMR product 8a. 
 
Figure SI53. 13C{1H} NMR product 8a. 
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Figure SI54. HPLC trace product 8a. 
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Figure SI55. 1H NMR product 8b. 
 
Figure SI56. 13C{1H} NMR product 8b. 
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Figure SI57. HPLC trace product 8b. 
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Figure SI58. 1H NMR product 10a. 
 
Figure SI59. 13C{1H} NMR product 10a. 
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Figure SI60. HPLC trace product 10a. 
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Figure SI61. 1H NMR product 10b. 
 
Figure SI62. 13C{1H} NMR product 10b. 
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Figure SI63. HPLC trace product 10b. 
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Figure SI64. 1H NMR product 12a. 
 
 
Figure SI65. 13C{1H} NMR product 12a. 
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Figure SI66. HPLC trace product 12a. 
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2B.6.9 Details of the DFT computational studies on the 
stereochemical outcome of the Ir-mediated asymmetric 
hydrogenation 
2B.6.9.1 Cyclometallated iridium complexes derived from 3a: 
As commented in the main text, we have explored the possibility of the 
hydrogenation pathway involving the formation of cyclometallated iridium 
complexes derived from 3a. The geometries are shown in Figure SI67. We 
have computed two possible isomers for L1 and one for L3. The relative 
energies of the four-membered iridacycles are much higher (>60 
kcal·mol
1
) than the transition states computed for the mechanism shown 
in Figure 3 of the manuscript, thus this pathway was not further explored. 
A likely explanation for the high energy of the cyclometallated iridium 
complexes is the strain of the four membered ring, where the N–Ir–C angle 
is close to 60º. 
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2B.6.9.2 Geometric and energetic study of the isomers of 
complexes [Ir(Cl)(H)2(H–H)(L1)] and [Ir(Cl)(H)2(H–
H)(L3)]: 
The geometries of the six isomers considered for the octahedral 
complex [Ir(Cl)(H)2(H–H)(L1)] are shown in Figure SI68 along with the 
relative energies. It can be observed that in the most favored isomers the 
chlorido ligand is located perpendicular to the plane that contains the 
POP and Ir atoms. In turn, the H–H ligand is occupying each of the two 
available positions in the aforementioned plane (in one case cis to the 
phosphine group and in the other cis to the phosphite motif). Figure SI69 
shows the optimized geometries and relative energies of complex 
[Ir(Cl)(H)2(H–H)(L3)]. In the most stable isomers, the chlorido ligand is 
located perpendicular to the plane that contains the POP and Ir atoms but 
with an opposite orientation to that observed for L1. The H–H ligand 
occupies each of the two possibilities in the aforementioned plane. This 
favored orientation with the Cl ligand pointing up, when the phosphite 
group is placed to the left, is due to the formation of an additional C–
H···Cl interaction in these isomers of complex [Ir(Cl)(H) 2(H–H)(L3)] with 
respect to the same isomers of complex [Ir(Cl)(H)2(H–H)(L1)] (see red 
lines in Figure SI69). 
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Figure SI69. Isomers of complex [Ir(Cl)(H)2(H–H)(L3)] and the relative energies in 
kcal·mol1. 
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2B.6.9.3 TSR derived from L1 and TSS of L3 leading to the minor 
enantiomers of the hydrogenation products : 
In Figure SI70 we show the transition states TSR and TSS computed for 
L1 and L3. As commented in the main text, the transition states TS S of L1 
is stabilized by a N–H···Cl hydrogen bond (see Figure 3a in the main text). 
The TSR transition state (L1) is also stabilized by an N–H···O hydrogen 
bond (see black dashed line in Figure SI70a) involving the phosphite group. 
Therefore, the difference between both transition states ( i.e. ΔΔG
#
 = 2.2 
kcal·mol
–1
) is governed by the different strength of both H-bonds. Since 
the N–H···Cl hydrogen bond involves an anionic ligand, it is 
electrostatically favored with respect to the N–H···O hydrogen bond. 
Similarly for L3, the TSR is stabilized by an N–H···Cl hydrogen bond (see 
Figure 3b in the main text). Instead, the TSS transition state of L3 is 
stabilized by an N–H··· interaction (see black dashed line in Figure 
SI70b) involving the phenyl group. 
 
Figure SI70. Optimized geometries of TSR (L1) and TSS (L3) with indication of some 
interactions. Distances in Å. 
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2B.6.9.4 Final products: 
Finally, in Figure SI71 we show the final products derived from the TSS 
and TSR computed for L1 and L3, denoted as [4a][Ir(Cl)(H)2(L1)] and 
[4a][Ir(Cl)(H)2(L3)], respectively. 
 
Figure SI71. Optimized geometries of [4a][Ir(Cl)(H)2(L1)] and [4a][Ir(Cl)(H)2(L3)] 
with indication of some interactions. Distances in Å.  
2B.6.9.5 Computational methods: 
The geometry of all the complexes included in this study was optimized 
at the BP86 /def2-SVP level of theory within the program TURBOMOLE 
version 7.0
83
 without geometric constrains. The def2-SVP basis set was 
used for all atoms. It employs effective core potentials for Ir.
84
 We initially 
used the M06-2X functional, however we encountered irresoluble 
convergence problems in the optimization of the largest systems. 
Consequently we decided to use the BP86 functional. The 
minimum/transition state nature of the complexes has been confirmed by 
means of frequency calculations using a fine grid. The imaginary 
frequency in the transition states connects the reactant to the product.  The 
thermal analysis correction has been performed at 273 K. In order to 
validate the level of theory, the energies of all stationary points 
corresponding to the mechanism of L1 have been also computed using the 
D3 correction
85
 in order to account for dispersion effects. As a result, the 
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 value remains unaltered, giving reliability to the level of theory. 
This is likely due to the absence of π–π interactions in the proposed 
mechanism. 
2B.7 Additional experiments 
2B.7.1 Hydrogenation of quinoline and other six-membered N-
heterocyclic derivatives mediated by [Ir(POP)] 
complexes derived from L1L4 
2B.7.1.1 Discussion: 
Previous reports from the group,
25
 demonstrated that the [Ir(POP)] 
complexes derived from ligand L1 had been successfully applied to the 
asymmetric hydrogenation of 2-substituted quinolines. Within the present 
PhD thesis, we sought to expand the substrate scope and examine the 
hydrogenation of 3- and 4-, methyl- and phenyl-substituted quinolines 
(13ad). Under the optimal reaction conditions developed for the 
hydrogenation of 2-substituted quinolines,
25
 compounds 13a and 13b could 
only be hydrogenated in low conversions (ca. 15%) leading to small 
amounts of the corresponding hydrogenation products with low 
enantiopurity (see entries 1 and 3 in Table 3). Interestingly, substrates 13a 
and 13b were fully hydrogenated in the presence of catalytic amounts of 
HCl (10 mol %; see entries 2 and 4 in Table 3). Unfortunately, the 
enantiopurity of the hydrogenation products was again very low. In 
contrast to the previously mentioned results, substrates 13c and 13d could 
not be hydrogenated, not even in the presence of catalytic amounts of HCl 
(see entries 58 in Table 3) or at a higher pressure (160 bar of H2; see 
entries 912 in Table 3). 
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Table 3. [Ir(POP)]-catalyzed asymmetric hydrogenation
a
 of quinoline derivatives 
13ad. 
 
Entry Substrate Conditions Additive 







13a 80 bar H2 
- 15 rac 
2 HCl >99 rac 
3 
13b 80 bar H2 
- <10 rac 
4 HCl >99 rac 
5 
13c 80 bar H2 
- <1 ndd 
6 HCl <2 nd 
7 
13d 80 bar H2 
- nre nd 
8 HCl nr nd 
9 
13c 160 bar H2 
- <2 nd 
10 HCl <3 nd 
11 
13d 160 bar H2 
- nr nd 
12 HCl nr nd 
a Reaction conditions: [{Ir(-Cl)(cod)}2]/L1/substrate = 2.5:5.5:100, respectively, for 
precatalyst amounts of 5 mol % at rt, 68 h and a substrate concentration of 0.20 M in 
THF. If additive was present, the indicated amount of additive with respect to 
substrate was added to a solution of the substrate before adding th e catalyst. The 
values shown are the average of at least two runs. b Conversions were determined by 
1H NMR. c Enantiomeric excesses (ee) were determined by HPLC analysis on chiral 
stationary phases. d nd ≡ not determined .  e nr ≡ no reaction.  
  
UNIVERSITAT ROVIRA I VIRGILI 







We also turned our attention to the hydrogenation of quinolines 
containing two methyl or two phenyl groups. Under the optimal reaction 
conditions developed for the hydrogenation of 2 -substituted quinolines,
25
 
substrate 13e (2,3-dimethylquinoline) could be fully hydrogenated. The 
hydrogenation mediated by [Ir(POP)] complexes derived from ligand L1 
led to a mixture of the cis- and trans-diastereomers in a 10 to 1 ratio, 
respectively. The cis-product was obtained in 8% ee in favor of the (S,S)-
configured product. The trans-product was obtained in 85% ee and the 
absolute configuration of the hydrogenation product could not be 
determined. In the presence of HCl, both the diastereoselectivity (6 to 1 in 
favor of the cis-product) and the enantioselectivity (6% ee for the cis-
product and 71% ee for the trans-product; see entries 58 in Table 4) of 
the reaction worsened. 
2,3-Diphenylquinoline (substrate 13f) could completely converted to 
the corresponding hydrogenated product, under the optimal reaction 
conditions developed for the hydrogenation of 2-substituted quinolines.
25
 
Whilst the hydrogenation took place with perfect diastereoselectivity (dr = 
99:1 in favor of the cis-compound), the enantioselectivity of the 
hydrogenations was low (10% ee in the absence of HCl, and 30% in the 
presence of catalytic amounts of this reagent) (see entries in 3 and 4 in 
Table 4). 
As regards the hydrogenation of 2,4-dimethyl- and 2,4-
diphenylquinoline (substrates 13g and 13h, respectively), the [Ir(POP)] 
complexes derived from ligand L1 were not efficient in mediating the 
hydrogenations, as no conversion was observed (see entries 58 in Table 
4). 
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ee of cis 
derivative 
[%]c 





- >99 9.8:1 8 (S,S) 85 () 
2 HCl >99 5.5:1 6 (S,S) 71 () 
3 
13f 
- >99 99:1 10 () nd 
4 HCl >99 99:1 30 () nd 
5 13g - nr
d nde nd nd 
6 HCl nr nd nd nd 
       7 
13h 
- nr nd nd nd 
8 HCl nr nd nd nd 
a Reaction conditions: [{Ir(-Cl)(cod)}2]/L1/substrate = 2.5:5.5:100, respectively, 
for precatalyst amounts of 5 mol % at rt, 68 h and a substrate concentration of 0.20 
M in THF. If additive was present, the indicated amount of additive with respect to 
substrate was added to a solution of the substrate before adding the catalyst. The 
values shown are the average of at least two runs. b Conversions were determined by 
1H NMR. c Enantiomeric excesses (ee) were determined by HPLC analysis on chiral 
stationary phases. Absolute configurations were assigned by comparison with the 
reported data. d nr ≡ no reaction. e nd ≡ not determined.  
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With the extended POP ligand library that was available at the late 
stages of the present PhD thesis (see the structure of ligands L2L4 in 
Table 5), we turned our attention to the hydrogenation of an array six -
membered N-heterocyclic derivatives (see the structure of substrates 
13im in Table 5) under the optimal reaction conditions developed by the 
group.
25,27
 It should be mentioned at this point that the results of the 
hydrogenations of substrates 13im employing ligand L1 had already been 
reported,
27
 however the results obtained with L1 have also been included 
in Table 5 to aid comparison. 
Ligand L2, whose main difference with respect to L1 is a 
5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol-derived phosph-
ite group instead of the [1,1'-binaphthalene]-2,2'-diol-derived one in L1, 
provided similar results to L1 in terms of conversion and 
enantioselectivity. Interestingly, ligand L3, incorporating a 3,3'-diphenyl-
5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol-derived phosph-
ite group, and ligand L4, incorporating a ((4R,5R)-2,2-dimethyl-1,3-
dioxolane-4,5-diyl)bis(diphenylmethanol)-derived phosphite group, 
followed a different trend. In case of methyl-substituted substrates (13i 
and 13k) opposite configurations for the hydrogenation products  were 
obtained (compare entries 1 and 3 in Table 5) for ligands L3 and L4 and 
for L2 (and L1). Ph-substituted substrates (13j, 13l and 13m) were 
hydrogenated in lower conversions with the [Ir(POP)] complexes derived 
from L3 and L4 than those observed for L2 (and L1). In contrast to what 
was observed for methyl-substituted products, ligands L1L4 led to 
hydrogenation products with the same configuration. This behavior is in 
agreement with the results obtained in the hydrogenation of seven -
membered C=N-containing heterocyclic derivatives, which have been 
previously discussed (see section 2B).  
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Table 5. Ir-(POP)-mediated asymmetric hydrogenation a of six-membered N-





















1 13i 99; 92 (S)d 99; 88 (S) 99; 4 (R) 99; 5 (R) 
2 13j 99; 95 (S)d 80; 94 (S) 6; 63 (S) <1; nd
e
 
3 13k 99; 85 (S) 99; 85 (S) 98; 38 (R) 4; 40 (R) 
4 13l 98; 99 (S)d 96; 99 (S) 7; 83 (S) <1; nd 
5 13m 96; 99 (S)d 97; 99 (S) 65; 91 (S) <2; nd 
a Reaction conditions: [{Ir(-Cl)(cod)}2]/POP ligand/substrate = 0.5:1.1:100, 
respectively, for precatalyst amounts of 1 mol % at rt, 20 h and a substrate 
concentration of 0.20 M in THF. If additive was present, the indicated amount of 
additive with respect to substrate was added to a solution of the substrate before 
adding the catalyst. The values shown are the average of at lea st two runs.  
b Conversions were determined by 1H NMR. c Enantiomeric excesses (ee) were 
determined by HPLC analysis on chiral stationary phases. Absolute configurations 
were assigned by comparison with the reported data. d Published results; see ref. 25 
for 13i and ref. 27 for 13j, 13l and 13m. e nd ≡ not determined.  
Lig 
Sub 
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2B.7.1.2 Experimental section: 
For the experimental procedure, see Section 2B.5.1.  
The HPLC analytic conditions for determining the enantiomeric 
excesses of the hydrogenation products 14am and their spectroscopic and 
characterization data are indicated below. 
3-methyl-1,2,3,4-tetrahydroquinoline (14a): Known compound,
86
 light 
yellow oil, HPLC conditions: Daicel Chiralcel
®
 OJ-H (25 cm x 0.46 cm), 
95:5 n-hexane/2-propanol, 0.5 mL/min, 254 nm, t1 = 29.3 min, t2 = 36.7 
min. 
3-phenyl-1,2,3,4-tetrahydroquinoline (14b): Known compound,
86
 
White solid, HPLC conditions: Daicel Chiralcel
®
 OD-H (25 cm x 0.46 cm), 
90:10 n-hexane/2-propanol, 0.6 mL/min, 254 nm, t1 = 18.6 min, t2 = 22.8 
min. 
4-methyl-1,2,3,4-tetrahydroquinoline (14c): Known compound,
87
 
HPLC conditions: Daicel Chiralcel
®
 OD-H (25 cm x 0.46 cm), 98:2 n-
hexane/2-propanol, 0.6 mL/min, t1 = 17.2 min (major), t2 = 18.6 min 
(minor). 
4-phenyl-1,2,3,4-tetrahydroquinoline (14d): Known compound,
87 
HPLC conditions: Daicel Chiralcel
®
 OD-H column (25 cm x 0.46 cm), 
90:10 n-hexane/2-propanol, 0.6 mL/min, t1 = 14.6 min (minor), t2 = 22.3 
min (major). 
cis- and trans-2,3-dimethyl-1,2,3,4-tetrahydroquinoline (14e): 
Known compound,
88
 HPLC conditions: Daicel Chiralcel
®
 OD-H (25 cm x 
0.46 cm), 98:2 n-hexane:2-propanol, 0.5 mL/min, 254 nm; cis-isomer: t1 = 
15.1 min (minor), t2 = 16.3 min (major); trans-isomer: t1 = 12.5 min 
(minor), t2 = 19.2 min (major).  
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cis-2,3-diphenyl-1,2,3,4-tetrahydroquinoline (14f): Known 
compound,
89 
HPLC conditions: Daicel Chiralcel
®
 OD-H (25 cm x 0.46 cm), 
90:10 n-hexane/2-propanol, 0.5 mL/min, 254 nm, t1 = 20.4 min (minor), t2 
= 25.2 min (major). 
2-methyl-1,2,3,4-tetrahydroquinoline (14i): Known compound,
90
 
HPLC conditions: Daicel Chiralcel
®
 OJ-H (25 cm x 0.46 cm), 95:5 n-





 HPLC conditions: Daicel Chiralcel
®
 OD-H (25 cm x 
0.46 cm), 80:20 n-hexane/2-propanol, 0.6 mL/min, 216 nm, t1 (R) = 18.6 
min, t2 (S) = 24.6 min. 
3-methyl-3,4-dihydroquinoxalin-2(1H)-one (14k): 
1
H NMR (400 
MHz, CDCl3) 7.847.68 (m, 1H), 6.926.86 (m, 1H), 6.806.73 (m, 
1H), 6.736.66 (m, 1H), 4.01 (q, J = 6.7 Hz, 1H), 3.82 (bs, 1H), 1.46 (d, J 




H} NMR (100 MHz, CDCl3)  133.7 (C), 125.8 (C), 
124.0 (CH), 119.8 (CH), 115.3 (CH), 114.4 (CH), 52.2 (CH), 18.0 (CH3). 
HRMS (ESI
+
): calculated for C9H10N2NaO (M+Na)
+ 
185.0685; found 
185.0694. mp = 130132 ºC; [α]D 
25= +51.7 (c 0.13, CH2Cl2) for 85% ee; 
HPLC conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 cm), 90:10 n-
hexane/2-propanol, 1.0 mL/min, 230 nm, t1 (S) = 19.6 min, t2 (R) = 21.2 
min. 
3-phenyl-3,4-dihydroquinoxalin-2(1H)-one (14l): Known compound,
92
 
HPLC conditions: Daicel Chiralcel
®
 OD-H (25 cm x 0.46 cm), 80:20 n-
hexane/2-propanol, 1.0 mL/min, 230 nm, t1 (S) = 15.2 min, t2 (R) = 23.3 
min. 
1-methyl-3-phenyl-3,4-dihydroquinoxalin-2(1H)-one (14m): Known 
compound,
93
 HPLC conditions: Daicel Chiralcel
®
 AD-H (25 cm x 0.46 
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cm), 80:20 n-hexane/2-propanol, 1.0 mL/min, 230 nm, t1 (+) = 12.7 min, t2 
() = 16.3 min. 
 
1H NMR of 14a 
 
13C{1H} NMR of 14a 
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1H NMR of 14b 
 
13C{1H} NMR of 14b 
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1H NMR of trans-14e 
 
13C{1H} NMR of trans-14e 
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1H NMR of 14f 
 
13C{1H} NMR of 14f 
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1H NMR of 14k 
 
13C{1H} NMR of 14k   


































































































































































UNIVERSITAT ROVIRA I VIRGILI 






Catalytic Asymmetric Hydrogenation of C=N-
Containing Heterocyclic Compounds 
2B.8 Summary on recent literature advances for 
substrate activation of N-heterocyclic compounds 
towards asymmetric hydrogenations 
We identified in the literature up to 2015 three different strategies to 
activate N-heterocyclic compounds towards asymmetric hydrogenation. 
These strategies were published as a review in 2015
52a
 and have been 
summarized in Subchapter 2A of the present thesis (see Scheme 1). The 
first strategy consists of facilitating hydrogenation by the formation of 
positively charged derivatives of the N-heterocyclic compounds. Catalyst 
deactivation processes arising upon binding of the substrate to the metal 
center can thus be prevented and, additionally, hydrogenation of positively 
charged N-heterocyclic compounds may also be more favored than that of 
their neutral analogues. The second strategy is based on introducing a 
ligating group onto the substrate to facilitate hydrogenation by chelation 
assistance to the metal center. The last strategy involves breaking the 
aromaticity of the N-heterocyclic compounds by inducing a double bond 
migration process. The above mentioned strategies have allowed the 
development of highly enantioselective catalytic hydrogenation methods of 
N-heterocyclic compounds for the production of fully or partially saturated 
chiral heterocycles. We summarize in the present section the latest and 
most relevant examples of substrate activation in asymmetric 
hydrogenation, which were not covered in Subchapter 2A of the present 
thesis. 
An efficient enantioselective hydrogenation method for transforming 
isoxazolium triflates (15 and 17) into highly enantioenriched 4-
isoxazolines (16) or isoxazolidines (18) has been reported by Kuwano et 
al.
94
 This hydrogenation method belongs to substrate activation Strategy I 
(see in Subchapter 2A) and uses an enantioselective catalyst prepared from 
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[{Ir(-Cl)(cod)}2], an enantiopure phosphino–oxazoline ligand and I2. The 
iridium-catalyzed hydrogenations proceeded in high to good 
enantioselectivities. The 3-substituted 5-arylisoxazolium salts (15 and 17) 
were transformed into 4-isoxazolines (16) with up to 90% ee when 
phosphino–oxazoline ligand L14 was used (Scheme 10a). 5-Alkylated 
substrates were also selectively converted into cis-3,5-disubstituted 
isoxazolidines (18) by using the iridium catalyst derived L15 (Scheme 
10b). 
 
Scheme 10. Asymmetric hydrogenation of isoxazolium triflates with a chiral 
iridium catalyst.  
The asymmetric hydrogenation of 3-amido-2-arylpyridinium salts (19) 
in the presence stoichiometric amounts of ()-CSA catalyzed by halide-
bridged dinuclear iridium complexes derived from the bisphosphine 
SEGPHOS (5 mol %, see Scheme 11 for the structure of the ligand) has 
recently been described by Mashima et al. (Scheme 11).
95
 This 
hydrogenation method also belongs to substrate activation Strategy I.  
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Although high temperatures were required (6080 ºC), high cis-
diastereoselectivities (up to >95:5) and moderately high 
enantioselectivities were obtained (10 examples, ee’s ranging from 70 to 
86%). The pyridinium salt without any substituent at the 2-position was 
not hydrogenated. Moreover, a benzoyl protecting groups at the amino 
group improved the enantioselectivity.  
 
Scheme 11. Asymmetric hydrogenation of 3-amido-2-arylpyridinium salts.  
Zhang, Zhao and coworkers have reported the Rh-mediated asymmetric 
hydrogenation of quinolones (21) and isoquinolines (23) to highly 
enantioenriched tetrahydroquinoline (22) and tetrahydroisoquinoline (24) 
derivatives (see Scheme 12).
96
 The addition of stoichiometric amounts of 
anhydrous HCl facilitates the hydrogenation of the above mentioned 
substrates in agreement with the advantages provided by substrate 
activation Strategy I. Furthermore, the addition of HCl facilitates the 
formation of a non-covalent interaction between the urea motif of the 
ligand and the chloride anion of the protonated substrates. The 
enantioselective catalyst developed by Zhang, Zhao and coworkers was 
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very active in terms of catalytic activity (conversions up to 99%) and  
provided very high enantioselectivities (up to 99% ee). 
 
Scheme 12. Asymmetric hydrogenation of quinolines and isoquinolines. 
Zhou et al. reported the highly enantioselective hydrogenation of 
quaternized heteroaromatic compounds bearing a hydroxyl group (i.e. 3-
hydroxypyridinium salts (25)). The authors have successfully developed an 
enantiopure iridium complex derived from (S,S)-f-Binaphane (see Scheme 
13 for the structure of the ligand; 3 mol %) as catalyst for this 
transformation. The combined used of the catalyst and stoichiometric 
amounts of NaHCO3 provided a direct access to trans-6-substituted 
piperidin-3-ols (26) as the major diastereoisomers in up to 95% ee (13 
examples, see Scheme 13).
97
 This hydrogenation method also belongs to 
substrate activation Strategy I.  
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Scheme 13. Asymmetric hydrogenation of 3-hydroxypyridinium salts.  
Following an analogous strategy (substrate activation Strategy I), 
Lefort et al.
 98
 reported the use of an enantiopure rhodium catalyst derived 
from L18 (see Scheme 14 for the structure of the ligand) as an efficient 
catalyst for the asymmetric hydrogenation of N-benzylated 3-substituted 
pyridinium salts (28) into the corresponding piperidines (29) (ee values up 
to 90%; 10 examples, Scheme 14). 
 
Scheme 14. Asymmetric hydrogenation of 3-substituted pyridinium salts.  
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Rhodium(I) complexes of a series of enantiopure phosphine-phosphite 
ligands were evaluated in the enantioselective hydrogenation of 
functionalized olefins. High activities (>99%) and moderate to excellent 
enantioselectivities (up to 99%) have been achieved. The effects on the 
enantioselectivities of TADDOL-derived phosphite groups (TADDOL = 
(2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(diphenylmethanol)) and 3,3’-
diphenyl substituted H8-BINOL-derived phosphite motifs (H8-BINOL = 
5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol) were compara-
tively studied. H8-BINOL-based ligands proved to be superior to the 
corresponding TADDOL-based ones in the current study and provided the 
highest enantioselectivities in the rhodium-mediated hydrogenation of 
functionalized alkenes within the whole series of POP ligands developed 
by the group. 
3.2 Introduction 
The design and development of efficient enantiopure phosphorus 
ligands and their potential application in several transition metal-mediated 
asymmetric transformations of interest constitute an expanding research 
area within academia and industry.
1
 From a practical perspective, 
enantioselective hydrogenation offers several advantages for the 
asymmetric synthesis of enantiomerically pure compounds (optimal atom 
economy, broad substrate scope, high reactivity and selectivity, and 
operational simplicity). As a consequence, the asymmetric hydrogenation 
of prochiral substrates (alkenes, imines, ketones, heteroaromatic 
compounds), mostly catalyzed by chiral Ir, Rh or Ru complexes, is 
certainly amongst the most efficient and reliable methodologies in 
catalytic asymmetric synthesis.
2
 Consequently, many industrial approaches 
for the production of optically active pharmaceuticals, agrochemicals, 
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fragrances, fine chemicals, and natural products rely on catalytic 
asymmetric hydrogenation reactions. Enantiopure bidentate ligands have 
become a crucial tool in the development of new metal -catalyzed 
asymmetric transformations
3
 and a broad variety of such ligands have been 
described and optimized over the last few decades.
4
 Among those, non-
symmetrical ligands with two electronically different coordinating 
functionalities have proven to be superior in certain cases to  C2-symmetric 
ligands, as they have allowed for a better adjustment to the specific 
requirements of a given transformation.
5
 In this context, enantiopure 
phosphine–phosphites have attracted much interest due to the different 
electronic properties of the two phosphorus functionalities .
6
 Ligands of 
this type have been successfully applied in Rh-catalyzed hydrogenation 
and hydroformylation reactions, amongst other transformations.
7
 
Despite the remarkably advanced state of the field, numerous research 
groups are still actively pursuing new catalytic systems that show higher 
activity and/or improved enantioselectivity for challenging substrates or 
for recently discovered pharmacologically active compounds. In this 
regard, our research group has employed a highly modular ligand design in 
combination with a fine-tuning methodology guided by computational 
analysis of the diastereomeric transition states in order to improve the 
performance of the catalytic systems. In this way, an array of enantiopure 
1,2-POP derivatives (mostly phosphine-phosphite ligands) have been 
developed and successfully applied in Pd-mediated asymmetric allylic 
substitutions,
8
 Ir-mediated asymmetric hydrogenation of heteroaromatic 
compounds
9
 and Rh-mediated asymmetric hydrogenation of functionalized 
olefins.
10
 As regards the Rh-mediated asymmetric hydrogenation, our 
group recently reported the highly enantioselective hydrogenation of a 
structurally diverse range of substrates catalyzed by cationic Rh complexes 
of ligands 3a and 3b (Scheme 1). Furthermore, very recently, Rh-catalysts 
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derived from POP ligands containing the 3,3’-disubstituted H8-BINOL- 
(H8-BINOL = 5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol]) 
and TADDOL-derived (TADDOL = (2,2-dimethyl-1,3-dioxolane-4,5-
diyl)bis(diphenylmethanol)) phosphite fragments have been efficiently 
employed in the hydrogenative kinetic resolution of racemic vinyl 
sulfoxides
11
 and the hydrogenative desymmetrization of achiral  dienes,
12
 
respectively. However, the effects of these phosphite fragments (i.e. H8-
BINOL and TADDOL groups) in the performance of the corresponding 
POP ligands in the Rh-mediated asymmetric hydrogenation of prochiral 
functionalized olefins had not been assessed. Hence, we sought herein to 
study the effects of these phosphite fragments in the asymmetric 
hydrogenation of an array of model functionalized olefins. 
3.3 Results and Discussion 
3.3.1 Ligand synthesis 
Our group has previously synthesized a library of structurally diverse 
POP ligands based on the use of enantiomerically pure Sharpless epoxy 
ether 1 as a starting material. This compound was transformed into the 
final ligands in two steps: ring-opening of the epoxide with a nucleophilic 
trivalent phosphorus derivative followed by O-phosphorylation of the 
phosphino alcohol intermediate with trivalent phosphorus electrophiles 
(i.e. a chlorophosphite derived from an enantiomerically pure diol ; see 
Scheme 1). The first step involved the opening of the epoxide ring, which 
proceeded smoothly at 30 ˚C to room temperature, and then in situ 
generation of corresponding borane protected adduct 2. The free phosphino 
alcohol was subsequently obtained by cleavage of the borane adduct 2, 
using 1,4-diazabicyclo[2.2.2]octane (DABCO; 2.2 equiv.) at 60 ˚C in 
toluene for two hours, and the in situ generated phosphino alcohol was 
subsequently derivatized with the corresponding chlorophosphite (1.1 
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equiv.). As previously mentioned (see pages 28-29 in Chapter 1 and the 
corresponding references cited therein), the phosphorylations of phosphino 
alcohol 2 with the chlorophosphites leading to ligands 3ad did not require 
the use of additional amounts of an auxiliary base:
13
 the excess of DABCO 
from the borane-cleavage step in the reaction media served for 
quantitatively mediating the reaction between the free phosphino alcohol 
and the chlorophosphite.
10 
However, the reaction of the free compound 2 
with TADDOL-derived chlorophosphites leading to ligands 3ei proceeded 
at a slower rate. In order to increase the reaction rate, catalytic amounts of 
N,N-dimethylpyridin-4-amine (DMAP; 5 mol %) and an excess of NEt3 as 
auxiliary base (20 equiv. with respect to the chlorophosphite) were 
used.
14,16
 Under these reaction conditions, ligands 3ei were prepared in 
yields ranging from 39% (for ligand 3g) to 73% (for ligand 3e). It should 
be mentioned at this point, that ligand 3i was obtained together with an 
unidentified by-product (the purity of 3i was determined to be ca. 58%, 
based on integration of the 
31
P NMR spectrum), which could not be 
completely removed. This by-product was efficiently removed in the 
following synthetic step (i.e. the complexation of the POP ligand with 
[Rh(nbd)2]BF4; section 3.5.2). 
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Scheme 1. Synthesis of phosphine-phosphite (POP) ligands. 
 
3.3.2 Complexation Studies of H8-BINOL- and TADDOL-
containing ligands with rhodium precursors 
To demonstrate the general ability of bidentate POP ligands to form 
stable, well-defined complexes with the rhodium precursor normally used 
in hydrogenation reactions ( i.e. [Rh(nbd)2]BF4), we performed 
complexation studies using enantiopure ligands 3c-i
15
 and the rhodium 
precursor previously mentioned. Rhodium complexes [Rh(nbd)(POP)]BF4 
derived from POP ligands 3ci were efficiently synthesized using 
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stoichiometric amounts of ligand and [Rh(nbd) 2]BF4 (Scheme 2). The 
corresponding [Rh(nbd)(POP)]BF4 complexes were isolated in high yields 
by crystallization (from 81 to 91%, Scheme 2). The spectroscopic data 
(NMR and MS) of the resulting complexes was in agreement with the 
proposed structure. Furthermore, single crystals of the rhodium complexes 
derived from ligands 3cg and 3i suitable for X-ray diffraction analysis 
could be grown and then analyzed to unambiguously confirm a six -
membered chelate coordination mode of the POP ligands to a square 
planar rhodium center (see Figure 1). The X-ray structures of two 
representative [Rh(nbd)(POP)] complexes are shown in Figure 1 (see 
Section 3.6.3 for the graphical representation of the rest of structures). 
 
Scheme 2. Complexation studies of the POP ligands 3ci. 
  
Figure 1. X-ray structures of the Rh-(POP) complexes. 4c (left) and 4e (right) 
(ORTEP drawings showing thermal ellipsoids at 50% probability ; some H-atoms (and 
the BF4 counterion for 4e) have been omitted for clarity). 
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3.3.3 Catalytic performance of Rh complexes derived from H8-
BINOL- and TADDOL-containing ligands in asymmetric 
hydrogenation of functionalized alkenes 
Having studied the complexation properties of ligands 3ci with 
[Rh(nbd)2]BF4, we then investigated the performance of these ligands in 
the Rh-mediated enantioselective hydrogenation of various prochiral 
functionalized olefins: -(acylamino)acrylates (5a and 5b), dimethyl 2-
methylenesuccinate (5c), N-(1-phenylvinyl)acetamide (5d) and 1-
phenylvinyl acetate (5e). The hydrogenation reactions were run under 
standard screening conditions (1.0 mol % of preformed or in situ prepared 
[Rh(nbd)(POP)]BF4 precatalyst, 20 bar of H2, THF as solvent at room 
temperature during 18 h). The results of this comparative study are 
summarized in Table 1. Complete conversions were observed in almost all 
cases. 
Although the results with ligands 3a and 3b have not been obtained 
within the present thesis,
10c
 their hydrogenation results have been included 
in Table 1 in order to aid comparison. Previous hydrogenation studies had 
already revealed that the phosphite group is the principal stereodirector in 
the asymmetric hydrogenation of functionalized alkenes: opposite absolute 
configurations of the hydrogenation products 5ae were obtained with 
ligands 3a and 3b, whose only difference is the opposite configuration of 
the stereogenic axis in the phosphite fragment (compare entries 1 and 2 in 
Table 1).
10c 
Thus, ligand 3a contains the matched combination of 
stereogenic elements, which translates into higher enantioselectivities than 
those obtained with ligand 3b. 
The presence of sterically crowded phosphite groups (ligands 3c and 
3d, see in Scheme 1) with phenyl substituents at the 3,3’-positions of the 
[1,1'-biaryl]-2,2'-diol motif led to an increase in the enantioselectivities for 
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all substrates tested (entries 3 and 4 in Table 1). Ligand 3c incorporating 
an (Sa)-configured phosphite fragment provided perfect enantioselectivities 
(99% ee) for the four types of substrates tested (entry 3, Table 1) and 
should be considered the highest performing POP ligand developed by the 
group for the rhodium-mediated asymmetric hydrogenation of 
functionalized olefins. Interestingly, its diastereomeric ligand (3d) 
incorporating an (Ra)-configured phosphite fragment also provided 
excellent enantioselectivities for substrates 5a, 5c and 5e (99% ee; see 
entry 4 in Table 1). 
Ligands with TADDOL-derived phosphite fragments (i.e. ligands 3ei) 
were also investigated in the asymmetric hydrogenation of the 
aforementioned functionalized olefins 5ae. Although all ligands tested 
showed high performance in terms of activity (conversions >99%), 
enantioselectivities were lower than those obtained for  the (H8-)BINOL 
containing ligands 3ad (compare entries 14 with entries 59 in Table 1). 
The choice of the optimal ligand clearly depended on substrate. For 
instance, (S,S)-TADDOL derived POP ligands 3e and 3g performed better 
for substrates 5c, 5d and 5e and provided higher enantioselectivities than 
those obtained with (R,R)-TADDOL-derived ligands (up to 91% ee for 
(S,S)-TADDOL derived POP ligands; compare the columns corresponding 
to substrates 5c, 5d and 5e in entries 5 and 7 with those in entries 6 and 8). 
On the contrary, (R,R)-TADDOL-derived ligands 3f and 3h led to better 
results in the case of -(acetamido)acrylates 5a and 5b (up to 86% ee for 
(R,R)-TADDOL derived POP ligands; compare the columns 
corresponding to substrates 5a and 5b in entries 5 and 7 with those in 
entries 6 and 8 in Table 1). Changing the phenyl substituents at the 
TADDOL-derived phosphite group (ligands 3e and 3g) by the bulkier 2-
naphthyl substituent (ligands 3f and 3h) did not lead to any significant 
effect on the observed enantioselectivities. Whenever a comparison is 
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possible between the configuration of the hydrogenation products obtained 
with (S,S)- and (R,R)-TADDOL-derived POP ligands (ligands 3e and 3g 
and ligands 3f and 3h, respectively), the performed hydrogenation studies 
confirmed that the phosphite group is the principal stereodirector of the 
asymmetric hydrogenation. As observed for (H8-)BINOL-derived ligands 
(3a-d), opposite absolute configurations of the hydrogenation products are 
obtained upon changing the configuration of the stereogenic centers of the 
TADDOL unit (compare entries 5 and 7 with entries 6 and 8 in Table 1). 
The only exception to this observation is that the hydrogenation product 5e 
employing ligands 3f and 3g (which contain phosphite fragments with 
opposite configurations; entries 7 and 8 in Table 1) had the same 
configuration. This observation would suggest a substrate- and ligand-
dependent mechanistic scenario in the hydrogenations. However, any 
mechanistic rationalizations about processes with low enantioselectivity 
(e.g. lower than 20% ee), should be made judiciously.  Lastly, TADDOL-
derived POP ligand 3i containing 1-naphthyl substituents at the phosphite 
group performed better in terms of enantioselectivities (5499% ee, see 
entry 9 Table 1) than any other TADDOL-containing ligand (compare 
entries 5, 6, 7 and 8 with 9, Table 1), except for substrate 5d. 
This comparative study on the catalytic performance of POP ligands 
with new phosphite motifs in rhodium-mediated asymmetric 
hydrogenations has revealed that 3,3’-disubstituted H8-BINOL-containing 
ligands are superior in terms of enantioselection than the TADDOL-based 
ligands or those lacking substituents at the 3,3’ -positions of the [1,1'-
biaryl]-2,2'-diol fragment. Unfortunately, an accurate structure-activity 
relationship (SAR) between the structural features of the different ligands 
and the observed enantioselectivities for the studied substrates is not 
possible. Detailed theoretical studies at a high computational level of the 
oxidative addition transition states of the different reaction manifolds for 
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the different substrates and ligands would probably be required for 
performing accurate SAR studies and these studies fall beyond the scope 
and capabilities of the present Ph.D. thesis. 
Table 1. Asymmetric hydrogenationa of functionalized olefins catalyzed by Rh 















1 3a 99% (R)
d 99% (R)d 99% (S)d 98% (R)d 96% (R)d 
2 3b 88% (S)
d 86% (S)d 97% (R)d 
f 
94% (S)d 90% (S)d 
3 3c 99% (R) 99% (R) 99% (S) 99% (R) 99% (R)
e 
4 3d 99% (S) 88% (S) 99% (R) 98% (S) 99% (S) 
5 3e 36% (R) 76% (R) 84% (S) 80% (R) 32% (R) 
6 3f 85% (S) 86% (S) 41% (R) 25% (S) 12% (S) 
7 3g 29% (R) 77% (R) 91% (S) 71% (R) 24% (R) 
8 3h 78% (S) 82% (S) 76% (R) 30% (S) 22% (R) 
9 3i 99% (R)
f 91% (R)f 91% (S)f 54% (R)f 64% (R)f 
a The values shown are the average of at least two independent runs. 
Hydrogenations were run in a parallel reactor: Reaction conditions: 
[Rh(nbd)2]BF4/POP ligand/substrate = 1.0:1.1:100, rt, 20 bar H 2, substrate 
concentration = 0.20 M in THF, 18 h. Conversions were determined by 1H NMR 
to be higher than 99%. b Enantiomeric excesses (ee) were determined by GC or 
HPLC analysis on chiral stationary phases, as indicated in the SI. c Absolute 
configurations were assigned by comparison of chromatographic elution orders 
with reported data. d Results published in ref. 10c and 10f.  e Conversion was 96%. 
f Reaction conditions: [Rh(nbd)(POP)]BF4/ substrate = 1.0:100. 
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In summary, we have expanded the structural diversity of the POP 
ligand library with 3,3'-diphenyl-H8-BINOL- and TADDOL-derived 
phosphite fragments. Efficient synthetic methods for the preparation of 
the new ligands have been developed. Complexation experiments 
between the POP ligands and the standard rhodium precursor for 
asymmetric hydrogenations afforded an array of [Rh(nbd)(POP)]BF4 
complexes, whose structures were unambiguosly confirmed by NMR 
and X-ray spectroscopic studies. The [Rh(nbd)(POP)]BF4 complexes 
have been evaluated in the asymmetric hydrogenation of functionalized 
olefins. High activities (conversion >99%) and medium to excellent 
enantioselectivities (up to 99%) have been achieved for the studied 
substrates. The effects of different phosphite groups on the 
enantioselectivities of the rhodium-mediated asymmetric 
hydrogenations had been comparatively studied. H8-BINOL-based 
ligands proved to be superior to the corresponding TADDOL-based 
ones in the current study and provided the highest enantioselectivities 
in the rhodium-mediated hydrogenation of functionalized alkenes within 
the whole series of POP ligands developed by the group. 
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3.5 Experimental Section 
All syntheses were carried out using chemicals as purchased from 
commercial sources, unless otherwise stated. Glassware was dried under 
vacuum and heated with a hot air gun before use. All manipulations and 
reactions were run under inert atmosphere using anhydrous solvents, in 
either a glove box or with standard Schlenk-type techniques. All solvents 
were dried by using a Solvent Purification System (SPS). Silica gel 60 
(230400 mesh) was used for column chromatography. NMR spectra were 
recorded in CDCl3 unless otherwise cited, using a 400 MHz or 500 MHz 
spectrometer. 
1




H} NMR chemical shifts are quoted in 












H} NMR chemical shifts are quoted in ppm relative to 
BF3·OEt2 in CDCl3. High resolution mass spectra (HRMS) were recorded 
by using an ESI ionization method in positive mode. Optical rotat ions were 
measured on a Jasco P-1030 polarimeter. Melting points were measured in 
open capillaries on a Büchi B-540 instrument and are uncorrected. 
Enantiomeric excesses were determined by GC or HPLC on using chiral 
stationary phases. GC analyses were performed on an Agilent 6890N 
chromatograph equipped with a FID detector. HPLC analyses were 
performed on an Agilent 1200 Series chromatograph equipped with a diode 
array UV detector. 
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3.5.1 General procedure for the synthesis of ligands 
The phosphine-borane complex
10c 
(1.0 mmol) and 
diazabyciclo[2.2.2]octane (2.0 mmol) were charged in a flame dried 
Schlenk flask. The system was purged three times with Ar . Dry and 
deoxygenated toluene (6.0 mL) was added. The reaction mixture was 
heated at 60 ºC and stirred for 2h, allowed to cool down to room 
temperature, passed through a short SiO2 pad under N2 atmosphere inside a 
glove box and further eluted with dry and deoxygenated toluene (4.0 mL) 
giving a solution of the corresponding phosphino alcohol, which was dried 
in vacuo. The residue was dissolved in THF (5.0 mL) and NEt3 (20 mmol) 
and DMAP (0.05 mmol) were added to the previous solution. The 
appropriate amount of chlorophosphite
17
 (1.1 mmol) in THF (12.0 mL) was 
added dropwise to the phosphino-alcohol solution. The mixture was stirred 
for 15 h at room temperature. The reaction mixture was filtered through 
Celite
®
 inside the glove box and the filtrate was evaporated in vacuo. 
Rapid chromatography of the residue over a short column of silica gel (12 
g) inside glove box using dry and deoxygenated solvents (2:1;  
DCM:Hexane) afforded the pure ligand. The syntheses and characterization 




 have been already published. 
Ligand 3g: Ligand 3g was synthesized following the general procedure, 
starting from the required phosphino-alcohol-
borane complex
10c
 (0.387 g, 1.06 mmol), 
diazabyciclo[2.2.2]octane (0.243 g, 2.13 
mmol), NEt3 (2.95 mL, 21.3 mmol), DMAP 
(6.49 mg, 0.053 mmol) and chlorophosphite
17
 
(0.568 g, 1.07 mmol). It was obtained as a 
white solid (0.584 g, 53% isolated yield). RF is 
0.46 in 2:1 (DCM:Hexane) as an eluent. mp 
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25  = +178 (c = 0.130 g/ 100 mL, DCM); IR absorption 
(neat) ῡ3054, 2987, 2923, 1598, 1505, 1452; 
1
H NMR (500 MHz, CDCl3) 
δ 8.63–8.58 (m, 1H), 8.24–8.22 (m, 1H), 8.19–8.17 (m, 1H), 8.12–8.10 (m, 
1H), 8.04–6.74 (m, 39H), 5.81 (d, 
3
JH-H = 8.1 Hz, 1H), 5.48 (d, 
3
JH-H = 8.1 
Hz, 1H), 4.61–4.53 (m, 1H), 3.82 (dd, 
2
JH-P = 4.9 Hz, 
3
JH-H = 2.9 Hz, 1H), 





H} NMR (100 MHz, CDCl3) δ 143.0 (C), 142.8 (C), 139.45 (C), 
139.41 (C), 139.2 (C), 136.7 (C), 136.6 (C), 136.5 (C), 134.6 (CH), 134.4 
(CH), 133.6 (CH), 133.4 (CH), 133.2 (C), 133.1 (C), 133.0 (C), 132.9 (C), 
132.7 (C), 132.6 (C), 131.0 (CH), 130.9 (CH), 129.3 (CH), 129.0 (CH), 
128.9 (CH), 128.84 (CH), 128.79 (CH), 128.7 (CH), 128.6 (CH), 128.4 
(CH), 128.2 (CH), 127.83 (CH), 127.76 (CH), 127.7 (CH), 127.6 (CH), 
127.5 (CH), 127.48 (CH), 127.4 (CH), 127.2 (CH), 126.5 (CH), 126.4 2 
(CH), 126.37 (CH), 126.20 (CH), 126.15 (CH), 126.1 (CH), 126.0 (CH), 
125.8 (CH), 125.6 (CH), 125.2 (CH), 114.2 (C), 87.1 (d, 
2
JC-P = 12.2 Hz, 
C), 83.6 (C), 82.4 (d, 
3
JC-P = 11.1 Hz, CH), 80.2 (d, 
3
JC-P = 4.7 Hz, CH), 
73.4–73.2 (m, CH2), 73.2–72.8 (m, CH), 58.6 (CH3), 47.5 (dd, 
1
JC-P = 14.1 
Hz, 
3




H} NMR (202 MHz, 
CDCl3) 142.7 (d, 
4
JP-P = 21.5 Hz, PO), –9.0 (d, 
4
JP-P = 21.5 Hz, PC); 
HRMS (ESI
+
) [calculated for C69H59O6P2 (M+H)
+
 1045.3781; observed 
1045.3772]. 
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Ligand 3h: Ligand 3h was synthesized following the general procedure,  
starting from the required phosphino-alcohol-
borane complex
10c
 (0.400 g, 1.08 mmol), 
diazabyciclo[2.2.2]octane (0.246 g, 2.15 
mmol), NEt3 (2.98 mL, 21.5 mmol), DMAP 
(6.57 mg, 0.0538 mmol) and chlorophosphite
17
 
(0.568 g, 1.07 mmol). It was obtained as a 
white solid (0.435 g, 39% isolated yield). RF is 
0.4 in 2:1 (DCM:Hexane) as an eluent. m.p. 
133135  ºC; [α]D
25  = 281.2 (c = 0.11 g/100 mL, DCM); IR absorption 
(neat) ῡ3054, 2985, 2919, 1598, 1504, 1452, 1433; 
1
H NMR (500 MHz, 
CDCl3)  8.61 (bs, 1H), 8.198.16 (m, 2H), 8.02 (bs, 1H), 7.997.4 (m, 
28H), 7.156.93 (m, 11H), 5.39 (s, 2H), 4.734.65 (m, 1H), 3.95 (dd, 
2
JH-P 
= 4.8 Hz, 
3
JH-H = 2.9 Hz, 1H), 3.413.34 (m, 1H), 3.21 (dd, 
2
JH-H = 9.2 Hz, 
3





(125 MHz, CDCl3) δ 143.6 (C), 143.2 (C), 139.3 (C), 138.5 (C), 137.4 (C), 
137.2 (C), 136.8 (C), 136.7 (C), 136.6 (C), 136.5 (C), 134.3 (CH), 134.1 
(CH), 133.8 (CH), 133.7 (CH), 133.1 (C), 133.05 (C), 132.96 (C), 132.83 
(C), 132.81 (C), 132.7 (C), 132.6 (C), 131.53 (CH), 131.47 (CH), 129.3 
(CH), 128.99 (CH), 128.96 (CH), 128.9 (CH), 128.54 (CH), 128.49 (CH), 
128.31 (CH), 128.28 (CH), 128.94 (CH), 127.91 (CH), 127.87 (CH), 
127.81 (CH), 127.74 (CH), 127.68 (CH), 127.58 (CH), 127.51 (CH), 
127.44 (CH), 126.9 (CH), 126.8 (CH), 126.6 (CH), 126.5 (CH), 126.4 (CH), 
126.3 (CH), 126.2 (CH), 126.02 (CH), 125.99 (CH), 125.86 (CH), 125.5 
(CH), 125.4 (CH), 113.1 (C), 85.3 (d, 
2
JC-P = 5.4 Hz, C), 83.0 (d, 
3
JC-P = 
20.6 Hz, CH), 82.7 (d, 
2
JC-P = 4.7 Hz, C), 81.7 (d, 
3
JC-P = 4.0 Hz, CH), 
73.5 (m, CH2), 72.7 (dd, 
2
JC-P = 16.3 Hz, 
2
JC-P = 11.9 Hz, CH), 58.8 
(CH3), 47.7 (dd, 
1
JC-P = 14.4 Hz, 
3





H} NMR (202 MHz, CDCl3) 147.6 (d, 
4
JP-P = 21.4 Hz, PO), 
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JP-P = 21.4 Hz, PC); HRMS (ESI
+
) [calculated for C69H59O6P2 
(M+H)
+
 1045.3781; observed 1045.3774]. 
Ligand 3i: Ligand 3i was synthesized following the general procedure, 
starting from the required phosphino-alcohol-
borane complex
10c
 (0.231 g, 0.629 mmol), 
diazabyciclo[2.2.2]octane (0.144 g, 1.26 mmol), 
NEt3 (1.75 mL, 12.6 mmol), DMAP (3.84 mg, 
0.0314 mmol) and with corresponding 
chlorophosphite (0.631 g, 0.66 mmol). After 
careful column chromatography in glovebox 
using 2:1 (DCM:Hexane) as an eluent the ligand 
3i was obtained as a white solid. Though the TLC of the obtained 
compound shows single spot, the ligand is not in pure form (0.158 g, 58% 
pure by 
31
P NMR). Hence the ligand was straightforwardly converted as its 
Rh precatalyst by treating with corresponding amount of Rh-precursor (i.e. 
[Rh(nbd)2]BF4) (see the preparation of Rh-complex 4i in the following 
section 3.5.2). 
3.5.2 General synthetic procedure for the preparation of Rh-
complexes 
A solution of the POP ligand (1 mmol) in anhydrous DCM (5.0 mL) 
was slowly added via cannula to a stirred solution of [Rh(nbd)2]BF4 (0.98 
mmol) in anhydrous DCM (5.0 mL). The reaction was stirred for 2 h at 
room temperature under Ar atmosphere. The solvent was concentrated in 
vacuo to reach a final volume of ca. 2.5 mL. Anhydrous Et2O (15.0 mL) 
was slowly added by syringe and the resulting solution was slowly stirred 
to yield an orange suspension. The solvent was filtered off under inert 
atmosphere by using a cannula filter and the resulting solid was washed 
with anhydrous Et2O (2 x 12.0 mL) and dried in vacuo to afford the pure 
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Rh complex [Rh(nbd)(POP)]BF4 as an orange powder. The syntheses and 




 has already been 
published. 
[Rh(nbd)(3d)]BF4 (4d): Rhodium complex 4d was prepared by 
following the general procedure, starting 
from 3d (197 mg, 0.239 mmol) and 
[Rh(nbd)2]BF4 (87.5 mg, 0.234 mmol). It 
was obtained as an orange powder (227.0 
mg, 86% isolated yield). 
1
H NMR (400 
MHz, CD2Cl2) δ 7.84–7.74 (m, 2H), 7.62–
7.39 (m, 9H), 7.37–7.14 (m, 5H), 7.10–6.85 
(m, 7H), 6.76–6.71 (m, 2H), 6.35–6.24 (m, 
2H), 5.93 (bs, 1H), 5.16 (bs, 1H), 4.52–4.44 (m, 1H), 4.02–3.96 (m, 2H), 
3.86 (bs, 1H), 3.61 (bd, J = 14.5 Hz, 1H), 3.13–2.60 (m, 11H), 2.49–2.26 




H} NMR (100 MHz, CD2Cl2) δ 143.4 
(C), 143.3 (C), 142.5 (C), 142.4 (C), 139.8 (C), 138.3 (C), 137.9 (C), 137.5 
(C), 137.1 (C), 136.7 (C), 135.3 (CH), 135.2 (CH), 132.70 (C), 132.68 (C), 
132.4 (C), 132.3 (C), 132.09 (C), 132.07 (C), 131.89 (CH), 131.82 (CH), 
131.82 (CH), 131.79 (CH), 131.69 (CH) 131.62 (CH), 131.59 (CH), 131.4 
(CH), 130.74 (CH), 130.70 (CH), 130.4 (CH), 130.3 (CH), 129.9 (C), 
129.8 (CH), 129.7 (CH), 129.5 (C), 129.4 (C), 129.3 (C), 129.2 (C), 129.1 
(CH), 129.0 (CH), 128.94 (CH), 128.88 (CH), 128.77 (CH), 128.3 (CH), 
128.2 (C), 128.1 (C), 127.64 (CH), 127.62 (CH), 103.3–102.9 (m, CH), 
99.9–99.6 (m, CH), 93.0–92.8 (m, CH), 78.6 (
2
JC-P = 8.1 Hz, CH), 75.5 
(CH), 72.8 (CH2), 71.7 (CH2), 59.6 (CH3), 56.3 (CH), 55.3 (CH), 43.7 (d, 
1
JC-P = 24.6 Hz, CH), 29.8 (CH2), 29.7 (CH2), 28.4 (CH2), 28.3 (CH2), 




H} NMR (162 MHz, CD2Cl2) δ 
131.3 (dd, 
1
JRh-P = 265.2 Hz, 
2
JP-P = 68.9 Hz, PO), 27.7 (dd, 
1
JRh-P = 
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JP-P = 68.9 Hz, PC). HRMS (ESI
+
) [Calculated for 
C61H58O4P2Rh (MBF4)
+ 
1019.2860; observed 1019.2833]. 
[Rh(nbd)(3f)]BF4 (4f): Rhodium complex 4f was prepared by following 
the general procedure, starting from 3f (59.3 
mg, 0.0704 mmol) and [Rh(nbd)2]BF4 (25.0 
mg, 0.0668 mmol). It was obtained as an 
orange powder (68.3 mg, 91% isolated 
yield). 
1
H NMR (500 MHz, CD2Cl2) δ 8.12–
8.09 (m, 2H), 7.72–6.89 (m, 31H), 6.35–6.26 
(m, 2H), 6.11 (bs, 1H), 5.91 (bs, 1H), 5.86 
(d, 
3
JH-H = 8.2 Hz, 1H), 5.36 (bs, 1H), 4.86 (d, 
3
JH-H = 8.2 Hz, 1H), 4.83 
(bs, 1H), 4.31 (s, 1H), 4.22 (s, 1H),  3.77 (d, 
2
JH-P = 16.4 Hz, 1H), 3.67–




JH-H = 8.8 Hz, 1H), 2.03–
1.96 (m, 1H), 1.79 (d, 
2
JH-H = 8.9 Hz, 1H), 1.75–1.71 (m, 1H), 1.29 (s, 




H} NMR (125 MHz, CD2Cl2) δ 145.2 (C), 145.1 
(C), 144.3 (C), 140.7 (C), 140.6 (C), 140.5 (C), 136.5 (CH), 136.4 (CH), 
133.7 (CH), 132.2 (CH), 132.1 (CH), 131.8 (C), 131.31 (CH), 131.29 
(CH), 130.6 (CH), 130.5 (CH), 129.6 (CH), 129.3 (CH), 129.2 (CH), 129.1 
(CH), 129.03 (CH), 128.98 (CH), 128.85 (CH), 128.8 (CH), 128.74 (CH), 
128.6 (CH), 128.55 (CH), 128.5 (CH), 128.34 (CH), 128.25 (CH), 127.4 
(CH), 127.3 (CH), 114.4 (C), 96.7 (CH), 96.3 (CH), 90.2 (C), 90.1 (C), 
88.8–88.6 (m, CH), 86.9–86.7 (m, CH), 82.0 (d, 
3
JC-P = 3.8 Hz, CH), 79.4 
(d, 
3
JC-P = 3.8 Hz, CH), 75.0 (d, 
2
JC-P = 6.2 Hz, CH), 72.0 (CH2), 70.5 (d, 
3
JC-P = 8.4 Hz, CH2), 58.9 (CH3), 56.4 (CH), 55.2 (CH), 42.2 (d, 
1
JC-P = 




H} NMR (202 MHz, CD2Cl2) 
= 107.0 (dd, 
1
JP-Rh = 266.7 Hz, 
2





JP-P = 68.4 Hz, PC). HRMS (ESI
+
) [calculated for 
C60H58O6P2Rh (MBF4)
+
 1039.2758; observed 1039.2734]. 
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[Rh(nbd)(3g)]BF4 (4g): Rhodium complex 4g was prepared by 
following the general procedure, starting 
from 3g (145.0 mg, 0.138 mmol) and 
[Rh(nbd)2]BF4 (47.0 mg, 0.126 mmol). It 
was obtained as an orange powder (135.0 
mg, 81% isolated yield). 
1
H NMR (500 
MHz, CD2Cl2)  8.176.80 (m, 41 H), 
6.686.55 (m, 2H), 6.15 (bs, 1H), 5.68 (d, 
3
JH-H = 7.9 Hz, 1H), 5.64 (d, 
3
JH-H = 7.9 Hz, 1H), 5.36 (bs, 1H), 5.13 (bs, 





JH-H, 1H), 2.07 (s, 3H), 1.771.61 (m, 2H), 1.481.39 




H} NMR (125 MHz, CD2Cl2) δ 
141.34 (C), 141.28 (C), 140.9 (C), 137.3 (C), 137.2 (C), 136.5 (C), 136.0 
(CH), 135.9 (CH), 133.8 (C), 133.7 (CH), 133.6 (CH), 133.5 (C), 133.4 
(C), 133.3 (C), 133.2 (C), 132.8 (C), 132.75 (C), 132.73 (CH), 132.65 
(CH), 132.62 (C), 132.3 (C), 131.55 (CH), 131.53 (CH), 130.83 (C), 
130.80 (CH), 130.7 (CH), 130.5 (C), 129.8 (CH), 129.6 (CH), 129.4 (CH), 
129.34 (CH), 129.28 (CH), 129.2 (CH), 129.1 (CH), 129.0 (CH), 129.0 
(C), 128.6 (C), 128.3 (CH), 128.2 (CH), 128.0 (CH), 127.9 (CH), 127.8 
(CH), 127.75 (CH), 127.68 (CH), 127.6 (CH), 127.5 (CH), 127.3 (CH), 
127.2 (CH), 127.0 (CH), 126.6 (CH), 126.3 (CH), 125.9 (CH), 125.6 (CH), 
125.5 (CH), 115.5 (C), 96.796.5 (m, CH), 95.995.7 (m, CH), 93.7 (d, 
2
JC-P = 20.9 Hz, C), 91.1 (d, 
2
JC-P = 17.0 Hz, C),  89.2 (CH), 88.6 (CH), 
80.5 (d, 
3
JC-P = 3.6 Hz, CH), 79.5 (d, 
3
JC-P = 4.5 Hz, CH), 75.0 (d, 
2
JC-P = 
7.9 Hz, CH), 72.1 (CH2), 69.1 (dd, 
3
JC-P = 8.8 Hz, CH2), 58.0 (CH3), 56.3 
(CH), 55.2 (CH), 41.1 (d, 
1




H} NMR (202 MHz, CD2Cl2)  106.8 (dd, 
1
JP-Rh = 268.6 Hz, 
2
JP-P = 
67.0 Hz, PO), 26.2 (dd, 
1
JP-Rh  149.5 Hz, 
2
JP-P  67.0 Hz, PC); HRMS 
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[Rh(nbd)(3h)]BF4 (4h): Rhodium complex 4h was prepared by 
following the general procedure, starting 
from 3h (124.0 mg, 0.119 mmol) and 
[Rh(nbd)2]BF4 (40.5 mg, 0.108 mmol). It 
was obtained as an orange powder (126.0 
mg, 88% isolated yield). 
1
H NMR (500 
MHz, CD2Cl2)  8.46 (bs, 1H), 8.257.38 
(m, 29H), 7.306.95 (m, 10 H), 6.426.25 
(m, 5H), 6.16 (bs, 1H), 5.45 (bs, 1H), 5.20 (d, 
3
JH-H  8.2 Hz, 1H), 4.84 
(bs, 1H), 4.26 (bs, 1H), 4.24 (bs, 1H), 3.713.57 (m, 2H), 2.21 (s, 3H), 
2.082.03 (m, 1H), 1.851.74 (m, 2H), 1.49 (s, 3H), 1.381.32 (m, 1H), 




H} NMR (125 MHz, CD2Cl2) δ 142.2 (C), 142.1 (C), 
141.1 (C), 137.9 (C), 137.8 (C), 137.2 (C), 136.5 (CH), 136.4 (CH), 133.9 
(CH), 133.8 (CH), 133.6 (C), 133.41 (C), 133.37 (C), 133.31 (C), 133.28 
(C), 132.9 (C), 132.8 (C), 132.6 (C), 132.2 (CH), 132.1 (CH), 131.4 (C), 
131.3 (CH), 130.7 (CH), 130.6 (CH), 129.8 (C), 129.4 (C), 129.25 (CH), 
129.20 (CH), 129.17 (CH), 129.12 (CH), 129.07 (CH), 128.9 (CH), 128.86 
(CH), 128.77 (CH), 128.73 (CH), 128.67 (CH), 128.5 (C), 128.26 (CH), 
128.16 (C), 128.10 (CH), 128.08 (CH), 128.06 (CH), 127.9 (CH), 127.8 
(CH), 127.7 (CH), 127.6 (CH), 127.5 (CH), 127.31 (CH), 127.2 (CH), 
127.0 (CH), 126.7 (CH), 126.2 (CH), 126.0 (CH), 125.8 (CH), 125.5 (CH), 
114.6 (C), 97.296.7 (m, 2 x CH), 90.5 (d, 
2
JC-P = 5.6 Hz, C), 90.4 (d, 
2
JC-P 
= 4.3 Hz, C), 89.288.9 (m, CH), 86.486.2 (m, CH), 82.5 (d, 
3
JC-P = 3.8 
Hz, CH), 79.3 (d, 
3
JC-P = 3.5 Hz, CH), 75.1 (d, 
2
JC-P = 6.1 Hz, CH), 72.2 
(CH2), 70.4 (dd, 
3
JC-P = 8.4 Hz, CH2), 58.3 (CH3), 56.4 (CH), 55.3 (CH), 
42.2 (d, 
1




H} NMR (202 
MHz, CD2Cl2)  109.6 (dd, 
1
JP-Rh = 264.3 Hz,
2
JP-P = 72.8 Hz, PO), 26.1 
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JP-Rh = 147.7 Hz, 
2
JP-P = 72.8 Hz, PC); HRMS (ESI
+
) [calculated for 
C69H59O6P2Rh (MBF4)
+
1147.2758; observed 1147.2737]. 
[Rh(nbd)(3i)]BF4 (4i): Rhodium complex 4i was prepared by following 
the reported complexation procedure from 
the group,
18
 the crude ligand 3i (140.0 mg, 
0.077 mmol, 58% pure by 
31
P NMR) and 
[Rh(nbd)2]BF4 (40.5 mg, 0.108 mmol). It 
was obtained as an orange powder (87.0 mg, 
88% isolated yield corresponds to Rh 
precursor). 
1
H NMR (500 MHz, CD2Cl2) δ 
8.52–8.48 (m, 1H), 8.44–8.34 (m, 2H), 8.29–8.22 (m, 3H), 8.15–6.72 (m, 
35H), 6.54–6.33 (m, 4H), 6.06 (bs, 1H), 4.61 (bs, 1H), 4.57 (bs, 1H), 3.96 
(bs, 2H), 3.67 (d, 
2
JH-P = 16.4 Hz, 1H), 3.19–3.06 (m, 1H), 2.98 (bs, 1H), 




JH-H = 9.5 Hz, 1H), 1.75–1.23 (m, 3H), 




H} NMR (125 MHz, CD2Cl2) δ 141.0 
(C), 140.9 (C), 139.3 (C), 136.5 (C), 136.4 (C), 135.7 (C), 135.1 (C), 135.0 
(C), 134.4 (CH), 134.3 (CH), 133.4 (CH), 133.3 (CH), 133.2 (C), 132.40 
(CH), 132.38 (CH), 132.2 (C), 132.15 (C), 132.07 (C), 132.05, 132.0 (CH), 
131.71 (CH), 131.69 (CH), 131.5 (CH), 131.3 (C), 131.2 (CH), 130.3 
(CH), 130.2 (CH), 130.1 (CH), 129.7 (CH), 129.1 (CH), 129.0 (CH), 128.9 
(CH), 128.8 (CH), 128.6 (CH), 128.1 (CH), 127.8 (CH), 127.6 (CH), 127.2 
(CH), 126.9 (CH), 126.8 (CH), 126.7 (CH), 126.6 (CH), 126.5 (CH), 
126.23 (CH), 126.19 (CH), 126.1 (CH), 125.76 (CH), 125.73 (CH), 125.5 
(CH), 125.3 (CH), 125.2 (CH), 125.1 (CH), 124.5 (CH), 116.7 (C), 
98.498.1 (m, CH), 95.0 (d, 
2
JC-P = 19.7 Hz, C), 94.894.5 (m, CH), 92.0 
(d, 
2
JC-P = 18.1 Hz, C), 89.8 (CH), 83.5 (CH), 80.8 (d, 
3
JC-P = 4.2 Hz, CH), 
79.7 (d, 
3
JC-P = 4.3 Hz, CH), 74.9 (CH), 72.4 (CH2), 68.8 (CH2), 58.5 
(CH3), 55.6 (CH), 55.1 (CH), 41.3 (d, 
1





H} NMR (202 MHz, CD2Cl2) δ 106.8 (dd, 
1
JRh-P = 269.3 
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JP-P = 68.0 Hz, PO), 24.3 (dd, 
1
JRh-P = 149.0 Hz, 
2
JP-P = 68.0 Hz, 
PC); HRMS (ESI
+




3.5.3 General procedure for the Rh-mediated asymmetric 
hydrogenation of substrates 5ae 
A solution of the required amount of [Rh(nbd)2]BF4 (1.0 mol %) and 
POP ligand 3ci (1.1 mol %) and the corresponding functionalized alkene 
5ae (0.10 mmol) in anhydrous and degassed THF (0.50 mL) was prepared 
inside a glass vessel under N2 atmosphere working in a glove box. In all 
cases, the molar concentration of a given substrate in the reaction medium 
was adjusted to 0.20 M. Once the reaction mixture had been loaded, the 
glass vessel was then placed into one of the positions of a steel autoclave 
reactor (HEL Cat-24 parallel pressure multireactor). The autoclave was 
purged three times with H2 gas at 5 bar and finally, the autoclave was 
pressurized under 20 bar of H2 gas. The reaction mixture was stirred at rt 
for 18 h (overnight reaction). The autoclave was then slowly 
depressurized. The reaction mixture was filtered through a short pad of 
SiO2 and eluted with EtOAc (1.0 mL). The resulting solution was 
concentrated under vacuum and the conversion was determined by 
1
H 
NMR. The enantiomeric excess was determined by GC or HPLC analysis 
on chiral stationary phases. 
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3.6 Supporting Information 
3.6.1 NMR spectra of ligands 3ci and rhodium complexes 
4ci: 
 
1H NMR spectrum of 3g
 
31P{1H} NMR spectrum of 3g 
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13C{1H} NMR spectrum of 3g 
 
13C{1H} Pendant NMR spectrum of 3g 
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1H NMR spectrum of 3h 
 
31P{1H} NMR spectrum of 3h 
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13C{1H} NMR spectra of 3h
 
13C{1H} Pendant NMR spectrum of 3h 
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1H NMR spectrum of 4d 
 
31P{1H} NMR spectrum of 4d 
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13C{1H} NMR spectrum of 4d 
 
13C{1H} Pendant NMR spectrum of 4d 
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1H NMR spectrum of 4f 
 
31P{1H} NMR spectrum of 4f 
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13C{1H} NMR spectrum of 4f 
 
13C{1H} Pendant NMR spectrum of 4f 
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1H NMR spectrum of 4g 
 
 
31P{1H} NMR spectrum of 4g 
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13C{1H} NMR spectra of 4g 
 
 
13C{1H} Pendant NMR spectrum of 4g 
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1H NMR spectrum of 4h 
 
 
31P{1H} NMR spectrum of 4h 
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13C{1H} NMR spectra of 4h 
 
13C{1H} Pendant NMR spectrum of 4h 
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1H NMR spectrum of 4i 
 
31P{1H} NMR spectrum of 4i 



































































































































































































































































































































































































UNIVERSITAT ROVIRA I VIRGILI 
DEVELOPMENT OF P-OP LIGANDS WITH NEW STRUCTURAL MOTIFS FOR RHODIUM- AND IRIDIUM- MEDIATED 
ASYMMETRIC HYDROGENATIONS 
Balakrishna Bugga 
[Rh(POP)] Precatalysts Incorporating New Phosphite Fragments 






13C{1H} NMR spectrum of 4i 
 
13C{1H} Pendant NMR spectrum of 4i 
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3.6.2 Determination of enantiomeric excesses: 
Hydrogenation product of 5a:
19
 GC conditions: Supelco Beta DEX
TM
 
120 (30 m x 0.25 mm x 0.25 m), isothermal 90 ºC, 15 psi He, t1 (S) = 59.3 
min, t2 (R) = 61.9 min. 
Hydrogenation product of 5b:
19
 HPLC conditions: Daicel Chiralcel
®
 
OJ-H (25 cm x 0.46 cm), 93:7 n-hexane/2-propanol, 1.0 mL/min, 216 nm, 
t1 (R) = 18.0 min, t2 (S) = 29.1 min. 
Hydrogenation product of 5c:
20
 GC conditions: Supelco Beta DEX
TM
 
225 (30 m x 0.25 mm x 0.25 m), isothermal 70 ºC, 15 psi He, t1 (S) = 
46.4 min, t2 (R) = 53.4 min. 
Hydrogenation product of 5d:
20
 HPLC conditions: Daicel Chiralcel
 ®
 
AD-H (25 cm x 0.46 cm), 95:5 n-hexane/2-propanol, 1.0 mL/min, 210 nm, 
t1 (R) = 10.0 min, t2 (S) = 12.6 min. 
Hydrogenation product of 5e:
21
 HPLC conditions: Daicel Chiralcel
®
 
OD-H (25 cm x 0.46 cm), 99:1 n-hexane/2-propanol, 0.30 mL/min, 210 
nm, t1 (R) = 20.0 min, t2 (S) = 21.8 min. 
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3.6.3 Single Crystal X-ray Structure Determinations: 
Crystal preparation: Crystals of 4c, 4d, 4e, 4g and 4i were grown by 
slow diffusion of diethyl ether into solutions in dichloromethane. Crystals 
of 4f were grown in toluene. The measured crystals were prepared under 
inert conditions immersed in perfluoropolyether as protecting oil for 
manipulation. 
Data collection: Crystal structure determinations for samples 4f was 
carried out using a Bruker-Nonius diffractometer equipped with an APEX 
II 4K CCD area detector, a FR591 rotating anode with MoK radiation, 
Montel mirrors as monochromator, a Kappa 4-axis goniometer and an 
Oxford Cryosystem plus low temperature device (T = -173 
°
C). Crystal 
structure determination for samples 4c, 4d, 4e, 4g, and 4i were carried out 
using a Apex DUO Kappa 4-axis goniometer equipped with an APPEX 2 
4K CCD area detector, a Microfocus Source E025 IuS using MoK 
radiation, Quazar MX multilayer Optics as monochromator and an Oxford 
Cryosystems low temperature device Cryostream 700 plus (T = -173 
°
C). 
Full-sphere data collection was used with  and  scans. Programs used: 
Data collection APEX-2,
22
 data reduction Bruker Saint
23




Structure Solution and Refinement: Crystal structure solution was 
achieved using the computer program SHELXT.
25
 Visualization was 
performed with the program SHELXle.
26
 Missing atoms were subsequently 
located from difference Fourier synthesis and added to the atom list. Least -
squares refinement on F
2
 using all measured intensities was carried out 
using the program SHELXL 2015.
27
 All non-hydrogen atoms were refined 
including anisotropic displacement parameters. The crystal data parameters 
for 4c, 4d, 4e, 4f, 4g, and 4i are listed below. 
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Figure 2. X-ray structure of the Rh-complex 4c (ORTEP drawings showing thermal 
ellipsoids at 50% probability). Some H-atoms have been omitted for clarity.  Selected 
bond lengths [Å] and angles [º]: Rh1-C55 = 2.170(6), Rh1-P1 = 2.1975(14), Rh1-C56 
= 2.204(6), Rh1-C59 = 2.314(5), Rh1-C58 = 2.319(5), Rh1-P2 = 2.3286(14), P1-Rh1-
P2 = 91.80(5). 
Table 2. Crystal data and structure refinement for 4c. 
Empirical formula  C65H68BF4O5P2Rh 
Formula weight  1180.85 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 9.691(2)Å = 90°. 
 b = 13.207(3)Å  = 95.977(5)°. 
 c = 21.863(5)Å  = 90°. 
Volume 2783.1(10) Å3 
Z 2 
Density (calculated) 1.409 Mg/m3 
Absorption coefficient  0.429 mm-1 
F(000) 1228 
Crystal size 0.20 x 0.07 x 0.03 mm3 
Theta range for data collection 2.220 to 30.699°. 
Index ranges -7<=h<=13,-18<=k<=18,-30<=l<=30 
Reflections collected 23737 
Independent reflections 14822[R(int) = 0.0539] 
Completeness to theta =30.699° 92.799995%  
Absorption correction Empirical 
Max. and min. transmission 0.987 and 0.641 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  14822/ 8/ 706 
Goodness-of-fit on F2 1.008 
Final R indices [I>2(I)] R1 = 0.0534, wR2 = 0.1375 
R indices (all data) R1 = 0.0638, wR2 = 0.1434 
Flack parameter x = -0.03(3) 
Largest diff. peak and hole 1.487 and -1.516 e.Å-3 
X-ray Analyses: 
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Figure 3. X-ray structure of the Rh-complex 4d (ORTEP drawings showing thermal 
ellipsoids at 50% probability). Some H-atoms have been omitted for clarity.  Selected 
bond lengths [Å] and angles [º]: Rh1A-P1A = 2.2015(8), Rh1A-P2A = 2.3218(9), 
Rh1A-C55A = 2.213(3), Rh1A-C56A = 2.178(3), Rh1A-C58A = 2.249(3), Rh1A-
C59A = 2.260(3), P1A-Rh1A-P2A= 91.97(3). 
Table 3. Crystal data and structure refinement for  4d. 
Empirical formula  C62H60BCl2F4O4P2Rh 
Formula weight  1191.66 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 12.9435(8)Å = 90° 
 b = 20.8472(11)Å  = 90° 
 c = 40.473(2)Å  = 90° 
Volume 10921.1(11) Å3 
Z 8 
Density (calculated) 1.450 Mg/m3 
Absorption coefficient  0.532 mm-1 
F(000) 4912 
Crystal size 0.04 x 0.04 x 0.01 mm3 
Theta range for data collection 1.006 to 32.429°. 
Index ranges -18<=h<=17, -21<=k<=30, -49<=l<=58 
Reflections collected 93447 
Independent reflections 34450[R(int) = 0.0398] 
Completeness to theta =32.429° 91.2%  
Absorption correction Empirical 
Max. and min. transmission 0.995 and 0.834 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  34450/ 312/ 1497 
Goodness-of-fit on F2 1.037 
Final R indices [I>2(I)] R1 = 0.0393, wR2 = 0.0840 
R indices (all data) R1 = 0.0484, wR2 = 0.0913 
Flack parameter x = -0.012(6) 
Largest diff. peak and hole 1.087 and -0.795 e.Å-3 
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Figure 4. X-ray structure of the Rh-complex 4e (ORTEP drawings showing thermal 
ellipsoids at 50% probability). Some H-atoms and the BF4 counterion have been 
omitted for clarity. Selected bond lengths [Å] and angles [º]: Rh1-P1 = 2.2415(9), 
Rh1-P2 = 2.2880(9), Rh1-C54 = 2.242(3), Rh1-C55 = 2.212(3), Rh1-C57 = 2.217(3), 
Rh1-C58 = 2.225(3), P1-Rh1-P2 = 91.43(3). 
Table 4. Crystal data and structure refinement for 4e. 
Empirical formula  C62H62BCl4F4O6P2Rh 
Formula weight  1296.58  
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1)  
Unit cell dimensions a = 10.6530(6) Å = 90.00 °. 
 b = 20.6711(11) Å  = 90.00 °. 
 c = 25.8364(13) Å  = 90.00 °. 
Volume 5689.4(5) Å3 
Z 4 
Density (calculated) 1.514 Mg/m3 
Absorption coefficient  0.610 mm-1 
F(000) 2664  
Crystal size 0.25 x 0.08 x 0.04 mm3 
Theta range for data collection 1.58 to 29.61 °. 
Index ranges -14<=h<=9, -27<=k<=28, -34<=l<=27  
Reflections collected 46051  
Independent reflections 15072 [R(int) = 0.0516 ] 
Completeness to theta = 29.61° 96.100006%  
Absorption correction Empirical 
Max. and min. transmission 0.9760 and 0.8624  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  15072/0/724 
Goodness-of-fit on F2 1.025  
Final R indices [I>2(I)] R1 = 0.0451, wR2 = 0.1003  
R indices (all data) R1 = 0.0570, wR2 = 0.1052  
Flack parameter x =0.00(2)  
Largest diff. peak and hole 1.166 and -0.919 e.Å-3 
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Figure 5. X-ray structure of the Rh-complex 4f (ORTEP drawings showing thermal 
ellipsoids at 50% probability). Some H-atoms and the BF4 counterion have been 
omitted for clarity. Selected bond lengths [Å] and angles [º]:  Rh1-P1 = 2.2174(4), 
Rh1-P2 = 2.2966(4), Rh1-C1 = 2.2102(14), Rh1-C2 = 2.1941(14), Rh1-C4 = 
2.2277(15), Rh1-C5 = 2.2580(15), P1-Rh1-P2 = 89.771(13) 
Table 5. Crystal data and structure refinement for  4f. 
Empirical formula  C74H74BF4O6P2Rh 
Formula weight  1310.99  
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 10.7603(12) Å = 90.00° 
 b = 23.165(3) Å  = 98.810(2)° 
 c = 12.7943(14) Å  = 90.00° 
Volume 3151.6(6) Å3 
Z 2 
Density (calculated) 1.382 Mg/m3 
Absorption coefficient  0.388 mm-1 
F(000) 1364 
Crystal size 0.25 x 0.12 x 0.08 mm3 
Theta range for data collection 1.61 to 33.31°. 
Index ranges -13<=h<=16,-35<=k<=35, -19<=l<=19 
Reflections collected 61802 
Independent reflections 23589 [R(int) = 0.0256] 
Completeness to theta = 33.31° 98.799995%  
Absorption correction Empirical 
Max. and min. transmission 0.9696 and 0.9092  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  23589/160/862 
Goodness-of-fit on F2 1.020  
Final R indices [I>2(I)] R1 = 0.0313, wR2 = 0.0772 
R indices (all data) R1 = 0.0337, wR2 = 0.0788 
Flack parameter x = -0.030(8)  
Largest diff. peak and hole 1.300 and -0.441 e.Å-3 
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Figure 6. X-ray structure of the Rh-complex 4g (ORTEP drawings showing thermal 
ellipsoids at 50% probability). Some H-atoms and the BF4 counterion have been 
omitted for clarity.  Selected bond lengths [Å] and angles [º]: Rh1-P1 = 2.3161(9), 
Rh1-P2 = 2.2132(8), Rh1-C1 = 2.270(3), Rh1-C2 = 2.277(3), Rh1-C4 = 2.200(3), 
Rh1-C5 = 2.190(3), P2-Rh1-P1 = 91.47(3). 
Table 6. Crystal data and structure refinement for  4g. 
Empirical formula  C92H98BF4O14P2Rh 
Formula weight  1679.36 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1)  
Unit cell dimensions a = 16.7357(4)Å = 90° 
 b = 16.8281(5)Å  = 90° 
 c = 29.8634(10)Å  = 90° 
Volume 8410.4(4) Å3 
Z 4 
Density (calculated) 1.326 Mg/m3 
Absorption coefficient  0.314 mm-1 
F(000) 3512 
Crystal size 0.04 x 0.03 x 0.02 mm3 
Theta range for data collection 1.364 to 31.007°. 
Index ranges -20<=h<=23, -22<=k<=23, -43<=l<=24 
Reflections collected 89263 
Independent reflections 24092[R(int) = 0.0301] 
Completeness to theta = 31.007° 92.1%  
Absorption correction Empirical 
Max. and min. transmission 0.994 and 0.919 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  24092/ 292/ 1094 
Goodness-of-fit on F2 1.077 
Final R indices [I>2(I)] R1 = 0.0404, wR2 = 0.1092 
R indices (all data) R1 = 0.0479, wR2 = 0.1160 
Flack parameter x = -0.021(4) 
Largest diff. peak and hole 0.884 and -0.740 e.Å-3 
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Figure 7. X-ray structure of the Rh-complex 4i (ORTEP drawings showing thermal 
ellipsoids at 50% probability). Some H-atoms and the BF4 counterion have been 
omitted for clarity.  Selected bond lengths [Å] and angles [º]: Rh1-P1 = 2.2134(9), 
Rh1-P2 = 2.3235(10), Rh1-C1 = 2.200(4), Rh1-C2 = 2.152(4), Rh1-C4 = 2.273(4), 
Rh1-C5 = 2.332(4), P1-Rh1-P2 = 92.58(4). 
Table 7. Crystal data and structure refinement for 4i. 
Empirical formula  C78H70BCl4F4O6P2Rh 
Formula weight  1496.80 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1)  
Unit cell dimensions a = 14.4966(7)Å = 90° 
 b = 19.3144(9)Å  = 90° 
 c = 24.3219(10)Å  = 90° 
Volume 6810.0(5) Å3 
Z 4 
Density (calculated) 1.460 Mg/m3 
Absorption coefficient  0.521 mm-1 
F(000) 3080 
Crystal size 0.20 x 0.20 x 0.03 mm3 
Theta range for data collection 1.635 to 28.976° 
Index ranges -8<=h<=19,-26<=k<=26,-32<=l<=32 
Reflections collected 58133 
Independent reflections 18019[R(int) = 0.0427] 
Completeness to theta = 28.976° 99.7% 
Absorption correction Empirical 
Max. and min. transmission 0.985 and 0.874 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  18019 / 112 / 899 
Goodness-of-fit on F2 1.051 
Final R indices [I>2(I)] R1 = 0.0400, wR2 = 0.0992 
R indices (all data) R1 = 0.0492, wR2 = 0.1054 
Flack parameter x = -0.044(8) 
Largest diff. peak and hole 0.909 and -0.937 e.Å-3 
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3.6.4 Selected GC/HPLC data from catalytic experiments:  
 
HPLC trace of product 6a 
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HPLC trace of product 6b 
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HPLC trace of product 6c 
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HPLC trace of product 6d 
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HPLC trace of product 6e 
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1. We optimized and developed a chromatography-free and practical 
preparation method for enantiopure [Rh(POP)] complexes. The 
synthetic route starts with the ring-opening of a Sharpless epoxy-
ether, followed by O-phosphorylation, complexation of the in situ 
generated POP ligand with the corresponding Rh-precursor and 
crystallization, to provide the target [Rh(POP)] precatalyst in up to 
95% yield in gram amounts.  
2. We expanded the structural diversity of the library of enantiopure 
phosphine-phosphite (POP) ligands to new phosphite fragments 
derived from 3,3'-diphenyl-octahydro-[1,1'-binaphthalene]-2,2'-diol 
and TADDOL motifs (TADDOL = 2,2-dimethyl-1,3-dioxolane-4,5-
diyl)bis(diarylmethanol).  
3. We have identified in the literature three different strategies to 
activate N-heteroaromatic substrates towards asymmetric 
hydrogenation. The first strategy consists of facilitat ing hydrogenation 
by the formation of positively charged derivatives from the initial N-
heteroaromatic compound. The second strategy is based on 
introducing a ligating group on the substrate to assist its coordination 
to the metal center and facilitate hydrogenation by chelation 
assistance. The last strategy involves breaking the aromaticity of the 
heteroarene by inducing double bond isomerization processes.  
4. We have expanded the scope of [Ir(POP)]-mediated asymmetric 
hydrogenations to new C=N-containing heterocyclic systems. Studies 
on [Ir(POP)]-mediated asymmetric hydrogenations of a variety of 
seven-membered heterocycles containing C=N bonds have revealed 
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that our iridium complexes are excellent catalysts (up to full 
conversion; up to 97% ee). 
5. An unexpected inversion of the configuration of the hydrogenated 
products in [Ir(POP)]-mediated asymmetric hydrogenations having 
equally configured stereogenic elements in the ligand, but differing in 
the substituents at the 3,3’-positions of the [1,1'-biaryl]-2,2'-diol-
derived phosphite group, has been rationalized by means of DFT 
calculations. These studies have identified the position of the Cl -
ligand in catalytically relevant iridium structures and a number of 
non-covalent interactions (i.e. NH···Cl, CH··· and CH···HIr 
interactions) as key features in rationalizing the stereochemical 
outcome of the reactions. 
6. We have investigated the performance of a series of POP ligands 
with new phosphite moieties in Rh-mediated asymmetric 
hydrogenation of functionalized olefins. High activities (up to >99%) 
and medium to excellent enantioselectivities (up to 99%) have been 
achieved for selected model substrates. Newly prepared ligands with 
substituents at the 3,3’-positions of the [1,1'-biaryl]-2,2'-diol-derived 
phosphite group proved to be superior to the corresponding TADDOL-
based ligands. Particularly, the ligand incorporating the 3,3' -diphenyl-
(Sa)-octahydro-[1,1'-binaphthalene]-2,2'-diol-derived phosphite 
fragment provided the highest performing enantioselective catalyst in 
this chemistry. 
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Resum del pla de recerca: 
L’objectiu de la present tesi està focalitzat en la síntesi de lligands 
enantiopurs de tipus fosfina-fosfit (POP) incorporant nous fragments 
fosfit. També s’ha abordat l’estudi de les seves propietats de coordinació 
amb precursors de rodi i d’iridi. Els lligands sintetitzats han estat emprats 
de forma satisfactòria en hidrogenacions asimètriques catalitzades per rodi 
i iridi. 
 
Esquema 1. Síntesi dels lligads fosfina-fosfit (POP). 
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Els lligands de tipus POP preparats han estat sintetitzats a través de 
rutes sintètiques prèviament desenvolupades pel grup, que, en primer lloc, 
es basen en l’apertura asimètrica d’epoxi-èters enantiopurs (de tipus 
Sharpless) mitjançant nucleòfils fosforats, seguit de l’addició  de borà per 
obtenir els complexes de tipus fosfino-alcohol i, en segon lloc, 
l’eliminació del borà seguit d’una O-fosforilació amb els corresponents 
electròfils fosforats (clorofosfits) resultant en els lligands objectiu (veure 
Esquema 1). 
En aquest context, s’ha desenvolupat una metodologia pràctica i sense 
purificacions cromatogràfiques per a la preparació de complexes de rodi(I) 
enantiopurs incorporant lligands del tipus POP, que actuen en general 
com a directors estereoquímics en la transformació asimètrica. Aquests 
precatalitzadors de rodi poden ser utilitzats eficientment com a 
catalitzadors en la hidrogenació asimètrica d’alquens funcionalitzats, la 
resolució cinètica de vinil sulfòxids i la desimetrització catalítica de diens 
aquirals. Aquesta metodologia està basada en l’apertura asimètrica 
d’epoxi-èters purs (mitjançant nucleòfils fosforats) seguit de l’adició de 
borà per rendir els complexes fosfino-alcohol, que són purificats i aïllats 
eficientment mitjançant un procés de cristal·lització. Posteriorment es 
realitza l’eliminació del borà, la fosforilació amb els corresponents 
clorofosfits (electròfils fosforats) i finalment, la complexació dels 
corresponents lligands (obtinguts in situ) amb[Rh(nbd)2]BF4 obtenint els 
precatalitzadors objectiu, els quals són aïllats mitjançant processos de 
cristal·lització (Esquema 2). 
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Esquema 2. Síntesi de complexes de Rh basats en lligands POP sense separacions 
cromatogràfiques.  
La recerca realitzada al nostre grup també s’ha estès a l’estudi d’altres 
tipus de substrats de tipus heteroaromàtic, així com també al 
desenvolupament de possibles estratègies (a través de modificacions en la 
seva estructura) per a l’activació d’aquests tipus de compostos en 
hidrogenacions asimètriques. Els exemples prèviament descrits a la 
bibliografia s’han classificat en tres estratègies diferents, i els detalls 
experimentals més rellevants (catalitzador utilitzat, condicions de reacció, 
tipus d’heteroarè, diversitat estructural i l’activitat catalítica en termes de 
conversió i enantioselectivitat) han estat resumits. La primera estratègia 
consisteix en facilitar el procés d’hidrogenació per protonació o 
quaternització d’àtoms de nitrogen continguts a l’heteroarè. D’aquesta 
manera, la desactivació del catalitzador per part del substrat pot ser evitada 
i, addicionalment, la hidrogenació d’aquests compostos (carregats 
positivament) pot estar més afavorida respecte als seus anàlegs neutres. La 
segona estratègia, engloba els casos on l’activació es produeix mit jançant 
la introducció d’un grup lligant, que facilita (per assistència quelant) la 
coordinació amb el metall. Finalment, la tercera estratègia es basa en la 
ruptura de l’aromaticitat de l’heteroarè a través de processos 
d’isomerització de dobles enllaços.  Aquest microreview resumeix els 
últims avanços en aquest tòpic, que han permès desenvolupar reaccions 
d’hidrogenació d’heteroarens altament enantioselectives per a la producció 
de sistemes heterocíclics total (o parcialment) saturats.  
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Esquema 3. Estratègies per a l’activació del substrat.  
Per tal d’ampliar l’aplicació d’hidrogenacions asimètriques de 
compostos heterocíclics (contenint enllaços CN) catalitzades per 
complexes d’iridi de tipus [Ir(POP)], els complexes derivats dels lligands 
POP 3b i 3d van ser satisfactòriament aplicats a la reacció d’hidrogenació 
asimètrica d’heterocicles de set membres (onze exemples, fins a 97% 
d’ee). El millor precatalitzador desenvolupat (derivat del lligand 3d) junt 
amb quantitats catalítiques de HCl ha mostrat propietats catalítiques 
excel·lents en la hidrogenació d’heterocicles de set membres substituïts 
amb grups de tipus alquílic. Malgrat que la reacció d’hidrogenació de 
substrats substituïts amb grups de tipus arílic va tenir lloc amb més 
dificultat, es van poder trobar condicions de reacció altament efectives 
(sense la presència de HCl) per substrats del tipus oxa - o tia-azepina fenil 
substituïts. L’origen de l’enantioselectivitat ha estat racionalitzada amb 
l’ajut de càlculs DFT, que han permès identificar la posició del lligand 
clorur, així com una sèrie d’interaccions de tipus no covalent ( i.e. 
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HIr), com a paràmetres clau en la 
racionalització de l’estereoquímica obtinguda a través de la reacció 
catalitzada per els complexes d’iridi derivats dels lligands 3a i 3b. 
 
Esquema 4. Hidrogenació asimètrica d’imines cícliques catalitzada per 
complexes d’iridi . 
Estudis de coordinació dels lligands POP (derivats de fosfits de tipus 
TADDOL o de 3,3'-difenil-octahidro-[1,1'-binaftalè]-2,2'-diol) amb 
precursors de rodi resultaren en la formació de complexes catiònics, 
l’estructura dels quals va ser determinada inequívocament mitjançant 
estudis de RMN i de difracció de rajos-X. Els complexes de rodi(I) 
derivats de una sèrie de lligands enantiopurs de tipus POP han estat 
avaluats en la reacció d’hidrogenació asimètrica d’a lquens funcionalitzats. 
Els precatalitzadors resultants mostraren excel·lent comportament en 
termes d’activitat (99%) i d’enantioselectivitat (f ins a 99% d’ee) en tots els 
casos assajats. La influència dels diferents fragments fosfit en els valors 
d’enantioselectivitat obtinguts ha estat també estudiada. En aquesta 
reacció, els lligands amb un grup fosfit de tipus biarílic mostraren ser més 
eficients que els anàlegs derivats de TADDOL. Particularment, el lligand 
derivat del fragment 3,3'-difenil-(Sa)-octahidro-[1,1'-binaftalè]-2,2'-diol 
(3c) va proporcionar els millors resultat en termes d’eficiència catalítica  i 
enantioselectivitat dels productes hidrogenats . 
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Esquema 5. Hidrogenació asimètrica d’alquens funcionalitzats catalitzada per rodi.  
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Summary in English: 
The synthesis of enantiopure phosphine-phosphite (POP) ligands with 
new phosphite fragments and coordination studies with rhodium and 
iridium precursors for asymmetric hydrogenations have been performed. 
The resulting POP-rhodium and iridium complexes were efficiently 
employed in asymmetric hydrogenations of an array of structurally diverse 
substrates. The designed POP ligands were synthesized by a well-
established synthetic route developed in the group, which comprised the 
ring-opening of an enantiopure Sharpless epoxy ether with a phosphorus 
nucleophile and the O-phosphorylation of the resulting phosphino alcohol 
with the corresponding phosphorus electrophiles (chlorophosphite 
derivatives). The synthetic route towards the highest performing 
precatalysts in rhodium-mediated hydrogenative transformations has been 
optimized by developing a chromatography-free synthesis involving the 
crystallization of the target [Rh(POP)] precatalysts as the purification 
method. Studies on [Ir(POP)]-mediated asymmetric hydrogenations of a 
variety of seven-membered heterocycles that contain C=N bonds have 
revealed that these iridium complexes are excellent catalysts (up to full 
conversion; up to 97% ee). The enantioselectivity has been rationalized by 
means of DFT calculations, which have identified the position of the Cl -
ligand in catalytically relevant iridium structures and a number of non -
covalent interactions (i.e. NH···Cl, CH···π and CH···HIr 
interactions) as key features in the rationalization of the stereochemical 
outcome of the reactions. As regards the hydrogenation of functionalized 
alkenes, [Rh(POP)] precatalysts incorporating new phosphite fragments 
have been prepared. High catalytic activity (>99% conversion) and 
excellent enantioselectivity (up to >99%) were achieved in asymmetric 
hydrogenations of a variety of functionalized alkenes by POP ligands 
incorporating 3,3’-diphenyl-[1,1'-biaryl]-2,2'-diol-derived phosphite 
groups. 
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Resum en català: 
S’ha dut a terme la síntesi de lligands enantiopurs fosfina -fosfit (POP) 
amb nous fragments fosfit i els corresponents estudis de coordinació amb 
precursors de rodi i iridi per hidrogenacions asimètriques. El complexes de 
tipus POP-rodi i iridi es van utilitzar eficientment a hidrogenacions 
asimètriques d’una sèrie diversa de substrats. Els lligands POP dissenyats 
es van sintetitzar mitjançant una ruta sintètica ben establerta pel grup 
d’investigació, que consisteix en l’apertura d’un epoxi -èter enantiopur de 
Sharpless amb un nucleòfil de fòsfor i la O-fosforilació del fosfino-alcohol 
resultant amb els electròfils de fòsfor corresponents (derivats de tipus 
clorofosfit). La ruta sintètica pels precatalitzadors més efectius a les 
transformacions hidrogenatives mediades per rodi es va optimitzar, 
desenvolupant una síntesi sense separacions cromatogràfiques basada en la 
cristal·lització dels precatalitzadors [Rh(POP)] desitjats com a mètode de 
purificació. Estudis sobre les hidrogenacions asimètriques utilitzant 
complexes [Ir(POP)] d’un conjunt de sistemes heterocíclics de set 
membres contenint la funció C=N va revelar que aquests complexes d’iridi 
són excel·lents catalitzadors (conversions completes i excessos 
enantiomèrics de fins el 97%). La enantioselectivitat d’aquest procés s’ha 
racionalitzat mitjançant càlculs teòrics DFT, que han identificat la posició 
del lligand-Cl a estructures catalíticament rellevants dels complexes 
d’iridi, així com també una sèrie d’interaccions no -covalents (per exemple 
interaccions NH···Cl, CH··· i CH···HIr), que són els trets clau a 
l’hora de racionalitzar el resultat estereoquímic de les reaccions. Pel que fa 
a la hidrogenació d’alquens funcionalitzats, es van preparar 
precatalitzadors [Rh(POP)] que incorporen nous fragments fosfit. Es va 
assolir una alta activitat catalítica (conversió >99%) i enantioselectivitat 
excel·lent (fins a >97%) a les hidrogenacions asimètriques d’un conjunt 
d’alquens funcionalitzats amb lligands POP que incorporaven grups 
derivats del 3,3’-difenil-[1,1’-biaril]-2,2’-diol. 
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Resumen en castellano: 
Se ha estudiado la síntesis de ligandos enantiopuros fosfina -fosfito 
(POP) con nuevos fragmentos fosfito, así como sus propiedades de 
coordinación con precursores de rodio e iridio para hidrogenación 
asimétrica. Dichos complejos de rodio e iridio se han utilizado 
satisfactoriamente en hidrogenaciones enantioselectivas de un conjunto de 
sustratos con estructuras diversas. Los ligandos POP diseñados se 
sintetizaron mediante una ruta sintética establecida por el grupo de 
investigación, que consiste en la apertura de un epoxi-éter enantiopuro de 
tipo Sharpless con un nucleófilo de fósforo, y posterior O-fosforilación del 
fosfino-alcohol resultante con los correspondientes electrófilos de fósforo 
(derivados de tipo clorofosfito). La ruta sintética de los precatalizadores de 
rodio más eficientes para transformaciones hidrogenativas se optimizó a 
través de una síntesis sin separaciones cromatográficas  basada en la 
cristalización de los correspondientes precatalizadores como método de 
purificación. Estudios realizados en hidrogenación asimétrica sobre una 
variedad de heterociclos de siete miembros con enlaces C=N en su 
estructura revelaron que complejos de iridio derivados de ligandos POP 
son catalizadores excelentes, proporcionando conversiones completas y 
enantioselec-tividades elevadas (hasta 97% ee). La enantioselectividad de 
la reacción fue racionalizada mediante cálculos DFT, los cuales 
identificaron la posición del ligando cloro, así como una serie de 
interacciones no covalentes (por ejemplo NH···Cl, CH···π y 
CH···HIr) en intermedios de iridio catalíticamente relevantes, como 
factores clave en la racionalización de los resultados. En lo que respecta a 
la hidrogenación de alquenos funcionalizados, precatalizadores de rodio 
incorporando nuevos fragmentos fosfito fueron evaluados, de los cuales 
aquellos derivados del grupo 3,3’-difenil-[1,1'-biaril]-2,2'-diol 
proporcionaron resultados excelentes tanto en términos de actividad 
catalítica (conversión >99%) como de enantioselectividad (>99% ee).  
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